LitCovid-sample-Enju  

PMC:7199903 / 1834-16161 JSONTXT 26 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T282 0-6 JJ denotes Severe
T283 7-12 JJ denotes acute
T284 13-24 JJ denotes respiratory
T285 25-33 NN denotes syndrome
T286 34-45 NN denotes coronavirus
T287 46-47 CD denotes 2
T288 48-49 -LRB- denotes (
T289 49-59 NN denotes SARS-CoV-2
T290 59-60 -RRB- denotes )
T291 60-61 -COMMA- denotes ,
T292 62-65 DT denotes the
T293 66-75 JJ denotes causative
T294 76-84 NN denotes pathogen
T295 85-87 IN denotes of
T296 88-99 NN denotes coronavirus
T297 100-104 CD denotes 2019
T298 105-106 -LRB- denotes (
T299 106-114 NN denotes COVID-19
T300 114-115 -RRB- denotes )
T301 116-117 -LRB- denotes (
T302 117-118 CD denotes 1
T303 118-119 -COMMA- denotes ,
T304 120-121 CD denotes 2
T305 121-122 -RRB- denotes )
T306 122-123 -COMMA- denotes ,
T307 124-131 VBZ denotes induces
T308 132-137 NN denotes fever
T309 137-138 -COMMA- denotes ,
T310 139-145 JJ denotes severe
T311 146-157 JJ denotes respiratory
T312 158-165 NN denotes illness
T313 165-166 -COMMA- denotes ,
T314 167-170 CC denotes and
T315 171-180 NN denotes pneumonia
T316 182-192 NN denotes SARS-CoV-2
T317 193-197 VBZ denotes uses
T318 198-200 DT denotes an
T319 201-212 RB denotes extensively
T320 213-225 VBN denotes glycosylated
T321 226-231 NN denotes spike
T322 232-233 -LRB- denotes (
T323 233-234 NN denotes S
T324 234-235 -RRB- denotes )
T325 236-243 NN denotes protein
T326 244-248 WDT denotes that
T327 249-258 VBZ denotes protrudes
T328 259-263 IN denotes from
T329 264-267 DT denotes the
T330 268-273 JJ denotes viral
T331 274-281 NN denotes surface
T332 282-284 TO denotes to
T333 285-289 VB denotes bind
T334 290-292 TO denotes to
T335 293-315 JJ denotes angiotensin-converting
T336 316-322 NN denotes enzyme
T337 323-324 CD denotes 2
T338 325-326 -LRB- denotes (
T339 326-330 NN denotes ACE2
T340 330-331 -RRB- denotes )
T341 332-334 TO denotes to
T342 335-342 VB denotes mediate
T343 343-352 JJ denotes host-cell
T344 353-358 NN denotes entry
T345 359-360 -LRB- denotes (
T346 360-361 CD denotes 3
T347 361-362 -RRB- denotes )
T348 364-367 DT denotes The
T349 368-369 NN denotes S
T350 370-377 NN denotes protein
T351 378-380 VBZ denotes is
T352 381-382 DT denotes a
T353 383-391 JJ denotes trimeric
T354 392-397 NN denotes class
T355 398-399 CD denotes I
T356 400-406 NN denotes fusion
T357 407-414 NN denotes protein
T358 414-415 -COMMA- denotes ,
T359 416-424 VBN denotes composed
T360 425-427 IN denotes of
T361 428-431 CD denotes two
T362 432-442 JJ denotes functional
T363 443-451 NNS denotes subunits
T364 451-452 -COMMA- denotes ,
T365 453-464 JJ denotes responsible
T366 465-468 IN denotes for
T367 469-477 NN denotes receptor
T368 478-485 NN denotes binding
T369 486-487 -LRB- denotes (
T370 487-489 NN denotes S1
T371 490-497 NN denotes subunit
T372 497-498 -RRB- denotes )
T373 499-502 CC denotes and
T374 503-511 NN denotes membrane
T375 512-518 NN denotes fusion
T376 519-520 -LRB- denotes (
T377 520-522 NN denotes S2
T378 523-530 NN denotes subunit
T379 530-531 -RRB- denotes )
T380 532-533 -LRB- denotes (
T381 533-534 CD denotes 4
T382 534-535 -COMMA- denotes ,
T383 536-537 CD denotes 5
T384 537-538 -RRB- denotes )
T385 540-543 DT denotes The
T386 544-551 NN denotes surface
T387 552-554 IN denotes of
T388 555-558 DT denotes the
T389 559-567 NN denotes envelope
T390 568-573 NN denotes spike
T391 574-576 VBZ denotes is
T392 577-586 VBN denotes dominated
T393 587-589 IN denotes by
T394 590-602 JJ denotes host-derived
T395 603-610 NNS denotes glycans
T396 610-611 -COMMA- denotes ,
T397 612-616 IN denotes with
T398 617-621 DT denotes each
T399 622-628 NN denotes trimer
T400 629-639 VBG denotes displaying
T401 640-642 CD denotes 66
T402 643-651 JJ denotes N-linked
T403 652-665 NN denotes glycosylation
T404 666-671 NNS denotes sites
T405 673-676 DT denotes The
T406 677-678 NN denotes S
T407 679-686 NN denotes protein
T408 687-689 VBZ denotes is
T409 690-691 DT denotes a
T410 692-695 JJ denotes key
T411 696-702 NN denotes target
T412 703-705 IN denotes in
T413 706-713 NN denotes vaccine
T414 714-720 NN denotes design
T415 721-728 NNS denotes efforts
T416 729-730 -LRB- denotes (
T417 730-731 CD denotes 6
T418 731-732 -RRB- denotes )
T419 732-733 -COMMA- denotes ,
T420 734-737 CC denotes and
T421 738-751 VBG denotes understanding
T422 752-755 DT denotes the
T423 756-769 NN denotes glycosylation
T424 770-772 IN denotes of
T425 773-784 JJ denotes recombinant
T426 785-790 JJ denotes viral
T427 791-797 NNS denotes spikes
T428 798-801 MD denotes can
T429 802-808 VB denotes reveal
T430 809-820 JJ denotes fundamental
T431 821-829 NNS denotes features
T432 830-832 IN denotes of
T433 833-838 JJ denotes viral
T434 839-846 NN denotes biology
T435 847-850 CC denotes and
T436 851-856 NN denotes guide
T437 857-864 NN denotes vaccine
T438 865-871 NN denotes design
T439 872-882 NNS denotes strategies
T440 883-884 -LRB- denotes (
T441 884-885 CD denotes 7
T442 885-886 -COMMA- denotes ,
T443 887-888 CD denotes 8
T444 888-889 -RRB- denotes )
T445 891-896 JJ denotes Viral
T446 897-910 NN denotes glycosylation
T447 911-914 VBZ denotes has
T448 915-927 JJ denotes wide-ranging
T449 928-933 NNS denotes roles
T450 934-936 IN denotes in
T451 937-942 JJ denotes viral
T452 943-955 NN denotes pathobiology
T453 955-956 -COMMA- denotes ,
T454 957-966 VBG denotes including
T455 967-976 VBG denotes mediating
T456 977-984 NN denotes protein
T457 985-992 NN denotes folding
T458 993-996 CC denotes and
T459 997-1006 NN denotes stability
T460 1007-1010 CC denotes and
T461 1011-1018 VBG denotes shaping
T462 1019-1024 JJ denotes viral
T463 1025-1032 NN denotes tropism
T464 1033-1034 -LRB- denotes (
T465 1034-1035 CD denotes 9
T466 1035-1036 -RRB- denotes )
T467 1038-1051 NN denotes Glycosylation
T468 1052-1057 NNS denotes sites
T469 1058-1061 VBP denotes are
T470 1062-1067 IN denotes under
T471 1068-1077 JJ denotes selective
T472 1078-1086 NN denotes pressure
T473 1087-1089 IN denotes as
T474 1090-1094 PRP denotes they
T475 1095-1105 VBP denotes facilitate
T476 1106-1112 JJ denotes immune
T477 1113-1120 NN denotes evasion
T478 1121-1123 IN denotes by
T479 1124-1133 VBG denotes shielding
T480 1134-1142 JJ denotes specific
T481 1143-1151 NNS denotes epitopes
T482 1152-1156 IN denotes from
T483 1157-1165 NN denotes antibody
T484 1166-1180 NN denotes neutralization
T485 1182-1189 RB denotes However
T486 1189-1190 -COMMA- denotes ,
T487 1191-1193 PRP denotes we
T488 1194-1198 VBP denotes note
T489 1199-1202 DT denotes the
T490 1203-1206 JJ denotes low
T491 1207-1215 NN denotes mutation
T492 1216-1220 NN denotes rate
T493 1221-1223 IN denotes of
T494 1224-1234 NN denotes SARS-CoV-2
T495 1235-1238 CC denotes and
T496 1239-1243 IN denotes that
T497 1244-1246 RB denotes as
T498 1247-1250 RB denotes yet
T499 1250-1251 -COMMA- denotes ,
T500 1252-1257 EX denotes there
T501 1258-1262 VBP denotes have
T502 1263-1267 VBN denotes been
T503 1268-1270 DT denotes no
T504 1271-1279 VBN denotes observed
T505 1280-1289 NNS denotes mutations
T506 1290-1292 TO denotes to
T507 1293-1301 JJ denotes N-linked
T508 1302-1315 NN denotes glycosylation
T509 1316-1321 NNS denotes sites
T510 1322-1323 -LRB- denotes (
T511 1323-1325 CD denotes 10
T512 1325-1326 -RRB- denotes )
T513 1328-1336 NNS denotes Surfaces
T514 1337-1341 IN denotes with
T515 1342-1344 DT denotes an
T516 1345-1354 RB denotes unusually
T517 1355-1359 JJ denotes high
T518 1360-1367 NN denotes density
T519 1368-1370 IN denotes of
T520 1371-1378 NNS denotes glycans
T521 1379-1382 MD denotes can
T522 1383-1387 RB denotes also
T523 1388-1394 VB denotes enable
T524 1395-1401 JJ denotes immune
T525 1402-1413 NN denotes recognition
T526 1414-1415 -LRB- denotes (
T527 1415-1416 CD denotes 9
T528 1416-1417 -COMMA- denotes ,
T529 1418-1420 CD denotes 11
T530 1420-1421 -COMMA- denotes ,
T531 1422-1424 CD denotes 12
T532 1424-1425 -RRB- denotes )
T533 1427-1430 DT denotes The
T534 1431-1435 NN denotes role
T535 1436-1438 IN denotes of
T536 1439-1452 NN denotes glycosylation
T537 1453-1455 IN denotes in
T538 1456-1468 VBG denotes camouflaging
T539 1469-1480 JJ denotes immunogenic
T540 1481-1488 NN denotes protein
T541 1489-1497 NNS denotes epitopes
T542 1498-1501 VBZ denotes has
T543 1502-1506 VBN denotes been
T544 1507-1514 VBN denotes studied
T545 1515-1518 IN denotes for
T546 1519-1524 JJ denotes other
T547 1525-1538 NNS denotes coronaviruses
T548 1539-1540 -LRB- denotes (
T549 1540-1542 CD denotes 10
T550 1542-1543 -COMMA- denotes ,
T551 1544-1546 CD denotes 13
T552 1546-1547 -COMMA- denotes ,
T553 1548-1550 CD denotes 14
T554 1550-1551 -RRB- denotes )
T555 1553-1566 NNS denotes Coronaviruses
T556 1567-1571 VBP denotes form
T557 1572-1579 NNS denotes virions
T558 1580-1582 IN denotes by
T559 1583-1590 VBG denotes budding
T560 1591-1595 IN denotes into
T561 1596-1599 DT denotes the
T562 1600-1605 NN denotes lumen
T563 1606-1608 IN denotes of
T564 1609-1620 JJ denotes endoplasmic
T565 1621-1636 NN denotes reticulum–Golgi
T566 1637-1649 JJ denotes intermediate
T567 1650-1662 NNS denotes compartments
T568 1663-1664 -LRB- denotes (
T569 1664-1666 CD denotes 15
T570 1666-1667 -COMMA- denotes ,
T571 1668-1670 CD denotes 16
T572 1670-1671 -RRB- denotes )
T573 1673-1680 RB denotes However
T574 1680-1681 -COMMA- denotes ,
T575 1682-1694 NNS denotes observations
T576 1695-1697 IN denotes of
T577 1698-1710 JJ denotes complex-type
T578 1711-1718 NNS denotes glycans
T579 1719-1721 IN denotes on
T580 1722-1729 RB denotes virally
T581 1730-1737 VBN denotes derived
T582 1738-1746 NN denotes material
T583 1747-1755 VBZ denotes suggests
T584 1756-1760 IN denotes that
T585 1761-1764 DT denotes the
T586 1765-1770 JJ denotes viral
T587 1771-1784 NNS denotes glycoproteins
T588 1785-1788 VBP denotes are
T589 1789-1798 VBN denotes subjected
T590 1799-1801 TO denotes to
T591 1802-1816 JJ denotes Golgi-resident
T592 1817-1827 NN denotes processing
T593 1828-1835 NNS denotes enzymes
T594 1836-1837 -LRB- denotes (
T595 1837-1839 CD denotes 13
T596 1839-1840 -COMMA- denotes ,
T597 1841-1843 CD denotes 17
T598 1843-1844 -RRB- denotes )
T599 1846-1850 JJ denotes High
T600 1851-1856 JJ denotes viral
T601 1857-1863 NN denotes glycan
T602 1864-1871 NN denotes density
T603 1872-1875 CC denotes and
T604 1876-1881 JJ denotes local
T605 1882-1889 NN denotes protein
T606 1890-1902 NN denotes architecture
T607 1903-1906 MD denotes can
T608 1907-1917 RB denotes sterically
T609 1918-1924 VB denotes impair
T610 1925-1928 DT denotes the
T611 1929-1935 NN denotes glycan
T612 1936-1946 NN denotes maturation
T613 1947-1954 NN denotes pathway
T614 1956-1964 JJ denotes Impaired
T615 1965-1971 NN denotes glycan
T616 1972-1982 NN denotes maturation
T617 1983-1992 VBG denotes resulting
T618 1993-1995 IN denotes in
T619 1996-1999 DT denotes the
T620 2000-2008 NN denotes presence
T621 2009-2011 IN denotes of
T622 2012-2029 JJ denotes oligomannose-type
T623 2030-2037 NNS denotes glycans
T624 2038-2041 MD denotes can
T625 2042-2044 VB denotes be
T626 2045-2046 DT denotes a
T627 2047-2056 JJ denotes sensitive
T628 2057-2065 NN denotes reporter
T629 2066-2068 IN denotes of
T630 2069-2080 JJ denotes native-like
T631 2081-2088 NN denotes protein
T632 2089-2101 NN denotes architecture
T633 2102-2103 -LRB- denotes (
T634 2103-2104 CD denotes 8
T635 2104-2105 -RRB- denotes )
T636 2105-2106 -COMMA- denotes ,
T637 2107-2110 CC denotes and
T638 2111-2124 JJ denotes site-specific
T639 2125-2131 NN denotes glycan
T640 2132-2140 NN denotes analysis
T641 2141-2144 MD denotes can
T642 2145-2147 VB denotes be
T643 2148-2152 VBN denotes used
T644 2153-2155 TO denotes to
T645 2156-2163 VB denotes compare
T646 2164-2173 JJ denotes different
T647 2174-2184 NNS denotes immunogens
T648 2185-2188 CC denotes and
T649 2189-2196 NN denotes monitor
T650 2197-2210 NN denotes manufacturing
T651 2211-2220 NNS denotes processes
T652 2221-2222 -LRB- denotes (
T653 2222-2224 CD denotes 18
T654 2224-2225 -RRB- denotes )
T655 2227-2239 RB denotes Additionally
T656 2239-2240 -COMMA- denotes ,
T657 2241-2254 NN denotes glycosylation
T658 2255-2258 MD denotes can
T659 2259-2268 VB denotes influence
T660 2269-2272 DT denotes the
T661 2273-2284 NN denotes trafficking
T662 2285-2287 IN denotes of
T663 2288-2299 JJ denotes recombinant
T664 2300-2309 NN denotes immunogen
T665 2310-2312 TO denotes to
T666 2313-2321 JJ denotes germinal
T667 2322-2329 NNS denotes centers
T668 2330-2331 -LRB- denotes (
T669 2331-2333 CD denotes 19
T670 2333-2334 -RRB- denotes )
T671 2336-2338 TO denotes To
T672 2339-2346 VB denotes resolve
T673 2347-2350 DT denotes the
T674 2351-2364 JJ denotes site-specific
T675 2365-2378 NN denotes glycosylation
T676 2379-2381 IN denotes of
T677 2382-2385 DT denotes the
T678 2386-2396 NN denotes SARS-CoV-2
T679 2397-2398 NN denotes S
T680 2399-2406 NN denotes protein
T681 2407-2410 CC denotes and
T682 2411-2420 VB denotes visualize
T683 2421-2424 DT denotes the
T684 2425-2437 NN denotes distribution
T685 2438-2440 IN denotes of
T686 2441-2451 NNS denotes glycoforms
T687 2452-2458 IN denotes across
T688 2459-2462 DT denotes the
T689 2463-2470 NN denotes protein
T690 2471-2478 NN denotes surface
T691 2478-2479 -COMMA- denotes ,
T692 2480-2482 PRP denotes we
T693 2483-2492 VBD denotes expressed
T694 2493-2496 CC denotes and
T695 2497-2505 VBN denotes purified
T696 2506-2511 CD denotes three
T697 2512-2522 JJ denotes biological
T698 2523-2533 NNS denotes replicates
T699 2534-2536 IN denotes of
T700 2537-2548 JJ denotes recombinant
T701 2549-2556 JJ denotes soluble
T702 2557-2565 NN denotes material
T703 2566-2568 IN denotes in
T704 2569-2571 DT denotes an
T705 2572-2581 JJ denotes identical
T706 2582-2588 NN denotes manner
T707 2589-2591 TO denotes to
T708 2592-2596 DT denotes that
T709 2597-2602 WDT denotes which
T710 2603-2606 VBD denotes was
T711 2607-2611 VBN denotes used
T712 2612-2614 TO denotes to
T713 2615-2621 VB denotes obtain
T714 2622-2625 DT denotes the
T715 2626-2641 JJ denotes high-resolution
T716 2642-2655 NN denotes cryo–electron
T717 2656-2666 NN denotes microscopy
T718 2667-2668 -LRB- denotes (
T719 2668-2675 NN denotes cryo-EM
T720 2675-2676 -RRB- denotes )
T721 2677-2686 NN denotes structure
T722 2686-2687 -COMMA- denotes ,
T723 2688-2694 IN denotes albeit
T724 2695-2702 IN denotes without
T725 2703-2704 DT denotes a
T726 2705-2722 NN denotes glycan-processing
T727 2723-2731 NN denotes blockade
T728 2732-2737 VBG denotes using
T729 2738-2749 NN denotes kifunensine
T730 2750-2751 -LRB- denotes (
T731 2751-2752 CD denotes 4
T732 2752-2753 -RRB- denotes )
T733 2755-2759 DT denotes This
T734 2760-2767 NN denotes variant
T735 2768-2770 IN denotes of
T736 2771-2774 DT denotes the
T737 2775-2776 NN denotes S
T738 2777-2784 NN denotes protein
T739 2785-2793 VBZ denotes contains
T740 2794-2797 DT denotes all
T741 2798-2800 CD denotes 22
T742 2801-2808 NNS denotes glycans
T743 2809-2811 IN denotes on
T744 2812-2815 DT denotes the
T745 2816-2826 NN denotes SARS-CoV-2
T746 2827-2828 NN denotes S
T747 2829-2836 NN denotes protein
T748 2837-2838 -LRB- denotes (
T749 2838-2842 NN denotes Fig.
T750 2843-2845 NN denotes 1A
T751 2845-2846 -RRB- denotes )
T752 2848-2861 NN denotes Stabilization
T753 2862-2864 IN denotes of
T754 2865-2868 DT denotes the
T755 2869-2877 JJ denotes trimeric
T756 2878-2887 NN denotes prefusion
T757 2888-2897 NN denotes structure
T758 2898-2901 VBD denotes was
T759 2902-2910 VBN denotes achieved
T760 2911-2913 IN denotes by
T761 2914-2919 VBG denotes using
T762 2920-2923 DT denotes the
T763 2924-2926 NN denotes 2P
T764 2927-2938 VBG denotes stabilizing
T765 2939-2948 NNS denotes mutations
T766 2949-2950 -LRB- denotes (
T767 2950-2952 CD denotes 20
T768 2952-2953 -RRB- denotes )
T769 2954-2956 IN denotes at
T770 2957-2965 NNS denotes residues
T771 2966-2969 CD denotes 986
T772 2970-2973 CC denotes and
T773 2974-2977 CD denotes 987
T774 2977-2978 -COMMA- denotes ,
T775 2979-2980 DT denotes a
T776 2981-2985 NN denotes GSAS
T777 2986-2987 -LRB- denotes (
T778 2987-3002 NN denotes Gly-Ser-Ala-Ser
T779 3002-3003 -RRB- denotes )
T780 3004-3016 NN denotes substitution
T781 3017-3019 IN denotes at
T782 3020-3023 DT denotes the
T783 3024-3029 NN denotes furin
T784 3030-3038 NN denotes cleavage
T785 3039-3043 NN denotes site
T786 3044-3045 -LRB- denotes (
T787 3045-3053 NNS denotes residues
T788 3054-3057 CD denotes 682
T789 3058-3060 TO denotes to
T790 3061-3064 CD denotes 685
T791 3064-3065 -RRB- denotes )
T792 3065-3066 -COMMA- denotes ,
T793 3067-3070 CC denotes and
T794 3071-3072 DT denotes a
T795 3073-3083 JJ denotes C-terminal
T796 3084-3097 NN denotes trimerization
T797 3098-3103 NN denotes motif
T798 3105-3109 DT denotes This
T799 3110-3115 VBZ denotes helps
T800 3116-3118 TO denotes to
T801 3119-3127 VB denotes maintain
T802 3128-3138 JJ denotes quaternary
T803 3139-3151 NN denotes architecture
T804 3152-3158 IN denotes during
T805 3159-3165 NN denotes glycan
T806 3166-3176 NN denotes processing
T807 3178-3184 IN denotes Before
T808 3185-3193 NN denotes analysis
T809 3193-3194 -COMMA- denotes ,
T810 3195-3206 NN denotes supernatant
T811 3207-3217 VBG denotes containing
T812 3218-3221 DT denotes the
T813 3222-3233 JJ denotes recombinant
T814 3234-3244 NN denotes SARS-CoV-2
T815 3245-3246 NN denotes S
T816 3247-3250 VBD denotes was
T817 3251-3259 VBN denotes purified
T818 3260-3262 IN denotes by
T819 3263-3267 NN denotes size
T820 3268-3277 NN denotes exclusion
T821 3278-3292 NN denotes chromatography
T822 3293-3295 TO denotes to
T823 3296-3302 VB denotes ensure
T824 3303-3307 IN denotes that
T825 3308-3312 RB denotes only
T826 3313-3324 JJ denotes native-like
T827 3325-3333 JJ denotes trimeric
T828 3334-3341 NN denotes protein
T829 3342-3345 VBD denotes was
T830 3346-3354 VBN denotes analyzed
T831 3355-3356 -LRB- denotes (
T832 3356-3360 NNP denotes Fig.
T833 3361-3363 NN denotes 1B
T834 3364-3367 CC denotes and
T835 3368-3371 NN denotes fig
T836 3373-3375 NN denotes S1
T837 3375-3376 -RRB- denotes )
T838 3378-3381 DT denotes The
T839 3382-3390 JJ denotes trimeric
T840 3391-3403 NN denotes conformation
T841 3404-3406 IN denotes of
T842 3407-3410 DT denotes the
T843 3411-3419 VBN denotes purified
T844 3420-3428 NN denotes material
T845 3429-3432 VBD denotes was
T846 3433-3442 VBN denotes validated
T847 3443-3445 IN denotes by
T848 3446-3451 VBG denotes using
T849 3452-3466 JJ denotes negative-stain
T850 3467-3469 NN denotes EM
T851 3470-3471 -LRB- denotes (
T852 3471-3475 NN denotes Fig.
T853 3476-3478 NN denotes 1C
T854 3478-3479 -RRB- denotes )
T855 3481-3485 NNP denotes Fig.
T856 3486-3487 CD denotes 1
T857 3489-3499 NN denotes Expression
T858 3500-3503 CC denotes and
T859 3504-3514 NN denotes validation
T860 3515-3517 IN denotes of
T861 3518-3521 DT denotes the
T862 3522-3532 NN denotes SARS-CoV-2
T863 3533-3534 NN denotes S
T864 3535-3547 NN denotes glycoprotein
T865 3549-3550 -LRB- denotes (
T866 3550-3551 NN denotes A
T867 3551-3552 -RRB- denotes )
T868 3553-3562 JJ denotes Schematic
T869 3563-3577 NN denotes representation
T870 3578-3580 IN denotes of
T871 3581-3584 DT denotes the
T872 3585-3595 NN denotes SARS-CoV-2
T873 3596-3597 NN denotes S
T874 3598-3610 NN denotes glycoprotein
T875 3612-3615 DT denotes The
T876 3616-3625 NNS denotes positions
T877 3626-3628 IN denotes of
T878 3629-3637 JJ denotes N-linked
T879 3638-3651 NN denotes glycosylation
T880 3652-3659 NNS denotes sequons
T881 3660-3661 -LRB- denotes (
T882 3661-3668 NN denotes N-X-S/T
T883 3668-3669 -COMMA- denotes ,
T884 3670-3675 WRB denotes where
T885 3676-3677 NN denotes X
T886 3678-3679 SYM denotes ≠
T887 3680-3681 NN denotes P
T888 3681-3682 -RRB- denotes )
T889 3683-3686 VBP denotes are
T890 3687-3692 VBN denotes shown
T891 3693-3695 IN denotes as
T892 3696-3704 NNS denotes branches
T893 3705-3706 -LRB- denotes (
T894 3706-3707 NN denotes N
T895 3707-3708 -COMMA- denotes ,
T896 3709-3712 NNP denotes Asn
T897 3712-3713 -SEMICOLON- denotes ;
T898 3714-3715 SYM denotes X
T899 3715-3716 -COMMA- denotes ,
T900 3717-3720 DT denotes any
T901 3721-3728 NN denotes residue
T902 3728-3729 -SEMICOLON- denotes ;
T903 3730-3731 NN denotes S
T904 3731-3732 -COMMA- denotes ,
T905 3733-3736 NN denotes Ser
T906 3736-3737 -SEMICOLON- denotes ;
T907 3738-3739 NN denotes T
T908 3739-3740 -COMMA- denotes ,
T909 3741-3744 NNP denotes Thr
T910 3744-3745 -SEMICOLON- denotes ;
T911 3746-3747 NN denotes P
T912 3747-3748 -COMMA- denotes ,
T913 3749-3752 NNP denotes Pro
T914 3752-3753 -RRB- denotes )
T915 3755-3762 NN denotes Protein
T916 3763-3770 NNS denotes domains
T917 3771-3774 VBP denotes are
T918 3775-3786 VBN denotes illustrated
T919 3786-3787 -COLON- denotes :
T920 3788-3798 JJ denotes N-terminal
T921 3799-3805 NN denotes domain
T922 3806-3807 -LRB- denotes (
T923 3807-3810 NN denotes NTD
T924 3810-3811 -RRB- denotes )
T925 3811-3812 -COMMA- denotes ,
T926 3813-3821 NN denotes receptor
T927 3822-3829 NN denotes binding
T928 3830-3836 NN denotes domain
T929 3837-3838 -LRB- denotes (
T930 3838-3841 NN denotes RBD
T931 3841-3842 -RRB- denotes )
T932 3842-3843 -COMMA- denotes ,
T933 3844-3850 NN denotes fusion
T934 3851-3858 NN denotes peptide
T935 3859-3860 -LRB- denotes (
T936 3860-3862 NN denotes FP
T937 3862-3863 -RRB- denotes )
T938 3863-3864 -COMMA- denotes ,
T939 3865-3871 NN denotes heptad
T940 3872-3878 NN denotes repeat
T941 3879-3880 CD denotes 1
T942 3881-3882 -LRB- denotes (
T943 3882-3885 NN denotes HR1
T944 3885-3886 -RRB- denotes )
T945 3886-3887 -COMMA- denotes ,
T946 3888-3895 JJ denotes central
T947 3896-3901 NN denotes helix
T948 3902-3903 -LRB- denotes (
T949 3903-3905 NN denotes CH
T950 3905-3906 -RRB- denotes )
T951 3906-3907 -COMMA- denotes ,
T952 3908-3917 NN denotes connector
T953 3918-3924 NN denotes domain
T954 3925-3926 -LRB- denotes (
T955 3926-3928 NN denotes CD
T956 3928-3929 -RRB- denotes )
T957 3929-3930 -COMMA- denotes ,
T958 3931-3934 CC denotes and
T959 3935-3948 JJ denotes transmembrane
T960 3949-3955 NN denotes domain
T961 3956-3957 -LRB- denotes (
T962 3957-3959 NN denotes TM
T963 3959-3960 -RRB- denotes )
T964 3962-3963 -LRB- denotes (
T965 3963-3964 NN denotes B
T966 3964-3965 -RRB- denotes )
T967 3966-3984 NN denotes SDS–polyacrylamide
T968 3985-3988 NN denotes gel
T969 3989-4004 NN denotes electrophoresis
T970 4005-4013 NN denotes analysis
T971 4014-4016 IN denotes of
T972 4017-4020 DT denotes the
T973 4021-4031 NN denotes SARS-CoV-2
T974 4032-4033 NN denotes S
T975 4034-4041 NN denotes protein
T976 4042-4043 -LRB- denotes (
T977 4043-4052 VBN denotes indicated
T978 4053-4055 IN denotes by
T979 4056-4059 DT denotes the
T980 4060-4069 NN denotes arrowhead
T981 4069-4070 -RRB- denotes )
T982 4071-4080 VBN denotes expressed
T983 4081-4083 IN denotes in
T984 4084-4089 JJ denotes human
T985 4090-4099 JJ denotes embryonic
T986 4100-4106 NN denotes kidney
T987 4107-4108 -LRB- denotes (
T988 4108-4111 NN denotes HEK
T989 4111-4112 -RRB- denotes )
T990 4113-4117 NN denotes 293F
T991 4118-4123 NNS denotes cells
T992 4125-4129 NN denotes Lane
T993 4130-4131 CD denotes 1
T994 4131-4132 -COLON- denotes :
T995 4133-4141 VBN denotes filtered
T996 4142-4153 NN denotes supernatant
T997 4154-4158 IN denotes from
T998 4159-4170 VBN denotes transfected
T999 4171-4176 NNS denotes cells
T1000 4176-4177 -SEMICOLON- denotes ;
T1001 4178-4182 NN denotes lane
T1002 4183-4184 CD denotes 2
T1003 4184-4185 -COLON- denotes :
T1004 4186-4198 NN denotes flow-through
T1005 4199-4203 IN denotes from
T1006 4204-4215 NN denotes StrepTactin
T1007 4216-4221 NN denotes resin
T1008 4221-4222 -SEMICOLON- denotes ;
T1009 4223-4227 NN denotes lane
T1010 4228-4229 CD denotes 3
T1011 4229-4230 -COLON- denotes :
T1012 4231-4235 NN denotes wash
T1013 4236-4240 IN denotes from
T1014 4241-4252 NN denotes StrepTactin
T1015 4253-4258 NN denotes resin
T1016 4258-4259 -SEMICOLON- denotes ;
T1017 4260-4264 NN denotes lane
T1018 4265-4266 CD denotes 4
T1019 4266-4267 -COLON- denotes :
T1020 4268-4275 NN denotes elution
T1021 4276-4280 IN denotes from
T1022 4281-4292 NN denotes StrepTactin
T1023 4293-4299 NN denotes resin.
T1024 4300-4301 -LRB- denotes (
T1025 4301-4302 NN denotes C
T1026 4302-4303 -RRB- denotes )
T1027 4304-4318 JJ denotes Negative-stain
T1028 4319-4321 NN denotes EM
T1029 4322-4324 NN denotes 2D
T1030 4325-4330 NN denotes class
T1031 4331-4339 NNS denotes averages
T1032 4340-4342 IN denotes of
T1033 4343-4346 DT denotes the
T1034 4347-4357 NN denotes SARS-CoV-2
T1035 4358-4359 NN denotes S
T1036 4360-4367 NN denotes protein
T1037 4369-4371 NN denotes 2D
T1038 4372-4377 NN denotes class
T1039 4378-4386 NNS denotes averages
T1040 4387-4389 IN denotes of
T1041 4390-4393 DT denotes the
T1042 4394-4404 NN denotes SARS-CoV-2
T1043 4405-4406 NN denotes S
T1044 4407-4414 NN denotes protein
T1045 4415-4418 VBP denotes are
T1046 4419-4424 VBN denotes shown
T1047 4424-4425 -COMMA- denotes ,
T1048 4426-4436 VBG denotes confirming
T1049 4437-4441 IN denotes that
T1050 4442-4445 DT denotes the
T1051 4446-4453 NN denotes protein
T1052 4454-4460 VBZ denotes adopts
T1053 4461-4464 DT denotes the
T1054 4465-4473 JJ denotes trimeric
T1055 4474-4483 NN denotes prefusion
T1056 4484-4496 NN denotes conformation
T1057 4497-4505 VBG denotes matching
T1058 4506-4509 DT denotes the
T1059 4510-4518 NN denotes material
T1060 4519-4523 VBN denotes used
T1061 4524-4526 TO denotes to
T1062 4527-4536 VB denotes determine
T1063 4537-4540 DT denotes the
T1064 4541-4550 NN denotes structure
T1065 4551-4552 -LRB- denotes (
T1066 4552-4553 CD denotes 4
T1067 4553-4554 -RRB- denotes )
T1068 4556-4558 TO denotes To
T1069 4559-4568 VB denotes determine
T1070 4569-4572 DT denotes the
T1071 4573-4586 JJ denotes site-specific
T1072 4587-4600 NN denotes glycosylation
T1073 4601-4603 IN denotes of
T1074 4604-4614 NN denotes SARS-CoV-2
T1075 4615-4616 NN denotes S
T1076 4616-4617 -COMMA- denotes ,
T1077 4618-4620 PRP denotes we
T1078 4621-4625 VBD denotes used
T1079 4626-4633 NN denotes trypsin
T1080 4633-4634 -COMMA- denotes ,
T1081 4635-4647 NN denotes chymotrypsin
T1082 4647-4648 -COMMA- denotes ,
T1083 4649-4652 CC denotes and
T1084 4653-4660 JJ denotes α-lytic
T1085 4661-4669 NN denotes protease
T1086 4670-4672 TO denotes to
T1087 4673-4681 VB denotes generate
T1088 4682-4687 CD denotes three
T1089 4688-4700 NN denotes glycopeptide
T1090 4701-4708 NNS denotes samples
T1091 4710-4715 DT denotes These
T1092 4716-4725 NNS denotes proteases
T1093 4726-4730 VBD denotes were
T1094 4731-4739 VBN denotes selected
T1095 4740-4742 TO denotes to
T1096 4743-4751 VB denotes generate
T1097 4752-4765 NNS denotes glycopeptides
T1098 4766-4770 WDT denotes that
T1099 4771-4778 VBP denotes contain
T1100 4779-4780 DT denotes a
T1101 4781-4787 JJ denotes single
T1102 4788-4796 JJ denotes N-linked
T1103 4797-4803 NN denotes glycan
T1104 4804-4810 NN denotes sequon
T1105 4812-4815 DT denotes The
T1106 4816-4829 NNS denotes glycopeptides
T1107 4830-4834 VBD denotes were
T1108 4835-4843 VBN denotes analyzed
T1109 4844-4846 IN denotes by
T1110 4847-4853 JJ denotes liquid
T1111 4854-4873 NN denotes chromatography–mass
T1112 4874-4886 NN denotes spectrometry
T1113 4886-4887 -COMMA- denotes ,
T1114 4888-4891 CC denotes and
T1115 4892-4895 DT denotes the
T1116 4896-4902 NN denotes glycan
T1117 4903-4915 NNS denotes compositions
T1118 4916-4920 VBD denotes were
T1119 4921-4931 VBN denotes determined
T1120 4932-4935 IN denotes for
T1121 4936-4939 DT denotes all
T1122 4940-4942 CD denotes 22
T1123 4943-4951 JJ denotes N-linked
T1124 4952-4958 NN denotes glycan
T1125 4959-4964 NNS denotes sites
T1126 4965-4966 -LRB- denotes (
T1127 4966-4970 NN denotes Fig.
T1128 4971-4972 CD denotes 2
T1129 4972-4973 -RRB- denotes )
T1130 4975-4977 TO denotes To
T1131 4978-4984 VB denotes convey
T1132 4985-4988 DT denotes the
T1133 4989-4993 JJ denotes main
T1134 4994-5004 NN denotes processing
T1135 5005-5013 NNS denotes features
T1136 5014-5016 IN denotes at
T1137 5017-5021 DT denotes each
T1138 5022-5026 NN denotes site
T1139 5026-5027 -COMMA- denotes ,
T1140 5028-5031 DT denotes the
T1141 5032-5042 NNS denotes abundances
T1142 5043-5045 IN denotes of
T1143 5046-5050 DT denotes each
T1144 5051-5057 NN denotes glycan
T1145 5058-5061 VBP denotes are
T1146 5062-5068 VBN denotes summed
T1147 5069-5073 IN denotes into
T1148 5074-5091 JJ denotes oligomannose-type
T1149 5091-5092 -COMMA- denotes ,
T1150 5093-5104 JJ denotes hybrid-type
T1151 5104-5105 -COMMA- denotes ,
T1152 5106-5109 CC denotes and
T1153 5110-5120 NNS denotes categories
T1154 5121-5123 IN denotes of
T1155 5124-5136 JJ denotes complex-type
T1156 5137-5150 NN denotes glycosylation
T1157 5151-5156 VBN denotes based
T1158 5157-5159 IN denotes on
T1159 5160-5169 NN denotes branching
T1160 5170-5173 CC denotes and
T1161 5174-5186 NN denotes fucosylation
T1162 5188-5191 DT denotes The
T1163 5192-5200 VBN denotes detailed
T1164 5200-5201 -COMMA- denotes ,
T1165 5202-5210 VBD denotes expanded
T1166 5211-5217 NNS denotes graphs
T1167 5218-5225 VBG denotes showing
T1168 5226-5229 DT denotes the
T1169 5230-5237 JJ denotes diverse
T1170 5238-5243 NN denotes range
T1171 5244-5246 IN denotes of
T1172 5247-5253 NN denotes glycan
T1173 5254-5266 NNS denotes compositions
T1174 5267-5270 VBP denotes are
T1175 5271-5280 VBN denotes presented
T1176 5281-5283 IN denotes in
T1177 5284-5289 NN denotes table
T1178 5290-5292 NN denotes S1
T1179 5293-5296 CC denotes and
T1180 5297-5300 NN denotes fig
T1181 5302-5304 NN denotes S2
T1182 5306-5310 NN denotes Fig.
T1183 5311-5312 CD denotes 2
T1184 5314-5327 JJ denotes Site-specific
T1185 5328-5336 JJ denotes N-linked
T1186 5337-5350 NN denotes glycosylation
T1187 5351-5353 IN denotes of
T1188 5354-5357 DT denotes the
T1189 5358-5368 NN denotes SARS-CoV-2
T1190 5369-5370 NN denotes S
T1191 5371-5383 NN denotes glycoprotein
T1192 5385-5388 DT denotes The
T1193 5389-5398 JJ denotes schematic
T1194 5399-5410 VBZ denotes illustrates
T1195 5411-5414 DT denotes the
T1196 5415-5420 NN denotes color
T1197 5421-5425 NN denotes code
T1198 5426-5429 IN denotes for
T1199 5430-5433 DT denotes the
T1200 5434-5443 JJ denotes principal
T1201 5444-5450 NN denotes glycan
T1202 5451-5456 NNS denotes types
T1203 5457-5461 WDT denotes that
T1204 5462-5465 MD denotes can
T1205 5466-5471 VB denotes arise
T1206 5472-5477 IN denotes along
T1207 5478-5481 DT denotes the
T1208 5482-5492 NN denotes maturation
T1209 5493-5500 NN denotes pathway
T1210 5501-5505 IN denotes from
T1211 5506-5519 NN denotes oligomannose-
T1212 5520-5522 TO denotes to
T1213 5523-5530 NN denotes hybrid-
T1214 5531-5533 TO denotes to
T1215 5534-5546 JJ denotes complex-type
T1216 5547-5554 NNS denotes glycans
T1217 5556-5559 DT denotes The
T1218 5560-5566 NNS denotes graphs
T1219 5567-5576 VBP denotes summarize
T1220 5577-5589 JJ denotes quantitative
T1221 5590-5594 NN denotes mass
T1222 5595-5608 JJ denotes spectrometric
T1223 5609-5617 NN denotes analysis
T1224 5618-5620 IN denotes of
T1225 5621-5624 DT denotes the
T1226 5625-5631 NN denotes glycan
T1227 5632-5642 NN denotes population
T1228 5643-5650 JJ denotes present
T1229 5651-5653 IN denotes at
T1230 5654-5664 JJ denotes individual
T1231 5665-5673 JJ denotes N-linked
T1232 5674-5687 NN denotes glycosylation
T1233 5688-5693 NNS denotes sites
T1234 5694-5704 VBN denotes simplified
T1235 5705-5709 IN denotes into
T1236 5710-5720 NNS denotes categories
T1237 5721-5723 IN denotes of
T1238 5724-5731 NNS denotes glycans
T1239 5733-5736 DT denotes The
T1240 5737-5754 JJ denotes oligomannose-type
T1241 5755-5761 NN denotes glycan
T1242 5762-5768 NN denotes series
T1243 5769-5770 -LRB- denotes (
T1244 5770-5772 NN denotes M9
T1245 5773-5775 TO denotes to
T1246 5776-5778 NN denotes M5
T1247 5778-5779 -SEMICOLON- denotes ;
T1248 5780-5791 NN denotes Man9GlcNAc2
T1249 5792-5794 TO denotes to
T1250 5795-5806 NN denotes Man5GlcNAc2
T1251 5806-5807 -RRB- denotes )
T1252 5808-5810 VBZ denotes is
T1253 5811-5818 VBN denotes colored
T1254 5819-5824 JJ denotes green
T1255 5824-5825 -COMMA- denotes ,
T1256 5826-5838 VBN denotes afucosylated
T1257 5839-5842 CC denotes and
T1258 5843-5854 VBN denotes fucosylated
T1259 5855-5866 JJ denotes hybrid-type
T1260 5867-5874 NNS denotes glycans
T1261 5875-5876 -LRB- denotes (
T1262 5876-5882 NN denotes hybrid
T1263 5883-5886 CC denotes and
T1264 5887-5888 NN denotes F
T1265 5889-5895 NN denotes hybrid
T1266 5895-5896 -RRB- denotes )
T1267 5897-5900 VBP denotes are
T1268 5901-5907 VBN denotes dashed
T1269 5908-5912 NN denotes pink
T1270 5912-5913 -COMMA- denotes ,
T1271 5914-5917 CC denotes and
T1272 5918-5925 JJ denotes complex
T1273 5926-5933 NNS denotes glycans
T1274 5934-5937 VBP denotes are
T1275 5938-5945 VBN denotes grouped
T1276 5946-5955 VBG denotes according
T1277 5956-5958 TO denotes to
T1278 5959-5962 DT denotes the
T1279 5963-5969 NN denotes number
T1280 5970-5972 IN denotes of
T1281 5973-5981 NNS denotes antennae
T1282 5982-5985 CC denotes and
T1283 5986-5994 NN denotes presence
T1284 5995-5997 IN denotes of
T1285 5998-6002 NN denotes core
T1286 6003-6015 NN denotes fucosylation
T1287 6016-6017 -LRB- denotes (
T1288 6017-6019 NN denotes A1
T1289 6020-6022 TO denotes to
T1290 6023-6026 NN denotes FA4
T1291 6026-6027 -RRB- denotes )
T1292 6028-6031 CC denotes and
T1293 6032-6035 VBP denotes are
T1294 6036-6043 VBN denotes colored
T1295 6044-6048 NN denotes pink
T1296 6050-6061 NN denotes Unoccupancy
T1297 6062-6064 IN denotes of
T1298 6065-6067 DT denotes an
T1299 6068-6076 JJ denotes N-linked
T1300 6077-6083 NN denotes glycan
T1301 6084-6088 NN denotes site
T1302 6089-6091 VBZ denotes is
T1303 6092-6103 VBN denotes represented
T1304 6104-6106 IN denotes in
T1305 6107-6111 NN denotes gray
T1306 6113-6116 DT denotes The
T1307 6117-6120 NN denotes pie
T1308 6121-6127 NNS denotes charts
T1309 6128-6137 VBP denotes summarize
T1310 6138-6141 DT denotes the
T1311 6142-6156 NN denotes quantification
T1312 6157-6159 IN denotes of
T1313 6160-6165 DT denotes these
T1314 6166-6173 NNS denotes glycans
T1315 6175-6181 NN denotes Glycan
T1316 6182-6187 NNS denotes sites
T1317 6188-6191 VBP denotes are
T1318 6192-6199 VBN denotes colored
T1319 6200-6209 VBG denotes according
T1320 6210-6212 TO denotes to
T1321 6213-6230 JJ denotes oligomannose-type
T1322 6231-6237 NN denotes glycan
T1323 6238-6245 NN denotes content
T1324 6245-6246 -COMMA- denotes ,
T1325 6247-6251 IN denotes with
T1326 6252-6255 DT denotes the
T1327 6256-6262 NN denotes glycan
T1328 6263-6268 NNS denotes sites
T1329 6269-6276 VBN denotes labeled
T1330 6277-6279 IN denotes in
T1331 6280-6285 JJ denotes green
T1332 6286-6287 -LRB- denotes (
T1333 6287-6289 CD denotes 80
T1334 6290-6292 TO denotes to
T1335 6293-6296 CD denotes 100
T1336 6296-6297 NN denotes %
T1337 6297-6298 -RRB- denotes )
T1338 6298-6299 -COMMA- denotes ,
T1339 6300-6306 NN denotes orange
T1340 6307-6308 -LRB- denotes (
T1341 6308-6310 CD denotes 30
T1342 6311-6313 TO denotes to
T1343 6314-6316 CD denotes 79
T1344 6316-6317 NN denotes %
T1345 6317-6318 -RRB- denotes )
T1346 6318-6319 -COMMA- denotes ,
T1347 6320-6323 CC denotes and
T1348 6324-6328 NN denotes pink
T1349 6329-6330 -LRB- denotes (
T1350 6330-6331 CD denotes 0
T1351 6332-6334 TO denotes to
T1352 6335-6337 CD denotes 29
T1353 6337-6338 NN denotes %
T1354 6338-6339 -RRB- denotes )
T1355 6341-6343 DT denotes An
T1356 6344-6352 VBN denotes extended
T1357 6353-6360 NN denotes version
T1358 6361-6363 IN denotes of
T1359 6364-6367 DT denotes the
T1360 6368-6381 JJ denotes site-specific
T1361 6382-6390 NN denotes analysis
T1362 6391-6398 VBG denotes showing
T1363 6399-6402 DT denotes the
T1364 6403-6416 NN denotes heterogeneity
T1365 6417-6423 IN denotes within
T1366 6424-6428 DT denotes each
T1367 6429-6437 NN denotes category
T1368 6438-6441 MD denotes can
T1369 6442-6444 VB denotes be
T1370 6445-6450 VBN denotes found
T1371 6451-6453 IN denotes in
T1372 6454-6459 NN denotes table
T1373 6460-6462 NN denotes S1
T1374 6463-6466 CC denotes and
T1375 6467-6470 NN denotes fig
T1376 6472-6474 NN denotes S2
T1377 6476-6479 DT denotes The
T1378 6480-6483 NN denotes bar
T1379 6484-6490 NNS denotes graphs
T1380 6491-6500 VBP denotes represent
T1381 6501-6504 DT denotes the
T1382 6505-6509 JJ denotes mean
T1383 6510-6520 NNS denotes quantities
T1384 6521-6523 IN denotes of
T1385 6524-6529 CD denotes three
T1386 6530-6540 JJ denotes biological
T1387 6541-6551 NNS denotes replicates
T1388 6551-6552 -COMMA- denotes ,
T1389 6553-6557 IN denotes with
T1390 6558-6563 NN denotes error
T1391 6564-6568 NNS denotes bars
T1392 6569-6581 VBG denotes representing
T1393 6582-6585 DT denotes the
T1394 6586-6594 JJ denotes standard
T1395 6595-6600 NN denotes error
T1396 6601-6603 IN denotes of
T1397 6604-6607 DT denotes the
T1398 6608-6612 NN denotes mean
T1399 6614-6617 CD denotes Two
T1400 6618-6623 NNS denotes sites
T1401 6624-6626 IN denotes on
T1402 6627-6637 NN denotes SARS-CoV-2
T1403 6638-6639 NN denotes S
T1404 6640-6643 VBP denotes are
T1405 6644-6655 RB denotes principally
T1406 6656-6673 JJ denotes oligomannose-type
T1407 6673-6674 -COLON- denotes :
T1408 6675-6679 NN denotes N234
T1409 6680-6683 CC denotes and
T1410 6684-6688 NN denotes N709
T1411 6690-6693 DT denotes The
T1412 6694-6705 JJ denotes predominant
T1413 6706-6723 JJ denotes oligomannose-type
T1414 6724-6730 NN denotes glycan
T1415 6731-6740 NN denotes structure
T1416 6741-6749 VBN denotes observed
T1417 6750-6756 IN denotes across
T1418 6757-6760 DT denotes the
T1419 6761-6768 NN denotes protein
T1420 6768-6769 -COMMA- denotes ,
T1421 6770-6774 IN denotes with
T1422 6775-6778 DT denotes the
T1423 6779-6788 NN denotes exception
T1424 6789-6791 IN denotes of
T1425 6792-6796 NN denotes N234
T1426 6796-6797 -COMMA- denotes ,
T1427 6798-6800 VBZ denotes is
T1428 6801-6812 NN denotes Man5GlcNAc2
T1429 6813-6814 -LRB- denotes (
T1430 6814-6817 NN denotes Man
T1431 6817-6818 -COMMA- denotes ,
T1432 6819-6826 NN denotes mannose
T1433 6826-6827 -SEMICOLON- denotes ;
T1434 6828-6834 NN denotes GlcNAc
T1435 6834-6835 -COMMA- denotes ,
T1436 6836-6855 NN denotes N-acetylglucosamine
T1437 6855-6856 -RRB- denotes )
T1438 6856-6857 -COMMA- denotes ,
T1439 6858-6863 WDT denotes which
T1440 6864-6876 VBZ denotes demonstrates
T1441 6877-6881 IN denotes that
T1442 6882-6887 DT denotes these
T1443 6888-6893 NNS denotes sites
T1444 6894-6897 VBP denotes are
T1445 6898-6905 RB denotes largely
T1446 6906-6916 JJ denotes accessible
T1447 6917-6919 TO denotes to
T1448 6920-6938 NNS denotes α-1,2-mannosidases
T1449 6939-6942 CC denotes but
T1450 6943-6946 VBP denotes are
T1451 6947-6951 JJ denotes poor
T1452 6952-6962 NNS denotes substrates
T1453 6963-6966 IN denotes for
T1454 6967-6976 NN denotes GlcNAcT-I
T1455 6976-6977 -COMMA- denotes ,
T1456 6978-6983 WDT denotes which
T1457 6984-6986 VBZ denotes is
T1458 6987-6990 DT denotes the
T1459 6991-6998 NN denotes gateway
T1460 6999-7005 NN denotes enzyme
T1461 7006-7008 IN denotes in
T1462 7009-7012 DT denotes the
T1463 7013-7022 NN denotes formation
T1464 7023-7025 IN denotes of
T1465 7026-7033 NN denotes hybrid-
T1466 7034-7037 CC denotes and
T1467 7038-7050 JJ denotes complex-type
T1468 7051-7058 NNS denotes glycans
T1469 7059-7061 IN denotes in
T1470 7062-7065 DT denotes the
T1471 7066-7071 NNP denotes Golgi
T1472 7072-7081 NN denotes apparatus
T1473 7083-7086 DT denotes The
T1474 7087-7092 NN denotes stage
T1475 7093-7095 IN denotes at
T1476 7096-7101 WDT denotes which
T1477 7102-7112 NN denotes processing
T1478 7113-7115 VBZ denotes is
T1479 7116-7123 VBN denotes impeded
T1480 7124-7126 VBZ denotes is
T1481 7127-7128 DT denotes a
T1482 7129-7138 NN denotes signature
T1483 7139-7146 VBN denotes related
T1484 7147-7149 TO denotes to
T1485 7150-7153 DT denotes the
T1486 7154-7161 NN denotes density
T1487 7162-7165 CC denotes and
T1488 7166-7178 NN denotes presentation
T1489 7179-7181 IN denotes of
T1490 7182-7189 NNS denotes glycans
T1491 7190-7192 IN denotes on
T1492 7193-7196 DT denotes the
T1493 7197-7202 JJ denotes viral
T1494 7203-7208 NN denotes spike
T1495 7210-7213 IN denotes For
T1496 7214-7221 NN denotes example
T1497 7221-7222 -COMMA- denotes ,
T1498 7223-7226 DT denotes the
T1499 7227-7231 RBR denotes more
T1500 7232-7239 RB denotes densely
T1501 7240-7252 VBN denotes glycosylated
T1502 7253-7259 NNS denotes spikes
T1503 7260-7262 IN denotes of
T1504 7263-7268 NN denotes HIV-1
T1505 7269-7272 NN denotes Env
T1506 7273-7276 CC denotes and
T1507 7277-7282 NNP denotes Lassa
T1508 7283-7288 NN denotes virus
T1509 7289-7290 -LRB- denotes (
T1510 7290-7294 NN denotes LASV
T1511 7294-7295 -RRB- denotes )
T1512 7296-7299 NN denotes GPC
T1513 7300-7307 VBP denotes exhibit
T1514 7308-7316 JJ denotes numerous
T1515 7317-7322 NNS denotes sites
T1516 7323-7332 VBN denotes dominated
T1517 7333-7335 IN denotes by
T1518 7336-7347 NN denotes Man9GlcNAc2
T1519 7348-7349 -LRB- denotes (
T1520 7349-7354 CD denotes 21–24
T1521 7354-7355 -RRB- denotes )
T1522 7357-7358 DT denotes A
T1523 7359-7366 NN denotes mixture
T1524 7367-7369 IN denotes of
T1525 7370-7383 NN denotes oligomannose-
T1526 7384-7387 CC denotes and
T1527 7388-7400 JJ denotes complex-type
T1528 7401-7408 NNS denotes glycans
T1529 7409-7412 MD denotes can
T1530 7413-7415 VB denotes be
T1531 7416-7421 VBN denotes found
T1532 7422-7424 IN denotes at
T1533 7425-7430 NNS denotes sites
T1534 7431-7434 NN denotes N61
T1535 7434-7435 -COMMA- denotes ,
T1536 7436-7440 NN denotes N122
T1537 7440-7441 -COMMA- denotes ,
T1538 7442-7446 NN denotes N603
T1539 7446-7447 -COMMA- denotes ,
T1540 7448-7452 NN denotes N717
T1541 7452-7453 -COMMA- denotes ,
T1542 7454-7458 NN denotes N801
T1543 7458-7459 -COMMA- denotes ,
T1544 7460-7463 CC denotes and
T1545 7464-7469 NN denotes N1074
T1546 7470-7471 -LRB- denotes (
T1547 7471-7475 NN denotes Fig.
T1548 7476-7477 CD denotes 2
T1549 7477-7478 -RRB- denotes )
T1550 7480-7482 IN denotes Of
T1551 7483-7486 DT denotes the
T1552 7487-7489 CD denotes 22
T1553 7490-7495 NNS denotes sites
T1554 7496-7498 IN denotes on
T1555 7499-7502 DT denotes the
T1556 7503-7504 NN denotes S
T1557 7505-7512 NN denotes protein
T1558 7512-7513 -COMMA- denotes ,
T1559 7514-7515 CD denotes 8
T1560 7516-7523 VBP denotes contain
T1561 7524-7535 JJ denotes substantial
T1562 7536-7547 NNS denotes populations
T1563 7548-7550 IN denotes of
T1564 7551-7568 JJ denotes oligomannose-type
T1565 7569-7576 NNS denotes glycans
T1566 7576-7577 -COMMA- denotes ,
T1567 7578-7590 VBG denotes highlighting
T1568 7591-7594 WRB denotes how
T1569 7595-7598 DT denotes the
T1570 7599-7609 NN denotes processing
T1571 7610-7612 IN denotes of
T1572 7613-7616 DT denotes the
T1573 7617-7627 NN denotes SARS-CoV-2
T1574 7628-7629 NN denotes S
T1575 7630-7637 NNS denotes glycans
T1576 7638-7640 VBZ denotes is
T1577 7641-7650 JJ denotes divergent
T1578 7651-7655 IN denotes from
T1579 7656-7660 NN denotes host
T1580 7661-7674 NNS denotes glycoproteins
T1581 7675-7676 -LRB- denotes (
T1582 7676-7678 CD denotes 25
T1583 7678-7679 -RRB- denotes )
T1584 7681-7684 DT denotes The
T1585 7685-7694 VBG denotes remaining
T1586 7695-7697 CD denotes 14
T1587 7698-7703 NNS denotes sites
T1588 7704-7707 VBP denotes are
T1589 7708-7717 VBN denotes dominated
T1590 7718-7720 IN denotes by
T1591 7721-7730 VBN denotes processed
T1592 7730-7731 -COMMA- denotes ,
T1593 7732-7744 JJ denotes complex-type
T1594 7745-7752 NNS denotes glycans
T65863 7754-7762 IN denotes Although
T60194 7763-7773 JJ denotes unoccupied
T7395 7774-7787 NN denotes glycosylation
T62677 7788-7793 NNS denotes sites
T81150 7794-7798 VBD denotes were
T42144 7799-7807 VBN denotes detected
T48798 7808-7810 IN denotes on
T2576 7811-7821 NNP denotes SARS-CoV-2
T51503 7822-7823 NNP denotes S
T76331 7823-7824 -COMMA- denotes ,
T71519 7825-7829 WRB denotes when
T77053 7830-7840 VBN denotes quantified
T75961 7841-7845 PRP denotes they
T6297 7846-7850 VBD denotes were
T58978 7851-7859 VBN denotes revealed
T59972 7860-7862 TO denotes to
T92745 7863-7867 VB denotes form
T33122 7868-7869 DT denotes a
T31132 7870-7874 RB denotes very
T38290 7875-7880 JJ denotes minor
T19196 7881-7890 NN denotes component
T48286 7891-7893 IN denotes of
T83039 7894-7897 DT denotes the
T68252 7898-7903 JJ denotes total
T62165 7904-7911 NN denotes peptide
T4213 7912-7916 NN denotes pool
T74217 7917-7918 -LRB- denotes (
T34758 7918-7923 NN denotes table
T7366 7924-7926 NN denotes S2
T74906 7926-7927 -RRB- denotes )
T57960 7929-7931 IN denotes In
T42540 7932-7937 NN denotes HIV-1
T15633 7938-7947 NN denotes immunogen
T63653 7948-7956 NN denotes research
T27827 7956-7957 -COMMA- denotes ,
T17042 7958-7961 DT denotes the
T33433 7962-7967 NNS denotes holes
T1898 7968-7977 VBN denotes generated
T37277 7978-7980 IN denotes by
T71199 7981-7991 JJ denotes unoccupied
T33886 7992-7998 NN denotes glycan
T74014 7999-8004 NNS denotes sites
T26582 8005-8009 VBP denotes have
T97350 8010-8014 VBN denotes been
T88152 8015-8020 VBN denotes shown
T81834 8021-8023 TO denotes to
T33097 8024-8026 VB denotes be
T62246 8027-8038 JJ denotes immunogenic
T48675 8039-8042 CC denotes and
T32889 8043-8054 RB denotes potentially
T36047 8055-8059 VBP denotes give
T43864 8060-8064 NN denotes rise
T23465 8065-8067 TO denotes to
T43488 8068-8079 VBG denotes distracting
T59820 8080-8088 NNS denotes epitopes
T82836 8089-8090 -LRB- denotes (
T41818 8090-8092 CD denotes 26
T87241 8092-8093 -RRB- denotes )
T58684 8095-8098 DT denotes The
T56128 8099-8103 JJ denotes high
T26972 8104-8113 NN denotes occupancy
T77052 8114-8116 IN denotes of
T61237 8117-8125 JJ denotes N-linked
T20466 8126-8132 NN denotes glycan
T55200 8133-8140 NNS denotes sequons
T78865 8141-8143 IN denotes of
T61277 8144-8154 NN denotes SARS-CoV-2
T93285 8155-8156 NN denotes S
T2047 8157-8166 VBZ denotes indicates
T47714 8167-8171 IN denotes that
T82325 8172-8183 JJ denotes recombinant
T38613 8184-8194 NNS denotes immunogens
T54133 8195-8199 MD denotes will
T6430 8200-8203 RB denotes not
T5233 8204-8211 VB denotes require
T93225 8212-8219 JJ denotes further
T87423 8220-8232 NN denotes optimization
T51599 8233-8235 TO denotes to
T32198 8236-8243 VB denotes enhance
T24696 8244-8248 NN denotes site
T22130 8249-8258 NN denotes occupancy
T30763 8260-8265 VBG denotes Using
T13476 8266-8269 DT denotes the
T42306 8270-8277 NN denotes cryo-EM
T91220 8278-8287 NN denotes structure
T69994 8288-8290 IN denotes of
T71591 8291-8294 DT denotes the
T48558 8295-8303 JJ denotes trimeric
T23500 8304-8314 NN denotes SARS-CoV-2
T25885 8315-8316 NN denotes S
T17500 8317-8324 NN denotes protein
T82169 8325-8326 -LRB- denotes [
T26800 8326-8333 NNP denotes Protein
T88396 8334-8338 NNP denotes Data
T36507 8339-8343 NNP denotes Bank
T86203 8344-8345 -LRB- denotes (
T72606 8345-8348 NN denotes PDB
T40590 8348-8349 -RRB- denotes )
T60839 8350-8352 NN denotes ID
T80673 8353-8357 NN denotes 6VSB
T76385 8357-8358 -RRB- denotes ]
T77178 8359-8360 -LRB- denotes (
T74643 8360-8361 CD denotes 4
T79252 8361-8362 -RRB- denotes )
T51300 8362-8363 -COMMA- denotes ,
T91587 8364-8366 PRP denotes we
T42207 8367-8373 VBD denotes mapped
T16134 8374-8377 DT denotes the
T78920 8378-8391 NN denotes glycosylation
T91709 8392-8398 NN denotes status
T64071 8399-8401 IN denotes of
T39211 8402-8405 DT denotes the
T28536 8406-8417 NN denotes coronavirus
T68075 8418-8423 NN denotes spike
T88891 8424-8431 NN denotes mimetic
T62553 8432-8436 IN denotes onto
T78411 8437-8440 DT denotes the
T93076 8441-8455 RB denotes experimentally
T78348 8456-8466 VBN denotes determined
T54540 8467-8484 JJ denotes three-dimensional
T71501 8485-8486 -LRB- denotes (
T32249 8486-8488 NN denotes 3D
T89594 8488-8489 -RRB- denotes )
T40374 8490-8499 NN denotes structure
T79174 8500-8501 -LRB- denotes (
T20422 8501-8505 NN denotes Fig.
T47865 8506-8507 CD denotes 3
T15458 8507-8508 -RRB- denotes )
T90727 8510-8514 DT denotes This
T31548 8515-8523 VBN denotes combined
T3218 8524-8528 NN denotes mass
T91160 8529-8542 JJ denotes spectrometric
T84264 8543-8546 CC denotes and
T10034 8547-8554 NN denotes cryo-EM
T55820 8555-8563 NN denotes analysis
T68991 8564-8571 VBZ denotes reveals
T78943 8572-8575 WRB denotes how
T61661 8576-8579 DT denotes the
T35615 8580-8588 JJ denotes N-linked
T51462 8589-8596 NNS denotes glycans
T99410 8597-8604 VBP denotes occlude
T96601 8605-8613 JJ denotes distinct
T82813 8614-8621 NNS denotes regions
T46834 8622-8628 IN denotes across
T85354 8629-8632 DT denotes the
T35997 8633-8640 NN denotes surface
T91002 8641-8643 IN denotes of
T22272 8644-8647 DT denotes the
T59592 8648-8658 NN denotes SARS-CoV-2
T72733 8659-8664 NN denotes spike
T91083 8666-8670 CD denotes Fig.
T18153 8671-8672 CD denotes 3
T43652 8674-8689 JJ denotes Structure-based
T52064 8690-8697 NN denotes mapping
T11584 8698-8700 IN denotes of
T45691 8701-8711 NN denotes SARS-CoV-2
T79720 8712-8713 NN denotes S
T99243 8714-8722 JJ denotes N-linked
T43425 8723-8730 NNS denotes glycans
T4224 8732-8746 JJ denotes Representative
T78957 8747-8754 NNS denotes glycans
T38375 8755-8758 VBP denotes are
T76680 8759-8766 VBN denotes modeled
T71277 8767-8771 IN denotes onto
T42592 8772-8775 DT denotes the
T58755 8776-8785 NN denotes prefusion
T93802 8786-8795 NN denotes structure
T87665 8796-8798 IN denotes of
T46332 8799-8802 DT denotes the
T49295 8803-8811 JJ denotes trimeric
T44071 8812-8822 NN denotes SARS-CoV-2
T10101 8823-8824 NN denotes S
T92216 8825-8837 NN denotes glycoprotein
T96919 8838-8839 -LRB- denotes (
T52860 8839-8842 NN denotes PDB
T6088 8843-8845 NN denotes ID
T81444 8846-8850 NN denotes 6VSB
T67362 8850-8851 -RRB- denotes )
T96733 8852-8853 -LRB- denotes (
T9353 8853-8854 CD denotes 4
T15280 8854-8855 -RRB- denotes )
T94320 8855-8856 -COMMA- denotes ,
T9342 8857-8861 IN denotes with
T91654 8862-8865 CD denotes one
T93537 8866-8869 NN denotes RBD
T60521 8870-8872 IN denotes in
T62722 8873-8876 DT denotes the
T68682 8877-8881 JJ denotes “up”
T38405 8882-8894 NN denotes conformation
T28926 8895-8898 CC denotes and
T31080 8899-8902 DT denotes the
T32013 8903-8908 JJ denotes other
T78420 8909-8912 CD denotes two
T75042 8913-8917 NNS denotes RBDs
T48759 8918-8920 IN denotes in
T62164 8921-8924 DT denotes the
T16991 8925-8931 JJ denotes “down”
T18108 8932-8944 NN denotes conformation
T22534 8946-8949 DT denotes The
T14769 8950-8957 NNS denotes glycans
T67317 8958-8961 VBP denotes are
T78729 8962-8969 VBN denotes colored
T15870 8970-8979 VBG denotes according
T74210 8980-8982 TO denotes to
T76324 8983-8995 VB denotes oligomannose
T65282 8996-9003 NN denotes content
T6151 9004-9006 IN denotes as
T51816 9007-9014 VBN denotes defined
T74018 9015-9017 IN denotes by
T17383 9018-9021 DT denotes the
T47203 9022-9025 NN denotes key
T98341 9027-9031 NN denotes ACE2
T17041 9032-9040 NN denotes receptor
T62347 9041-9048 NN denotes binding
T77469 9049-9054 NNS denotes sites
T46469 9055-9058 VBP denotes are
T34524 9059-9070 VBN denotes highlighted
T14995 9071-9073 IN denotes in
T62142 9074-9079 NN denotes light
T59383 9080-9084 NN denotes blue
T28104 9086-9089 DT denotes The
T5347 9090-9092 NN denotes S1
T24386 9093-9096 CC denotes and
T6552 9097-9099 NN denotes S2
T53787 9100-9108 NNS denotes subunits
T67051 9109-9112 VBP denotes are
T50925 9113-9121 VBN denotes rendered
T99323 9122-9126 IN denotes with
T16983 9127-9138 JJ denotes translucent
T63195 9139-9146 NN denotes surface
T80553 9147-9161 NN denotes representation
T50249 9161-9162 -COMMA- denotes ,
T9247 9163-9170 VBD denotes colored
T28069 9171-9176 NN denotes light
T2545 9177-9180 CC denotes and
T22182 9181-9185 JJ denotes dark
T85485 9186-9190 NN denotes gray
T26051 9190-9191 -COMMA- denotes ,
T98176 9192-9204 RB denotes respectively
T16644 9206-9209 DT denotes The
T22152 9210-9218 JJ denotes flexible
T38285 9219-9224 NNS denotes loops
T90544 9225-9227 IN denotes on
T78889 9228-9233 WDT denotes which
T34813 9234-9237 DT denotes the
T66781 9238-9241 NN denotes N74
T95854 9242-9245 CC denotes and
T98675 9246-9250 NN denotes N149
T64342 9251-9257 NN denotes glycan
T71736 9258-9263 NNS denotes sites
T10589 9264-9270 NN denotes reside
T13933 9271-9274 VBP denotes are
T98047 9275-9286 VBN denotes represented
T54489 9287-9289 IN denotes as
T92476 9290-9294 JJ denotes gray
T79027 9295-9301 JJ denotes dashed
T39891 9302-9307 NNS denotes lines
T70266 9307-9308 -COMMA- denotes ,
T36877 9309-9313 IN denotes with
T12694 9314-9320 NN denotes glycan
T25149 9321-9326 NNS denotes sites
T43281 9327-9329 IN denotes on
T5639 9330-9333 DT denotes the
T34505 9334-9339 NNS denotes loops
T6303 9340-9346 VBN denotes mapped
T82526 9347-9349 IN denotes at
T82531 9350-9355 PRP-DOLLAR- denotes their
T64164 9356-9367 JJ denotes approximate
T23600 9368-9375 NNS denotes regions
T58449 9377-9386 NN denotes Shielding
T28529 9387-9389 IN denotes of
T5747 9390-9393 DT denotes the
T98568 9394-9402 NN denotes receptor
T89375 9403-9410 NN denotes binding
T54690 9411-9416 NNS denotes sites
T85870 9417-9419 IN denotes on
T26176 9420-9423 DT denotes the
T37663 9424-9434 NN denotes SARS-CoV-2
T63166 9435-9440 NN denotes spike
T63470 9441-9443 IN denotes by
T24684 9444-9452 JJ denotes proximal
T78149 9453-9466 NN denotes glycosylation
T54872 9467-9472 NNS denotes sites
T62513 9473-9474 -LRB- denotes (
T4900 9474-9478 NN denotes N165
T14840 9478-9479 -COMMA- denotes ,
T39942 9480-9484 NN denotes N234
T51156 9484-9485 -COMMA- denotes ,
T48381 9486-9490 NN denotes N343
T51553 9490-9491 -RRB- denotes )
T58350 9492-9495 MD denotes can
T58513 9496-9498 VB denotes be
T19457 9499-9507 VBN denotes observed
T15145 9507-9508 -COMMA- denotes ,
T59932 9509-9519 RB denotes especially
T12181 9520-9524 WRB denotes when
T47142 9525-9528 DT denotes the
T6856 9529-9537 NN denotes receptor
T18107 9538-9545 NN denotes binding
T3324 9546-9552 NN denotes domain
T48261 9553-9555 VBZ denotes is
T13056 9556-9558 IN denotes in
T67892 9559-9562 DT denotes the
T64170 9563-9569 JJ denotes “down”
T94966 9570-9582 NN denotes conformation
T92249 9584-9587 DT denotes The
T59586 9588-9597 NN denotes shielding
T5292 9598-9600 IN denotes of
T70689 9601-9609 NN denotes receptor
T8257 9610-9617 NN denotes binding
T27437 9618-9623 NNS denotes sites
T61614 9624-9626 IN denotes by
T82323 9627-9634 NNS denotes glycans
T86889 9635-9637 VBZ denotes is
T30307 9638-9639 DT denotes a
T12215 9640-9646 JJ denotes common
T51427 9647-9654 NN denotes feature
T49590 9655-9657 IN denotes of
T38802 9658-9663 JJ denotes viral
T61183 9664-9677 NNS denotes glycoproteins
T76907 9677-9678 -COMMA- denotes ,
T37332 9679-9681 IN denotes as
T98432 9682-9690 VBN denotes observed
T45593 9691-9693 IN denotes on
T71768 9694-9704 NN denotes SARS-CoV-1
T77776 9705-9706 NN denotes S
T77141 9707-9708 -LRB- denotes (
T35190 9708-9710 CD denotes 10
T97187 9710-9711 -COMMA- denotes ,
T78772 9712-9714 CD denotes 13
T10341 9714-9715 -RRB- denotes )
T94527 9715-9716 -COMMA- denotes ,
T22015 9717-9722 NN denotes HIV-1
T22100 9723-9726 NN denotes Env
T57063 9727-9728 -LRB- denotes (
T5763 9728-9730 CD denotes 27
T97555 9730-9731 -RRB- denotes )
T57498 9731-9732 -COMMA- denotes ,
T85313 9733-9742 NN denotes influenza
T97193 9743-9756 NN denotes hemagglutinin
T20094 9757-9758 -LRB- denotes (
T68894 9758-9760 CD denotes 28
T9711 9760-9761 -COMMA- denotes ,
T14487 9762-9764 CD denotes 29
T79925 9764-9765 -RRB- denotes )
T14459 9765-9766 -COMMA- denotes ,
T91683 9767-9770 CC denotes and
T25890 9771-9775 NN denotes LASV
T33313 9776-9779 NN denotes GPC
T68781 9780-9781 -LRB- denotes (
T25051 9781-9783 CD denotes 24
T35249 9783-9784 -RRB- denotes )
T9674 9786-9791 VBN denotes Given
T16190 9792-9795 DT denotes the
T24105 9796-9806 JJ denotes functional
T57734 9807-9818 NNS denotes constraints
T80185 9819-9821 IN denotes of
T49272 9822-9830 NN denotes receptor
T85530 9831-9838 NN denotes binding
T83026 9839-9844 NNS denotes sites
T78059 9845-9848 CC denotes and
T37003 9849-9852 DT denotes the
T67847 9853-9862 VBG denotes resulting
T72670 9863-9866 JJ denotes low
T95866 9867-9875 NN denotes mutation
T64589 9876-9881 NNS denotes rates
T69365 9882-9884 IN denotes of
T16503 9885-9890 DT denotes these
T58459 9891-9899 NNS denotes residues
T18586 9899-9900 -COMMA- denotes ,
T62335 9901-9906 EX denotes there
T33505 9907-9909 VBZ denotes is
T12318 9910-9916 JJ denotes likely
T99016 9917-9926 JJ denotes selective
T86957 9927-9935 NN denotes pressure
T75378 9936-9938 TO denotes to
T28105 9939-9942 VB denotes use
T72006 9943-9951 JJ denotes N-linked
T2972 9952-9959 NNS denotes glycans
T22260 9960-9962 TO denotes to
T34986 9963-9973 VB denotes camouflage
T24076 9974-9977 CD denotes one
T21165 9978-9980 IN denotes of
T9973 9981-9984 DT denotes the
T11278 9985-9989 RBS denotes most
T77436 9990-9999 VBN denotes conserved
T58170 10000-10003 CC denotes and
T50830 10004-10015 RB denotes potentially
T24871 10016-10026 JJ denotes vulnerable
T52029 10027-10032 NNS denotes areas
T36121 10033-10035 IN denotes of
T20657 10036-10041 PRP-DOLLAR- denotes their
T54396 10042-10052 JJ denotes respective
T26508 10053-10066 NNS denotes glycoproteins
T81527 10067-10068 -LRB- denotes (
T28240 10068-10070 CD denotes 30
T58247 10070-10071 -COMMA- denotes ,
T69248 10072-10074 CD denotes 31
T48597 10074-10075 -RRB- denotes )
T88864 10077-10079 PRP denotes We
T19325 10080-10084 VBP denotes note
T40917 10085-10088 DT denotes the
T91383 10089-10099 NN denotes dispersion
T80652 10100-10102 IN denotes of
T8601 10103-10120 JJ denotes oligomannose-type
T53142 10121-10128 NNS denotes glycans
T93048 10129-10135 IN denotes across
T36311 10136-10140 CC denotes both
T95534 10141-10144 DT denotes the
T56006 10145-10147 NN denotes S1
T9468 10148-10151 CC denotes and
T14515 10152-10154 NN denotes S2
T69070 10155-10163 NNS denotes subunits
T58933 10165-10169 DT denotes This
T8349 10170-10172 VBZ denotes is
T32961 10173-10175 IN denotes in
T11374 10176-10184 NN denotes contrast
T37781 10185-10187 TO denotes to
T38653 10188-10193 JJ denotes other
T19871 10194-10199 JJ denotes viral
T18452 10200-10213 NNS denotes glycoproteins
T63829 10213-10214 -SEMICOLON- denotes ;
T81382 10215-10218 IN denotes for
T81639 10219-10226 NN denotes example
T68824 10226-10227 -COMMA- denotes ,
T74600 10228-10231 DT denotes the
T75459 10232-10237 JJ denotes dense
T89951 10238-10244 NN denotes glycan
T85605 10245-10253 NNS denotes clusters
T15079 10254-10256 IN denotes in
T84691 10257-10264 JJ denotes several
T80203 10265-10272 NNS denotes strains
T42509 10273-10275 IN denotes of
T9223 10276-10281 NN denotes HIV-1
T85904 10282-10285 NNP denotes Env
T39591 10286-10292 VBP denotes induce
T34970 10293-10310 JJ denotes oligomannose-type
T30840 10311-10318 NNS denotes glycans
T45153 10319-10323 WDT denotes that
T63554 10324-10327 VBP denotes are
T4647 10328-10338 VBN denotes recognized
T39962 10339-10341 IN denotes by
T85483 10342-10352 NNS denotes antibodies
T24812 10353-10354 -LRB- denotes (
T57703 10354-10356 CD denotes 32
T38925 10356-10357 -COMMA- denotes ,
T19195 10358-10360 CD denotes 33
T95768 10360-10361 -RRB- denotes )
T55772 10363-10365 IN denotes In
T93860 10366-10376 NNP denotes SARS-CoV-2
T11027 10377-10378 NNP denotes S
T74449 10378-10379 -COMMA- denotes ,
T90837 10380-10383 DT denotes the
T15204 10384-10401 JJ denotes oligomannose-type
T55177 10402-10412 NNS denotes structures
T53039 10413-10416 VBP denotes are
T53002 10417-10423 RB denotes likely
T87754 10424-10433 VBN denotes protected
T50880 10434-10436 IN denotes by
T93426 10437-10440 DT denotes the
T45604 10441-10448 NN denotes protein
T87038 10449-10458 NN denotes component
T10097 10458-10459 -COMMA- denotes ,
T50034 10460-10462 IN denotes as
T49931 10463-10474 VBN denotes exemplified
T94522 10475-10477 IN denotes by
T43296 10478-10481 DT denotes the
T9232 10482-10486 NN denotes N234
T92160 10487-10493 NN denotes glycan
T26033 10493-10494 -COMMA- denotes ,
T24753 10495-10500 WDT denotes which
T5394 10501-10503 VBZ denotes is
T50345 10504-10513 RB denotes partially
T12006 10514-10524 VBN denotes sandwiched
T68446 10525-10532 IN denotes between
T35576 10533-10536 DT denotes the
T75341 10537-10547 JJ denotes N-terminal
T80869 10548-10551 CC denotes and
T19878 10552-10560 NN denotes receptor
T46080 10561-10568 NN denotes binding
T48157 10569-10576 NNS denotes domains
T40385 10577-10578 -LRB- denotes (
T68457 10578-10582 NN denotes Fig.
T5059 10583-10584 CD denotes 3
T30234 10584-10585 -RRB- denotes )
T53023 10587-10589 PRP denotes We
T64078 10590-10603 VBD denotes characterized
T72449 10604-10607 DT denotes the
T71912 10608-10616 JJ denotes N-linked
T43581 10617-10624 NNS denotes glycans
T26765 10625-10627 IN denotes on
T68798 10628-10636 VBN denotes extended
T49458 10637-10645 JJ denotes flexible
T79314 10646-10650 NN denotes loop
T51040 10651-10661 NNS denotes structures
T29601 10662-10663 -LRB- denotes (
T76290 10663-10666 NN denotes N74
T70290 10667-10670 CC denotes and
T27482 10671-10675 NN denotes N149
T27322 10675-10676 -RRB- denotes )
T93822 10677-10680 CC denotes and
T60496 10681-10683 IN denotes at
T42037 10684-10687 DT denotes the
T35879 10688-10705 JJ denotes membrane-proximal
T40506 10706-10707 NN denotes C
T31718 10708-10716 NN denotes terminus
T50724 10717-10718 -LRB- denotes (
T45140 10718-10723 NN denotes N1158
T90831 10723-10724 -COMMA- denotes ,
T91670 10725-10730 NN denotes N1173
T30606 10730-10731 -COMMA- denotes ,
T45292 10732-10737 NN denotes N1194
T2087 10737-10738 -RRB- denotes )
T81032 10739-10743 WDT denotes that
T70492 10744-10748 VBD denotes were
T19707 10749-10752 RB denotes not
T6638 10753-10761 VBN denotes resolved
T39395 10762-10764 IN denotes in
T46002 10765-10768 DT denotes the
T1686 10769-10776 NN denotes cryo-EM
T16242 10777-10781 NNS denotes maps
T68390 10782-10783 -LRB- denotes (
T82471 10783-10784 CD denotes 4
T6682 10784-10785 -RRB- denotes )
T69540 10787-10792 DT denotes These
T82832 10793-10797 VBD denotes were
T9689 10798-10808 VBN denotes determined
T92598 10809-10811 TO denotes to
T14271 10812-10814 VB denotes be
T16375 10815-10827 JJ denotes complex-type
T15784 10828-10835 NNS denotes glycans
T46638 10835-10836 -COMMA- denotes ,
T71510 10837-10847 JJ denotes consistent
T81074 10848-10852 IN denotes with
T80516 10853-10859 JJ denotes steric
T22568 10860-10873 NN denotes accessibility
T27742 10874-10876 IN denotes of
T32319 10877-10882 DT denotes these
T83830 10883-10891 NNS denotes residues
T44252 10893-10900 IN denotes Whereas
T8171 10901-10904 DT denotes the
T39795 10905-10922 JJ denotes oligomannose-type
T73596 10923-10929 NN denotes glycan
T59365 10930-10937 NN denotes content
T99808 10938-10939 -LRB- denotes (
T34115 10939-10941 CD denotes 28
T21559 10941-10942 NN denotes %
T47422 10942-10943 -RRB- denotes )
T52753 10944-10945 -LRB- denotes (
T61056 10945-10950 NN denotes table
T40589 10951-10953 NN denotes S2
T96095 10953-10954 -RRB- denotes )
T22184 10955-10957 VBZ denotes is
T69759 10958-10963 IN denotes above
T22986 10964-10968 IN denotes that
T24433 10969-10977 VBN denotes observed
T62977 10978-10980 IN denotes on
T34380 10981-10988 JJ denotes typical
T20152 10989-10993 NN denotes host
T61533 10994-11007 NNS denotes glycoproteins
T13550 11007-11008 -COMMA- denotes ,
T27606 11009-11011 PRP denotes it
T82381 11012-11014 VBZ denotes is
T28293 11015-11020 JJR denotes lower
T56709 11021-11025 IN denotes than
T85625 11026-11031 JJ denotes other
T35332 11032-11037 JJ denotes viral
T47969 11038-11051 NNS denotes glycoproteins
T28276 11053-11056 IN denotes For
T16362 11057-11064 NN denotes example
T16646 11064-11065 -COMMA- denotes ,
T86047 11066-11069 CD denotes one
T49490 11070-11072 IN denotes of
T73507 11073-11076 DT denotes the
T59944 11077-11081 RBS denotes most
T25572 11082-11089 RB denotes densely
T28586 11090-11102 VBN denotes glycosylated
T97814 11103-11108 JJ denotes viral
T45720 11109-11114 NN denotes spike
T63316 11115-11123 NNS denotes proteins
T67493 11124-11126 VBZ denotes is
T5107 11127-11132 NN denotes HIV-1
T33765 11133-11136 NN denotes Env
T65352 11136-11137 -COMMA- denotes ,
T93662 11138-11143 WDT denotes which
T82020 11144-11152 VBZ denotes exhibits
T54543 11153-11156 CD denotes ~60
T27723 11156-11157 NN denotes %
T66901 11158-11175 JJ denotes oligomannose-type
T75833 11176-11183 NNS denotes glycans
T67860 11184-11185 -LRB- denotes (
T96850 11185-11187 CD denotes 21
T16706 11187-11188 -COMMA- denotes ,
T77788 11189-11191 CD denotes 34
T37032 11191-11192 -RRB- denotes )
T66377 11194-11198 DT denotes This
T59113 11199-11207 VBZ denotes suggests
T7350 11208-11212 IN denotes that
T84608 11213-11216 DT denotes the
T79579 11217-11227 NN denotes SARS-CoV-2
T90817 11228-11229 NN denotes S
T46370 11230-11237 NN denotes protein
T49742 11238-11240 VBZ denotes is
T65139 11241-11245 RBR denotes less
T25953 11246-11253 RB denotes densely
T38725 11254-11266 VBN denotes glycosylated
T99018 11267-11270 CC denotes and
T61137 11271-11275 IN denotes that
T86967 11276-11279 DT denotes the
T63886 11280-11287 NNS denotes glycans
T21482 11288-11292 VBP denotes form
T93073 11293-11297 JJR denotes less
T83016 11298-11300 IN denotes of
T33280 11301-11302 DT denotes a
T85733 11303-11309 NN denotes shield
T30140 11310-11318 VBN denotes compared
T50036 11319-11323 IN denotes with
T75732 11324-11329 JJ denotes other
T97967 11330-11335 JJ denotes viral
T29563 11336-11349 NNS denotes glycoproteins
T29111 11349-11350 -COMMA- denotes ,
T12944 11351-11360 VBG denotes including
T78853 11361-11366 NN denotes HIV-1
T41077 11367-11370 NN denotes Env
T98405 11371-11374 CC denotes and
T41548 11375-11379 NN denotes LASV
T28392 11380-11383 NN denotes GPC
T20621 11383-11384 -COMMA- denotes ,
T35209 11385-11390 WDT denotes which
T31115 11391-11394 MD denotes may
T83078 11395-11397 VB denotes be
T44859 11398-11408 JJ denotes beneficial
T25244 11409-11412 IN denotes for
T31092 11413-11416 DT denotes the
T2299 11417-11428 NN denotes elicitation
T33174 11429-11431 IN denotes of
T63621 11432-11444 VBG denotes neutralizing
T62387 11445-11455 NNS denotes antibodies
T17701 11457-11469 RB denotes Additionally
T99697 11469-11470 -COMMA- denotes ,
T80820 11471-11474 DT denotes the
T76134 11475-11485 NN denotes processing
T62423 11486-11488 IN denotes of
T20120 11489-11501 JJ denotes complex-type
T70317 11502-11509 NNS denotes glycans
T54945 11510-11512 VBZ denotes is
T38495 11513-11515 DT denotes an
T67133 11516-11525 JJ denotes important
T62820 11526-11539 NN denotes consideration
T6640 11540-11542 IN denotes in
T89341 11543-11552 NN denotes immunogen
T16198 11553-11564 NN denotes engineering
T34295 11564-11565 -COMMA- denotes ,
T17998 11566-11576 RB denotes especially
T48208 11577-11588 VBG denotes considering
T59621 11589-11593 IN denotes that
T38335 11594-11602 NNS denotes epitopes
T17632 11603-11605 IN denotes of
T52650 11606-11618 VBG denotes neutralizing
T94803 11619-11629 NNS denotes antibodies
T96472 11630-11637 IN denotes against
T15388 11638-11648 NN denotes SARS-CoV-2
T65870 11649-11650 NN denotes S
T54929 11651-11654 MD denotes can
T48495 11655-11662 VB denotes contain
T83428 11663-11674 VBN denotes fucosylated
T33605 11675-11682 NNS denotes glycans
T61395 11683-11685 IN denotes at
T85817 11686-11690 NN denotes N343
T96270 11691-11692 -LRB- denotes (
T72262 11692-11694 CD denotes 35
T73516 11694-11695 -RRB- denotes )
T58385 11697-11703 IN denotes Across
T33257 11704-11707 DT denotes the
T7279 11708-11710 CD denotes 22
T66085 11711-11719 JJ denotes N-linked
T50825 11720-11733 NN denotes glycosylation
T5111 11734-11739 NNS denotes sites
T97279 11739-11740 -COMMA- denotes ,
T26983 11741-11743 CD denotes 52
T69394 11743-11744 NN denotes %
T83730 11745-11748 VBP denotes are
T54583 11749-11760 VBN denotes fucosylated
T26054 11761-11764 CC denotes and
T85194 11765-11767 CD denotes 15
T20514 11767-11768 NN denotes %
T72708 11769-11771 IN denotes of
T31556 11772-11775 DT denotes the
T75023 11776-11783 NNS denotes glycans
T91101 11784-11791 VBP denotes contain
T15113 11792-11794 IN denotes at
T84490 11795-11800 JJS denotes least
T40607 11801-11804 CD denotes one
T99043 11805-11811 JJ denotes sialic
T62355 11812-11816 NN denotes acid
T95450 11817-11824 NN denotes residue
T41689 11825-11826 -LRB- denotes (
T78019 11826-11831 NN denotes table
T59791 11832-11834 NN denotes S2
T12029 11835-11838 CC denotes and
T36301 11839-11842 NN denotes fig
T18591 11844-11846 NN denotes S3
T69202 11846-11847 -RRB- denotes )
T88205 11849-11852 PRP-DOLLAR- denotes Our
T66239 11853-11861 NN denotes analysis
T85946 11862-11869 VBZ denotes reveals
T29321 11870-11874 IN denotes that
T6259 11875-11879 NN denotes N343
T81525 11880-11882 VBZ denotes is
T30157 11883-11889 RB denotes highly
T97849 11890-11901 VBN denotes fucosylated
T21442 11902-11906 IN denotes with
T82188 11907-11909 CD denotes 98
T6571 11909-11910 NN denotes %
T40587 11911-11913 IN denotes of
T88519 11914-11922 VBN denotes detected
T23189 11923-11930 NNS denotes glycans
T84265 11931-11938 VBG denotes bearing
T71335 11939-11945 NN denotes fucose
T50000 11946-11954 NNS denotes residues
T89016 11956-11962 NN denotes Glycan
T93436 11963-11976 NNS denotes modifications
T75195 11977-11980 MD denotes can
T94836 11981-11983 VB denotes be
T43397 11984-11991 RB denotes heavily
T35429 11992-12002 VBN denotes influenced
T42310 12003-12005 IN denotes by
T34958 12006-12009 DT denotes the
T16911 12010-12018 JJ denotes cellular
T68653 12019-12029 NN denotes expression
T23470 12030-12036 NN denotes system
T99582 12037-12041 VBN denotes used
T97181 12043-12045 PRP denotes We
T55441 12046-12050 VBP denotes have
T9573 12051-12061 RB denotes previously
T58273 12062-12074 VBN denotes demonstrated
T28968 12075-12078 IN denotes for
T34125 12079-12084 NN denotes HIV-1
T85697 12085-12088 NN denotes Env
T43925 12089-12102 NN denotes glycosylation
T72928 12103-12107 IN denotes that
T20432 12108-12111 DT denotes the
T74575 12112-12122 NN denotes processing
T86628 12123-12125 IN denotes of
T60989 12126-12138 JJ denotes complex-type
T13027 12139-12146 NNS denotes glycans
T11801 12147-12149 VBZ denotes is
T93111 12150-12156 VBN denotes driven
T68502 12157-12159 IN denotes by
T25582 12160-12163 DT denotes the
T45914 12164-12172 NN denotes producer
T65172 12173-12177 NN denotes cell
T99350 12178-12181 CC denotes but
T88282 12182-12186 IN denotes that
T3049 12187-12190 DT denotes the
T57577 12191-12197 NNS denotes levels
T64683 12198-12200 IN denotes of
T18565 12201-12218 JJ denotes oligomannose-type
T45265 12219-12226 NNS denotes glycans
T16371 12227-12231 VBD denotes were
T17100 12232-12239 RB denotes largely
T68235 12240-12251 JJ denotes independent
T82363 12252-12254 IN denotes of
T15827 12255-12258 DT denotes the
T31780 12259-12269 NN denotes expression
T24822 12270-12276 NN denotes system
T93088 12277-12280 CC denotes and
T37436 12281-12284 VBP denotes are
T64666 12285-12289 RB denotes much
T48018 12290-12294 RBR denotes more
T54557 12295-12302 RB denotes closely
T92543 12303-12310 JJ denotes related
T5056 12311-12313 TO denotes to
T95680 12314-12317 DT denotes the
T83467 12318-12325 NN denotes protein
T6736 12326-12335 NN denotes structure
T70311 12336-12339 CC denotes and
T36895 12340-12346 NN denotes glycan
T93693 12347-12354 NN denotes density
T72545 12355-12356 -LRB- denotes (
T3335 12356-12358 CD denotes 36
T19113 12358-12359 -RRB- denotes )
T9240 12361-12367 RB denotes Highly
T26423 12368-12373 JJ denotes dense
T31010 12374-12380 NN denotes glycan
T61332 12381-12388 NNS denotes shields
T42569 12388-12389 -COMMA- denotes ,
T84675 12390-12394 JJ denotes such
T66981 12395-12397 IN denotes as
T81523 12398-12403 DT denotes those
T87200 12404-12412 VBN denotes observed
T40154 12413-12415 IN denotes on
T65532 12416-12420 NN denotes LASV
T5772 12421-12424 NN denotes GPC
T67488 12425-12428 CC denotes and
T10699 12429-12434 NN denotes HIV-1
T62172 12435-12438 NNP denotes Env
T90671 12438-12439 -COMMA- denotes ,
T16287 12440-12447 VBP denotes feature
T48112 12448-12457 JJ denotes so-called
T32762 12458-12465 NN denotes mannose
T70291 12466-12474 NNS denotes clusters
T21137 12475-12476 -LRB- denotes (
T80604 12476-12478 CD denotes 22
T6972 12478-12479 -COMMA- denotes ,
T79738 12480-12482 CD denotes 24
T38967 12482-12483 -RRB- denotes )
T98752 12484-12486 IN denotes on
T93512 12487-12490 DT denotes the
T39612 12491-12498 NN denotes protein
T9646 12499-12506 NN denotes surface
T50448 12507-12508 -LRB- denotes (
T81826 12508-12512 NN denotes Fig.
T39766 12513-12514 CD denotes 4
T89772 12514-12515 -RRB- denotes )
T66450 12517-12524 IN denotes Whereas
T54192 12525-12530 JJ denotes small
T75704 12531-12543 JJ denotes mannose-type
T64679 12544-12552 NNS denotes clusters
T67961 12553-12557 VBP denotes have
T50872 12558-12562 VBN denotes been
T72397 12563-12576 VBN denotes characterized
T86083 12577-12579 IN denotes on
T19628 12580-12583 DT denotes the
T60379 12584-12586 NN denotes S1
T95927 12587-12594 NN denotes subunit
T61088 12595-12597 IN denotes of
T88650 12598-12604 NNP denotes Middle
T77913 12605-12609 NNP denotes East
T59650 12610-12621 JJ denotes respiratory
T56889 12622-12630 NN denotes syndrome
T75209 12631-12632 -LRB- denotes (
T65502 12632-12636 NNS denotes MERS
T47025 12636-12637 -RRB- denotes )
T38619 12637-12641 NN denotes –CoV
T85027 12642-12643 NN denotes S
T41284 12644-12645 -LRB- denotes (
T20092 12645-12647 CD denotes 10
T67731 12647-12648 -RRB- denotes )
T60447 12648-12649 -COMMA- denotes ,
T26837 12650-12652 DT denotes no
T36825 12653-12657 JJ denotes such
T21633 12658-12668 NN denotes phenomenon
T72717 12669-12672 VBZ denotes has
T43289 12673-12677 VBN denotes been
T51132 12678-12686 VBN denotes observed
T85295 12687-12690 IN denotes for
T9791 12691-12694 DT denotes the
T26717 12695-12705 NN denotes SARS-CoV-1
T27044 12706-12708 CC denotes or
T2105 12709-12719 NN denotes SARS-CoV-2
T82926 12720-12721 NN denotes S
T59746 12722-12730 NNS denotes proteins
T75148 12732-12735 DT denotes The
T54305 12736-12749 JJ denotes site-specific
T98072 12750-12763 NN denotes glycosylation
T89974 12764-12772 NN denotes analysis
T24686 12773-12781 VBN denotes reported
T87402 12782-12786 RB denotes here
T6472 12787-12795 VBZ denotes suggests
T51130 12796-12800 IN denotes that
T65358 12801-12804 DT denotes the
T44449 12805-12811 NN denotes glycan
T74101 12812-12818 NN denotes shield
T43467 12819-12821 IN denotes of
T56834 12822-12832 NN denotes SARS-CoV-2
T19380 12833-12834 NN denotes S
T58633 12835-12837 VBZ denotes is
T93230 12838-12848 JJ denotes consistent
T34762 12849-12853 IN denotes with
T40649 12854-12859 JJ denotes other
T26331 12860-12873 NNS denotes coronaviruses
T79087 12874-12877 CC denotes and
T88865 12878-12887 RB denotes similarly
T45562 12888-12896 VBZ denotes exhibits
T4794 12897-12905 JJ denotes numerous
T90262 12906-12921 NNS denotes vulnerabilities
T96677 12922-12932 IN denotes throughout
T25127 12933-12936 DT denotes the
T33100 12937-12943 NN denotes glycan
T82801 12944-12950 NN denotes shield
T15404 12951-12952 -LRB- denotes (
T44325 12952-12954 CD denotes 10
T22249 12954-12955 -RRB- denotes )
T88430 12957-12961 JJ denotes Last
T44884 12961-12962 -COMMA- denotes ,
T47301 12963-12965 PRP denotes we
T38431 12966-12974 VBD denotes detected
T93001 12975-12980 NN denotes trace
T59318 12981-12987 NNS denotes levels
T23777 12988-12990 IN denotes of
T97663 12991-12999 JJ denotes O-linked
T9150 13000-13013 NN denotes glycosylation
T9101 13014-13016 IN denotes at
T19875 13017-13030 NN denotes Thr323/Ser325
T53360 13031-13032 -LRB- denotes (
T44595 13032-13041 NN denotes T323/S325
T76708 13041-13042 -RRB- denotes )
T47554 13042-13043 -COMMA- denotes ,
T13997 13044-13048 IN denotes with
T37628 13049-13053 IN denotes over
T46382 13054-13056 CD denotes 99
T30911 13056-13057 NN denotes %
T73157 13058-13060 IN denotes of
T21636 13061-13066 DT denotes these
T17607 13067-13072 NNS denotes sites
T16530 13073-13083 JJ denotes unmodified
T31888 13084-13085 -LRB- denotes (
T21233 13085-13088 NN denotes fig
T31805 13090-13092 NN denotes S4
T7918 13092-13093 -RRB- denotes )
T49699 13093-13094 -COMMA- denotes ,
T4878 13095-13105 VBG denotes suggesting
T67436 13106-13110 IN denotes that
T16574 13111-13119 JJ denotes O-linked
T4862 13120-13133 NN denotes glycosylation
T34118 13134-13136 IN denotes of
T78710 13137-13141 DT denotes this
T91351 13142-13148 NN denotes region
T67334 13149-13151 VBZ denotes is
T6257 13152-13159 JJ denotes minimal
T27983 13160-13164 WRB denotes when
T10765 13165-13168 DT denotes the
T94953 13169-13178 NN denotes structure
T41179 13179-13181 VBZ denotes is
T51038 13182-13193 JJ denotes native-like
T98166 13195-13199 NNP denotes Fig.
T19270 13200-13201 CD denotes 4
T62291 13203-13218 NN denotes Underprocessing
T85384 13219-13221 IN denotes of
T57188 13222-13227 JJ denotes viral
T62225 13228-13234 NN denotes glycan
T89247 13235-13242 NNS denotes shields
T41336 13244-13248 IN denotes From
T97920 13249-13253 VBN denotes left
T3138 13254-13256 TO denotes to
T98195 13257-13262 NN denotes right
T98726 13262-13263 -COMMA- denotes ,
T65645 13264-13272 NN denotes MERS-CoV
T55778 13273-13274 NN denotes S
T79525 13275-13276 -LRB- denotes (
T68767 13276-13278 CD denotes 10
T41460 13278-13279 -RRB- denotes )
T31844 13279-13280 -COMMA- denotes ,
T7043 13281-13291 NN denotes SARS-CoV-1
T97863 13292-13293 NN denotes S
T92081 13294-13295 -LRB- denotes (
T69656 13295-13297 CD denotes 10
T67545 13297-13298 -RRB- denotes )
T47349 13298-13299 -COMMA- denotes ,
T62941 13300-13310 NN denotes SARS-CoV-2
T30429 13311-13312 NNP denotes S
T58688 13312-13313 -COMMA- denotes ,
T40283 13314-13318 NN denotes LASV
T77775 13319-13322 NN denotes GPC
T96446 13323-13324 -LRB- denotes (
T18926 13324-13326 CD denotes 24
T91299 13326-13327 -RRB- denotes )
T3350 13327-13328 -COMMA- denotes ,
T10998 13329-13332 CC denotes and
T7671 13333-13338 NN denotes HIV-1
T16812 13339-13342 NN denotes Env
T28102 13343-13344 -LRB- denotes (
T93293 13344-13345 CD denotes 8
T27600 13345-13346 -COMMA- denotes ,
T65727 13347-13349 CD denotes 21
T28148 13349-13350 -RRB- denotes )
T15226 13352-13365 JJ denotes Site-specific
T75794 13366-13374 JJ denotes N-linked
T71346 13375-13381 NN denotes glycan
T89202 13382-13394 NN denotes oligomannose
T68062 13395-13410 NNS denotes quantifications
T84121 13411-13414 VBP denotes are
T74313 13415-13422 VBN denotes colored
T62704 13423-13432 VBG denotes according
T82646 13433-13435 TO denotes to
T60233 13436-13439 DT denotes the
T78311 13440-13443 NN denotes key
T46576 13445-13448 DT denotes All
T7521 13449-13462 NNS denotes glycoproteins
T49353 13463-13467 VBD denotes were
T79250 13468-13477 VBN denotes expressed
T39461 13478-13480 IN denotes as
T6442 13481-13488 JJ denotes soluble
T51716 13489-13496 NNS denotes trimers
T96313 13497-13499 IN denotes in
T76075 13500-13503 NN denotes HEK
T83301 13504-13508 NN denotes 293F
T61867 13509-13514 NNS denotes cells
T91642 13515-13520 RB denotes apart
T87881 13521-13525 IN denotes from
T78049 13526-13530 NN denotes LASV
T7141 13531-13534 NN denotes GPC
T10679 13534-13535 -COMMA- denotes ,
T35984 13536-13541 WDT denotes which
T80005 13542-13545 VBD denotes was
T17581 13546-13553 VBN denotes derived
T67465 13554-13558 IN denotes from
T10445 13559-13569 JJ denotes virus-like
T56154 13570-13579 NNS denotes particles
T16557 13580-13584 IN denotes from
T21578 13585-13596 JJ denotes Madin-Darby
T80613 13597-13603 JJ denotes canine
T39899 13604-13610 NN denotes kidney
T98529 13611-13613 CD denotes II
T92146 13614-13619 NNS denotes cells
T53028 13621-13624 PRP-DOLLAR- denotes Our
T82153 13625-13638 NN denotes glycosylation
T40708 13639-13647 NN denotes analysis
T61579 13648-13650 IN denotes of
T12079 13651-13661 NN denotes SARS-CoV-2
T49219 13662-13668 VBZ denotes offers
T94729 13669-13670 DT denotes a
T57933 13671-13679 JJ denotes detailed
T74120 13680-13689 NN denotes benchmark
T48966 13690-13692 IN denotes of
T58340 13693-13706 JJ denotes site-specific
T31488 13707-13713 NN denotes glycan
T43905 13714-13724 NNS denotes signatures
T84329 13725-13739 JJ denotes characteristic
T21494 13740-13742 IN denotes of
T57185 13743-13744 DT denotes a
T30603 13745-13753 RB denotes natively
T58151 13754-13760 VBN denotes folded
T94639 13761-13769 JJ denotes trimeric
T50255 13770-13775 NN denotes spike
T49489 13777-13779 IN denotes As
T30681 13780-13782 DT denotes an
T53669 13783-13793 VBG denotes increasing
T65899 13794-13800 NN denotes number
T82409 13801-13803 IN denotes of
T8477 13804-13822 JJ denotes glycoprotein-based
T94196 13823-13830 NN denotes vaccine
T43282 13831-13841 NNS denotes candidates
T96948 13842-13845 VBP denotes are
T96900 13846-13851 VBG denotes being
T67675 13852-13861 VBN denotes developed
T62659 13861-13862 -COMMA- denotes ,
T20755 13863-13868 PRP-DOLLAR- denotes their
T47361 13869-13877 JJ denotes detailed
T51541 13878-13884 NN denotes glycan
T66124 13885-13893 NN denotes analysis
T40599 13894-13900 VBZ denotes offers
T90463 13901-13902 DT denotes a
T34862 13903-13908 NN denotes route
T97151 13909-13912 IN denotes for
T93438 13913-13922 VBG denotes comparing
T16844 13923-13932 NN denotes immunogen
T61238 13933-13942 NN denotes integrity
T30860 13943-13946 CC denotes and
T24785 13947-13951 MD denotes will
T90065 13952-13956 RB denotes also
T99893 13957-13959 VB denotes be
T50945 13960-13969 JJ denotes important
T69841 13970-13972 TO denotes to
T90334 13973-13980 VB denotes monitor
T29169 13981-13983 IN denotes as
T25038 13984-13997 NN denotes manufacturing
T2806 13998-14007 NNS denotes processes
T74292 14008-14011 VBP denotes are
T70120 14012-14018 VBN denotes scaled
T94082 14019-14022 IN denotes for
T25098 14023-14031 JJ denotes clinical
T10017 14032-14035 NN denotes use
T12304 14037-14043 NN denotes Glycan
T79926 14044-14053 NN denotes profiling
T48513 14054-14058 MD denotes will
T46336 14059-14068 RB denotes therefore
T92867 14069-14073 RB denotes also
T57413 14074-14076 VB denotes be
T41872 14077-14079 DT denotes an
T99603 14080-14089 JJ denotes important
T40050 14090-14097 NN denotes measure
T31145 14098-14100 IN denotes of
T69406 14101-14108 NN denotes antigen
T71732 14109-14116 NN denotes quality
T75814 14117-14119 IN denotes in
T39084 14120-14123 DT denotes the
T83900 14124-14135 NN denotes manufacture
T63349 14136-14138 IN denotes of
T35288 14139-14150 JJ denotes serological
T45219 14151-14158 NN denotes testing
T20226 14159-14163 NNS denotes kits
T63904 14165-14169 JJ denotes Last
T97760 14169-14170 -COMMA- denotes ,
T65795 14171-14175 IN denotes with
T65559 14176-14179 DT denotes the
T81020 14180-14186 NN denotes advent
T37516 14187-14189 IN denotes of
T28720 14190-14206 JJ denotes nucleotide-based
T21690 14207-14215 NNS denotes vaccines
T20374 14215-14216 -COMMA- denotes ,
T66422 14217-14219 PRP denotes it
T36320 14220-14224 MD denotes will
T53107 14225-14227 VB denotes be
T18553 14228-14237 JJ denotes important
T20438 14238-14240 TO denotes to
T43342 14241-14251 VB denotes understand
T90541 14252-14255 WRB denotes how
T45086 14256-14261 DT denotes those
T83637 14262-14270 NN denotes delivery
T13791 14271-14281 NNS denotes mechanisms
T62450 14282-14288 VBP denotes affect
T67741 14289-14298 NN denotes immunogen
T75860 14299-14309 NN denotes processing
T3133 14310-14313 CC denotes and
T84057 14314-14326 NN denotes presentation
R1000 T999 T997 arg2Of cells,from
R1001 T999 T998 arg2Of cells,transfected
R1002 T996 T1000 arg1Of supernatant,;
R1003 T1001 T1000 arg2Of lane,;
R1004 T1001 T1002 arg1Of lane,2
R1005 T1001 T1003 arg1Of lane,:
R1006 T1005 T1004 arg1Of from,flow-through
R1007 T1001 T1005 arg1Of lane,from
R1008 T1008 T1005 arg2Of ;,from
R1009 T1007 T1006 arg1Of resin,StrepTactin
R1010 T1007 T1008 arg1Of resin,;
R1011 T1009 T1008 arg2Of lane,;
R1012 T1009 T1010 arg1Of lane,3
R1013 T1001 T1011 arg1Of lane,:
R1014 T1013 T1012 arg1Of from,wash
R1015 T1001 T1013 arg1Of lane,from
R1016 T1015 T1013 arg2Of resin,from
R1017 T1015 T1014 arg1Of resin,StrepTactin
R1018 T1001 T1016 arg1Of lane,;
R1019 T1017 T1016 arg2Of lane,;
R10199 T61332 T42569 arg1Of shields,","
R1020 T1017 T1018 arg1Of lane,4
R10200 T99893 T30860 arg2Of be,and
R1021 T1017 T1019 arg1Of lane,:
R1022 T1021 T1020 arg1Of from,elution
R1023 T1017 T1021 arg1Of lane,from
R1024 T1031 T1021 arg2Of averages,from
R1025 T1031 T1022 arg1Of averages,StrepTactin
R10257 T61533 T62977 arg2Of glycoproteins,on
R1026 T1031 T1023 arg1Of averages,resin.
R1027 T1031 T1024 arg1Of averages,(
R1028 T1025 T1024 arg2Of C,(
R1029 T1026 T1024 arg3Of ),(
R1030 T1031 T1027 arg1Of averages,Negative-stain
R10308 T50255 T58151 arg1Of spike,folded
R1031 T1031 T1028 arg1Of averages,EM
R1032 T1031 T1029 arg1Of averages,2D
R1033 T1031 T1030 arg1Of averages,class
R1034 T1031 T1032 arg1Of averages,of
R1035 T1036 T1032 arg2Of protein,of
R1036 T1036 T1033 arg1Of protein,the
R1037 T1036 T1034 arg1Of protein,SARS-CoV-2
R1038 T1036 T1035 arg1Of protein,S
R1039 T1039 T1037 arg1Of averages,2D
R1040 T1039 T1038 arg1Of averages,class
R1041 T1039 T1040 arg1Of averages,of
R1042 T1044 T1040 arg2Of protein,of
R1043 T1044 T1041 arg1Of protein,the
R10434 T36507 T26800 arg1Of Bank,Protein
R1044 T1044 T1042 arg1Of protein,SARS-CoV-2
R1045 T1044 T1043 arg1Of protein,S
R1046 T1039 T1045 arg1Of averages,are
R1047 T1046 T1045 arg2Of shown,are
R1048 T1039 T1046 arg2Of averages,shown
R1049 T1048 T1046 arg3Of confirming,shown
R1050 T1046 T1047 arg1Of shown,","
R10503 T63886 T21482 arg1Of glycans,form
R1051 T1039 T1048 arg1Of averages,confirming
R1052 T1052 T1048 arg2Of adopts,confirming
R1053 T1052 T1049 arg1Of adopts,that
R1054 T1051 T1050 arg1Of protein,the
R1055 T1051 T1052 arg1Of protein,adopts
R1056 T1056 T1052 arg2Of conformation,adopts
R1057 T1056 T1053 arg1Of conformation,the
R1058 T1056 T1054 arg1Of conformation,trimeric
R1059 T1056 T1055 arg1Of conformation,prefusion
R1060 T1056 T1057 arg1Of conformation,matching
R1061 T1059 T1057 arg2Of material,matching
R1062 T1059 T1058 arg1Of material,the
R1063 T1059 T1060 arg2Of material,used
R1064 T1062 T1060 arg3Of determine,used
R1065 T1062 T1061 arg1Of determine,to
R1066 T1059 T1062 arg1Of material,determine
R1067 T1064 T1062 arg2Of structure,determine
R1068 T1064 T1063 arg1Of structure,the
R10683 T21233 T16530 arg3Of fig,unmodified
R1069 T1064 T1065 arg1Of structure,(
R1070 T1066 T1065 arg2Of 4,(
R10701 T91587 T30763 arg1Of we,Using
R1071 T1067 T1065 arg3Of ),(
R1072 T1069 T1068 arg1Of determine,To
R1073 T1078 T1068 modOf used,To
R1074 T1072 T1069 arg2Of glycosylation,determine
R1075 T1072 T1070 arg1Of glycosylation,the
R1076 T1072 T1071 arg1Of glycosylation,site-specific
R1077 T1072 T1073 arg1Of glycosylation,of
R1078 T1075 T1073 arg2Of S,of
R1079 T1075 T1074 arg1Of S,SARS-CoV-2
R1080 T1078 T1076 arg1Of used,","
R1081 T1077 T1078 arg1Of we,used
R1082 T1083 T1078 arg2Of and,used
R1083 T1087 T1078 arg3Of generate,used
R1084 T1079 T1080 arg1Of trypsin,","
R1085 T1081 T1080 arg2Of chymotrypsin,","
R10855 T46370 T38725 arg2Of protein,glycosylated
R1086 T1083 T1082 arg1Of and,","
R10863 T57413 T75814 arg1Of be,in
R1087 T1080 T1083 arg1Of ",",and
R1088 T1085 T1083 arg2Of protease,and
R1089 T1085 T1084 arg1Of protease,α-lytic
R10896 T88891 T39211 arg1Of mimetic,the
R1090 T1087 T1086 arg1Of generate,to
R1091 T1077 T1087 arg1Of we,generate
R10910 T65899 T96900 arg1Of number,being
R1092 T1090 T1087 arg2Of samples,generate
R1093 T1090 T1088 arg1Of samples,three
R1094 T1090 T1089 arg1Of samples,glycopeptide
R10943 T92160 T12006 arg2Of glycan,sandwiched
R1095 T1092 T1091 arg1Of proteases,These
R1096 T1092 T1093 arg1Of proteases,were
R1097 T1094 T1093 arg2Of selected,were
R1098 T1092 T1094 arg2Of proteases,selected
R10980 T59586 T92249 arg1Of shielding,The
R1099 T1096 T1094 arg3Of generate,selected
R1100 T1096 T1095 arg1Of generate,to
R1101 T1092 T1096 arg1Of proteases,generate
R1102 T1097 T1096 arg2Of glycopeptides,generate
R1103 T1097 T1098 arg1Of glycopeptides,that
R1104 T1097 T1099 arg1Of glycopeptides,contain
R11044 T90334 T69841 arg1Of monitor,to
R1105 T1104 T1099 arg2Of sequon,contain
R1106 T1104 T1100 arg1Of sequon,a
R1107 T1104 T1101 arg1Of sequon,single
R11072 T61332 T66981 arg1Of shields,as
R1108 T1104 T1102 arg1Of sequon,N-linked
R1109 T1104 T1103 arg1Of sequon,glycan
R1110 T1106 T1105 arg1Of glycopeptides,The
R1111 T1106 T1107 arg1Of glycopeptides,were
R1112 T1108 T1107 arg2Of analyzed,were
R1113 T1112 T1108 arg1Of spectrometry,analyzed
R11134 T76134 T80820 arg1Of processing,the
R1114 T1106 T1108 arg2Of glycopeptides,analyzed
R1115 T1112 T1109 arg2Of spectrometry,by
R11154 T80604 T21137 arg2Of 22,(
R1116 T1112 T1110 arg1Of spectrometry,liquid
R1117 T1112 T1111 arg1Of spectrometry,chromatography–mass
R11177 T35997 T91002 arg1Of surface,of
R1118 T1114 T1113 arg1Of and,","
R1119 T1108 T1114 arg1Of analyzed,and
R1120 T1119 T1114 arg2Of determined,and
R1121 T1117 T1115 arg1Of compositions,the
R1122 T1117 T1116 arg1Of compositions,glycan
R11225 T66239 T88205 arg1Of analysis,Our
R1123 T1117 T1118 arg1Of compositions,were
R1124 T1119 T1118 arg2Of determined,were
R1125 T1117 T1119 arg2Of compositions,determined
R1126 T1119 T1120 arg1Of determined,for
R1127 T1125 T1120 arg2Of sites,for
R1128 T1122 T1121 arg1Of 22,all
R1129 T1125 T1122 arg1Of sites,22
R1130 T1125 T1123 arg1Of sites,N-linked
R11304 T3324 T18107 arg1Of domain,binding
R1131 T1125 T1124 arg1Of sites,glycan
R1132 T1125 T1126 arg1Of sites,(
R1133 T1127 T1126 arg2Of Fig.,(
R1134 T1129 T1126 arg3Of ),(
R1135 T1127 T1128 arg1Of Fig.,2
R1136 T1131 T1130 arg1Of convey,To
R1137 T1146 T1130 modOf summed,To
R11371 T56006 T9468 arg1Of S1,and
R1138 T1141 T1131 arg1Of abundances,convey
R11381 T65870 T15388 arg1Of S,SARS-CoV-2
R1139 T1135 T1131 arg2Of features,convey
R1140 T1135 T1132 arg1Of features,the
R1141 T1135 T1133 arg1Of features,main
R1142 T1135 T1134 arg1Of features,processing
R11429 T50000 T84265 arg2Of residues,bearing
R1143 T1131 T1136 arg1Of convey,at
R1144 T1138 T1136 arg2Of site,at
R1145 T1138 T1137 arg1Of site,each
R1146 T1146 T1139 arg1Of summed,","
R1147 T1141 T1140 arg1Of abundances,the
R1148 T1141 T1142 arg1Of abundances,of
R11487 T59820 T23465 arg2Of epitopes,to
R1149 T1144 T1142 arg2Of glycan,of
R1150 T1144 T1143 arg1Of glycan,each
R1151 T1141 T1145 arg1Of abundances,are
R11512 T10589 T98047 arg2Of reside,represented
R1152 T1146 T1145 arg2Of summed,are
R11520 T80869 T40385 arg1Of and,(
R11523 T33505 T18586 arg1Of is,","
R1153 T1141 T1146 arg2Of abundances,summed
R1154 T1146 T1147 arg1Of summed,into
R1155 T1152 T1147 arg2Of and,into
R1156 T1152 T1148 arg1Of and,oligomannose-type
R1157 T1152 T1149 arg1Of and,","
R1158 T1152 T1151 arg1Of and,","
R1159 T1150 T1152 arg1Of hybrid-type,and
R1160 T1153 T1152 arg2Of categories,and
R1161 T1153 T1154 arg1Of categories,of
R1162 T1156 T1154 arg2Of glycosylation,of
R1163 T1156 T1155 arg1Of glycosylation,complex-type
R1164 T1153 T1157 arg1Of categories,based
R1165 T1158 T1157 arg2Of on,based
R1166 T1160 T1158 arg2Of and,on
R1167 T1159 T1160 arg1Of branching,and
R1168 T1161 T1160 arg2Of fucosylation,and
R1169 T1165 T1164 arg1Of expanded,","
R1170 T1166 T1165 arg2Of graphs,expanded
R1171 T1166 T1167 arg1Of graphs,showing
R1172 T1170 T1167 arg2Of range,showing
R1173 T1170 T1168 arg1Of range,the
R1174 T1170 T1169 arg1Of range,diverse
R1175 T1170 T1171 arg1Of range,of
R1176 T1173 T1171 arg2Of compositions,of
R1177 T1173 T1172 arg1Of compositions,glycan
R11776 T76134 T48208 arg1Of processing,considering
R1178 T1175 T1174 arg2Of presented,are
R1179 T1175 T1176 arg1Of presented,in
R1180 T1179 T1176 arg2Of and,in
R1181 T1179 T1177 arg1Of and,table
R1182 T1178 T1179 arg1Of S1,and
R11827 T28586 T25572 arg1Of glycosylated,densely
R1183 T1180 T1179 arg2Of fig,and
R1184 T1186 T1182 arg1Of glycosylation,Fig.
R1185 T1186 T1183 arg1Of glycosylation,2
R1186 T1186 T1184 arg1Of glycosylation,Site-specific
R1187 T1186 T1185 arg1Of glycosylation,N-linked
R1188 T1186 T1187 arg1Of glycosylation,of
R1189 T1191 T1187 arg2Of glycoprotein,of
R1190 T1191 T1188 arg1Of glycoprotein,the
R1191 T1191 T1189 arg1Of glycoprotein,SARS-CoV-2
R1192 T1191 T1190 arg1Of glycoprotein,S
R1193 T1193 T1192 arg1Of schematic,The
R1194 T1193 T1194 arg1Of schematic,illustrates
R1195 T1197 T1194 arg2Of code,illustrates
R1196 T1197 T1195 arg1Of code,the
R1197 T1197 T1196 arg1Of code,color
R1198 T1197 T1198 arg1Of code,for
R1199 T1202 T1198 arg2Of types,for
R1200 T1202 T1199 arg1Of types,the
R1201 T1202 T1200 arg1Of types,principal
R1202 T1202 T1201 arg1Of types,glycan
R1203 T1202 T1203 arg1Of types,that
R1204 T1202 T1204 arg1Of types,can
R1205 T1205 T1204 arg2Of arise,can
R1206 T1202 T1205 arg1Of types,arise
R1207 T1205 T1206 arg1Of arise,along
R1208 T1209 T1206 arg2Of pathway,along
R1209 T1209 T1207 arg1Of pathway,the
R12092 T33505 T9674 arg1Of is,Given
R1210 T1209 T1208 arg1Of pathway,maturation
R1211 T1209 T1210 arg1Of pathway,from
R1212 T1211 T1210 arg2Of oligomannose-,from
R1213 T1197 T1212 arg1Of code,to
R1214 T1213 T1212 arg2Of hybrid-,to
R1215 T1213 T1214 arg1Of hybrid-,to
R1216 T1216 T1214 arg2Of glycans,to
R1217 T1216 T1215 arg1Of glycans,complex-type
R1218 T1218 T1217 arg1Of graphs,The
R1219 T1218 T1219 arg1Of graphs,summarize
R12192 T4213 T62165 arg1Of pool,peptide
R1220 T1223 T1219 arg2Of analysis,summarize
R1221 T1223 T1220 arg1Of analysis,quantitative
R1222 T1223 T1221 arg1Of analysis,mass
R1223 T1223 T1222 arg1Of analysis,spectrometric
R1224 T1223 T1224 arg1Of analysis,of
R12247 T63166 T26176 arg1Of spike,the
R1225 T1227 T1224 arg2Of population,of
R1226 T1227 T1225 arg1Of population,the
R1227 T1227 T1226 arg1Of population,glycan
R1228 T1227 T1228 arg1Of population,present
R1229 T1228 T1229 arg1Of present,at
R1230 T1233 T1229 arg2Of sites,at
R1231 T1233 T1230 arg1Of sites,individual
R1232 T1233 T1231 arg1Of sites,N-linked
R1233 T1233 T1232 arg1Of sites,glycosylation
R1234 T1233 T1234 arg2Of sites,simplified
R1235 T1234 T1235 arg1Of simplified,into
R1236 T1236 T1235 arg2Of categories,into
R12361 T92216 T96733 arg1Of glycoprotein,(
R1237 T1236 T1237 arg1Of categories,of
R12378 T4213 T68252 arg1Of pool,total
R1238 T1238 T1237 arg2Of glycans,of
R1239 T1242 T1239 arg1Of series,The
R1240 T1242 T1240 arg1Of series,oligomannose-type
R1241 T1242 T1241 arg1Of series,glycan
R1242 T1242 T1243 arg1Of series,(
R1243 T1244 T1243 arg2Of M9,(
R1244 T1251 T1243 arg3Of ),(
R1245 T1244 T1245 arg1Of M9,to
R1246 T1246 T1245 arg2Of M5,to
R1247 T1244 T1247 arg1Of M9,;
R1248 T1248 T1247 arg2Of Man9GlcNAc2,;
R1249 T1248 T1249 arg1Of Man9GlcNAc2,to
R12497 T51040 T79314 arg1Of structures,loop
R1250 T1250 T1249 arg2Of Man5GlcNAc2,to
R12505 T85027 T86083 arg2Of S,on
R1251 T1242 T1252 arg1Of series,is
R1252 T1253 T1252 arg2Of colored,is
R1253 T1242 T1253 arg2Of series,colored
R1254 T1254 T1253 arg3Of green,colored
R1255 T1242 T1254 arg1Of series,green
R1256 T1253 T1255 arg1Of colored,","
R1257 T1268 T1255 arg2Of dashed,","
R1258 T1260 T1256 arg1Of glycans,afucosylated
R12584 T33433 T62246 arg1Of holes,immunogenic
R1259 T1258 T1257 arg1Of fucosylated,and
R1260 T1260 T1258 arg1Of glycans,fucosylated
R1261 T1260 T1259 arg1Of glycans,hybrid-type
R1262 T1260 T1261 arg1Of glycans,(
R1263 T1263 T1261 arg2Of and,(
R1264 T1266 T1261 arg3Of ),(
R1265 T1262 T1263 arg1Of hybrid,and
R1266 T1265 T1263 arg2Of hybrid,and
R12664 T82801 T25127 arg1Of shield,the
R12669 T61867 T76075 arg1Of cells,HEK
R1267 T1265 T1264 arg1Of hybrid,F
R1268 T1260 T1267 arg1Of glycans,are
R1269 T1268 T1267 arg2Of dashed,are
R1270 T1260 T1268 arg2Of glycans,dashed
R1271 T1269 T1268 arg3Of pink,dashed
R1272 T1271 T1270 arg1Of and,","
R1273 T1255 T1271 arg1Of ",",and
R12731 T87754 T55772 arg1Of protected,In
R1274 T1292 T1271 arg2Of and,and
R12740 T72262 T96270 arg2Of 35,(
R1275 T1273 T1272 arg1Of glycans,complex
R1276 T1273 T1274 arg1Of glycans,are
R1277 T1275 T1274 arg2Of grouped,are
R1278 T1273 T1275 arg2Of glycans,grouped
R1279 T1275 T1276 arg1Of grouped,according
R1280 T1277 T1276 arg2Of to,according
R1281 T1279 T1277 arg2Of number,to
R1282 T1279 T1278 arg1Of number,the
R1283 T1279 T1280 arg1Of number,of
R1284 T1282 T1280 arg2Of and,of
R12844 T97849 T30157 arg1Of fucosylated,highly
R1285 T1281 T1282 arg1Of antennae,and
R12852 T23600 T64164 arg1Of regions,approximate
R1286 T1283 T1282 arg2Of presence,and
R1287 T1283 T1284 arg1Of presence,of
R1288 T1286 T1284 arg2Of fucosylation,of
R12880 T51132 T85295 arg1Of observed,for
R1289 T1286 T1285 arg1Of fucosylation,core
R1290 T1286 T1287 arg1Of fucosylation,(
R1291 T1288 T1287 arg2Of A1,(
R1292 T1291 T1287 arg3Of ),(
R1293 T1288 T1289 arg1Of A1,to
R1294 T1290 T1289 arg2Of FA4,to
R1295 T1275 T1292 arg1Of grouped,and
R1296 T1294 T1292 arg2Of colored,and
R1297 T1273 T1293 arg1Of glycans,are
R1298 T1294 T1293 arg2Of colored,are
R1299 T1273 T1294 arg2Of glycans,colored
R1300 T1295 T1294 arg3Of pink,colored
R1301 T1296 T1297 arg1Of Unoccupancy,of
R1302 T1301 T1297 arg2Of site,of
R1303 T1301 T1298 arg1Of site,an
R1304 T1301 T1299 arg1Of site,N-linked
R1305 T1301 T1300 arg1Of site,glycan
R1306 T1296 T1302 arg1Of Unoccupancy,is
R1307 T1303 T1302 arg2Of represented,is
R1308 T1296 T1303 arg2Of Unoccupancy,represented
R1309 T1303 T1304 arg1Of represented,in
R1310 T1305 T1304 arg2Of gray,in
R1311 T1308 T1306 arg1Of charts,The
R1312 T1308 T1307 arg1Of charts,pie
R1313 T1308 T1309 arg1Of charts,summarize
R1314 T1311 T1309 arg2Of quantification,summarize
R1315 T1311 T1310 arg1Of quantification,the
R1316 T1311 T1312 arg1Of quantification,of
R1317 T1314 T1312 arg2Of glycans,of
R1318 T1314 T1313 arg1Of glycans,these
R1319 T1316 T1315 arg1Of sites,Glycan
R1320 T1316 T1317 arg1Of sites,are
R1321 T1318 T1317 arg2Of colored,are
R1322 T1316 T1318 arg2Of sites,colored
R1323 T1347 T1318 arg3Of and,colored
R1324 T1318 T1319 arg1Of colored,according
R1325 T1320 T1319 arg2Of to,according
R1326 T1323 T1320 arg2Of content,to
R1327 T1323 T1321 arg1Of content,oligomannose-type
R1328 T1323 T1322 arg1Of content,glycan
R1329 T1318 T1324 arg1Of colored,","
R1330 T1318 T1325 arg1Of colored,with
R1331 T1328 T1325 arg2Of sites,with
R1332 T1328 T1326 arg1Of sites,the
R1333 T1328 T1327 arg1Of sites,glycan
R1334 T1328 T1329 arg2Of sites,labeled
R1335 T1329 T1330 arg1Of labeled,in
R1336 T1331 T1330 arg2Of green,in
R1337 T1331 T1332 arg1Of green,(
R1338 T1336 T1332 arg2Of %,(
R1339 T1337 T1332 arg3Of ),(
R1340 T1336 T1333 arg1Of %,80
R1341 T1333 T1334 arg1Of 80,to
R1342 T1335 T1334 arg2Of 100,to
R1343 T1318 T1338 arg1Of colored,","
R1344 T1339 T1340 arg1Of orange,(
R1345 T1344 T1340 arg2Of %,(
R1346 T1345 T1340 arg3Of ),(
R1347 T1344 T1341 arg1Of %,30
R1348 T1341 T1342 arg1Of 30,to
R1349 T1343 T1342 arg2Of 79,to
R1350 T1347 T1346 arg1Of and,","
R13500 T11027 T93860 arg1Of S,SARS-CoV-2
R1351 T1339 T1347 arg1Of orange,and
R1352 T1348 T1347 arg2Of pink,and
R1353 T1348 T1349 arg1Of pink,(
R1354 T1353 T1349 arg2Of %,(
R1355 T1354 T1349 arg3Of ),(
R1356 T1353 T1350 arg1Of %,0
R1357 T1350 T1351 arg1Of 0,to
R1358 T1352 T1351 arg2Of 29,to
R1359 T1357 T1355 arg1Of version,An
R1360 T1357 T1356 arg2Of version,extended
R1361 T1357 T1358 arg1Of version,of
R1362 T1361 T1358 arg2Of analysis,of
R1363 T1361 T1359 arg1Of analysis,the
R1364 T1361 T1360 arg1Of analysis,site-specific
R1365 T1361 T1362 arg1Of analysis,showing
R13650 T43925 T34125 arg1Of glycosylation,HIV-1
R1366 T1364 T1362 arg2Of heterogeneity,showing
R1367 T1364 T1363 arg1Of heterogeneity,the
R1368 T1364 T1365 arg1Of heterogeneity,within
R1369 T1367 T1365 arg2Of category,within
R13697 T33605 T48495 arg2Of glycans,contain
R1370 T1367 T1366 arg1Of category,each
R13700 T24433 T22184 arg2Of observed,is
R1371 T1357 T1368 arg1Of version,can
R1372 T1370 T1368 arg2Of found,can
R1373 T1357 T1369 arg1Of version,be
R1374 T1370 T1369 arg2Of found,be
R1375 T1357 T1370 arg2Of version,found
R1376 T1370 T1371 arg1Of found,in
R1377 T1374 T1371 arg2Of and,in
R1378 T1374 T1372 arg1Of and,table
R1379 T1373 T1374 arg1Of S1,and
R1380 T1375 T1374 arg2Of fig,and
R1381 T1379 T1377 arg1Of graphs,The
R1382 T1379 T1378 arg1Of graphs,bar
R1383 T1379 T1380 arg1Of graphs,represent
R1384 T1383 T1380 arg2Of quantities,represent
R1385 T1383 T1381 arg1Of quantities,the
R1386 T1383 T1382 arg1Of quantities,mean
R1387 T1383 T1384 arg1Of quantities,of
R1388 T1387 T1384 arg2Of replicates,of
R1389 T1387 T1385 arg1Of replicates,three
R1390 T1387 T1386 arg1Of replicates,biological
R1391 T1380 T1388 arg1Of represent,","
R1392 T1380 T1389 arg1Of represent,with
R1393 T1391 T1389 arg2Of bars,with
R1394 T1392 T1389 arg3Of representing,with
R1395 T1391 T1390 arg1Of bars,error
R1396 T1391 T1392 arg1Of bars,representing
R1397 T1395 T1392 arg2Of error,representing
R1398 T1395 T1393 arg1Of error,the
R1399 T1395 T1394 arg1Of error,standard
R13998 T53142 T80652 arg2Of glycans,of
R1400 T1395 T1396 arg1Of error,of
R1401 T1398 T1396 arg2Of mean,of
R1402 T1398 T1397 arg1Of mean,the
R1403 T1400 T1399 arg1Of sites,Two
R1404 T1400 T1401 arg1Of sites,on
R14042 T26972 T2047 arg1Of occupancy,indicates
R1405 T1403 T1401 arg2Of S,on
R1406 T1403 T1402 arg1Of S,SARS-CoV-2
R14066 T93537 T91654 arg1Of RBD,one
R1407 T1400 T1404 arg1Of sites,are
R1408 T1409 T1404 arg2Of and,are
R14084 T92160 T26033 arg1Of glycan,","
R1409 T1406 T1405 arg1Of oligomannose-type,principally
R1410 T1409 T1406 arg1Of and,oligomannose-type
R1411 T1406 T1407 arg1Of oligomannose-type,:
R1412 T1408 T1409 arg1Of N234,and
R1413 T1410 T1409 arg2Of N709,and
R1414 T1415 T1411 arg1Of structure,The
R1415 T1415 T1412 arg1Of structure,predominant
R1416 T1415 T1413 arg1Of structure,oligomannose-type
R1417 T1415 T1414 arg1Of structure,glycan
R1418 T1415 T1416 arg2Of structure,observed
R1419 T1416 T1417 arg1Of observed,across
R1420 T1419 T1417 arg2Of protein,across
R1421 T1419 T1418 arg1Of protein,the
R1422 T1416 T1420 arg1Of observed,","
R14220 T97181 T55441 arg1Of We,have
R1423 T1416 T1421 arg1Of observed,with
R1424 T1423 T1421 arg2Of exception,with
R1425 T1423 T1422 arg1Of exception,the
R1426 T1423 T1424 arg1Of exception,of
R14261 T47422 T99808 arg3Of ),(
R1427 T1425 T1424 arg2Of N234,of
R1428 T1427 T1426 arg1Of is,","
R1429 T1415 T1427 arg1Of structure,is
R1430 T1428 T1427 arg2Of Man5GlcNAc2,is
R1431 T1428 T1429 arg1Of Man5GlcNAc2,(
R1432 T1430 T1429 arg2Of Man,(
R1433 T1437 T1429 arg3Of ),(
R1434 T1430 T1431 arg1Of Man,","
R1435 T1433 T1431 arg2Of ;,","
R1436 T1432 T1433 arg1Of mannose,;
R14368 T47969 T56709 arg2Of glycoproteins,than
R1437 T1434 T1433 arg2Of GlcNAc,;
R1438 T1430 T1435 arg1Of Man,","
R1439 T1436 T1435 arg2Of N-acetylglucosamine,","
R14393 T22986 T69759 arg2Of that,above
R1440 T1428 T1438 arg1Of Man5GlcNAc2,","
R1441 T1428 T1439 arg1Of Man5GlcNAc2,which
R1442 T1428 T1440 arg1Of Man5GlcNAc2,demonstrates
R1443 T1449 T1440 arg2Of but,demonstrates
R1444 T1449 T1441 arg1Of but,that
R1445 T1443 T1442 arg1Of sites,these
R1446 T1443 T1444 arg1Of sites,are
R1447 T1446 T1444 arg2Of accessible,are
R1448 T1446 T1445 arg1Of accessible,largely
R1449 T1443 T1446 arg1Of sites,accessible
R1450 T1446 T1447 arg1Of accessible,to
R1451 T1448 T1447 arg2Of "α-1,2-mannosidases",to
R1452 T1444 T1449 arg1Of are,but
R1453 T1450 T1449 arg2Of are,but
R1454 T1443 T1450 arg1Of sites,are
R1455 T1452 T1450 arg2Of substrates,are
R1456 T1452 T1451 arg1Of substrates,poor
R1457 T1452 T1453 arg1Of substrates,for
R1458 T1454 T1453 arg2Of GlcNAcT-I,for
R1459 T1454 T1455 arg1Of GlcNAcT-I,","
R1460 T1454 T1456 arg1Of GlcNAcT-I,which
R14603 T69394 T54583 arg2Of %,fucosylated
R1461 T1454 T1457 arg1Of GlcNAcT-I,is
R1462 T1460 T1457 arg2Of enzyme,is
R14625 T26331 T34762 arg2Of coronaviruses,with
R1463 T1460 T1458 arg1Of enzyme,the
R14634 T23470 T68653 arg1Of system,expression
R1464 T1460 T1459 arg1Of enzyme,gateway
R1465 T1460 T1461 arg1Of enzyme,in
R1466 T1463 T1461 arg2Of formation,in
R1467 T1463 T1462 arg1Of formation,the
R1468 T1463 T1464 arg1Of formation,of
R1469 T1468 T1464 arg2Of glycans,of
R1470 T1468 T1465 arg1Of glycans,hybrid-
R1471 T1465 T1466 arg1Of hybrid-,and
R1472 T1467 T1466 arg2Of complex-type,and
R1473 T1468 T1467 arg1Of glycans,complex-type
R1474 T1468 T1469 arg1Of glycans,in
R1475 T1472 T1469 arg2Of apparatus,in
R1476 T1472 T1470 arg1Of apparatus,the
R1477 T1472 T1471 arg1Of apparatus,Golgi
R1478 T1474 T1473 arg1Of stage,The
R1479 T1479 T1475 arg1Of impeded,at
R1480 T1474 T1475 arg2Of stage,at
R1481 T1474 T1476 arg1Of stage,which
R1482 T1477 T1478 arg1Of processing,is
R1483 T1479 T1478 arg2Of impeded,is
R1484 T1477 T1479 arg2Of processing,impeded
R1485 T1474 T1480 arg1Of stage,is
R14856 T89974 T6472 arg1Of analysis,suggests
R1486 T1482 T1480 arg2Of signature,is
R1487 T1482 T1481 arg1Of signature,a
R1488 T1482 T1483 arg2Of signature,related
R1489 T1483 T1484 arg1Of related,to
R1490 T1487 T1484 arg2Of and,to
R1491 T1487 T1485 arg1Of and,the
R1492 T1486 T1487 arg1Of density,and
R1493 T1488 T1487 arg2Of presentation,and
R1494 T1487 T1489 arg1Of and,of
R1495 T1490 T1489 arg2Of glycans,of
R1496 T1487 T1491 arg1Of and,on
R1497 T1494 T1491 arg2Of spike,on
R1498 T1494 T1492 arg1Of spike,the
R1499 T1494 T1493 arg1Of spike,viral
R1500 T1513 T1495 arg1Of exhibit,For
R1501 T1496 T1495 arg2Of example,For
R1502 T1513 T1497 arg1Of exhibit,","
R1503 T1502 T1498 arg1Of spikes,the
R1504 T1500 T1499 arg1Of densely,more
R15047 T91383 T40917 arg1Of dispersion,the
R1505 T1501 T1500 arg1Of glycosylated,densely
R1506 T1502 T1501 arg1Of spikes,glycosylated
R1507 T1502 T1503 arg1Of spikes,of
R1508 T1506 T1503 arg2Of and,of
R1509 T1505 T1504 arg1Of Env,HIV-1
R1510 T1505 T1506 arg1Of Env,and
R1511 T1512 T1506 arg2Of GPC,and
R1512 T1508 T1507 arg1Of virus,Lassa
R1513 T1512 T1508 arg1Of GPC,virus
R1514 T1508 T1509 arg1Of virus,(
R1515 T1510 T1509 arg2Of LASV,(
R1516 T1511 T1509 arg3Of ),(
R1517 T1502 T1513 arg1Of spikes,exhibit
R15171 T40590 T86203 arg3Of ),(
R1518 T1515 T1513 arg2Of sites,exhibit
R15185 T82801 T33100 arg1Of shield,glycan
R1519 T1515 T1514 arg1Of sites,numerous
R1520 T1515 T1516 arg2Of sites,dominated
R1521 T1516 T1517 arg1Of dominated,by
R15219 T39891 T54489 arg2Of lines,as
R1522 T1518 T1517 arg2Of Man9GlcNAc2,by
R1523 T1518 T1519 arg1Of Man9GlcNAc2,(
R1524 T1520 T1519 arg2Of 21–24,(
R1525 T1521 T1519 arg3Of ),(
R1526 T1523 T1522 arg1Of mixture,A
R1527 T1523 T1524 arg1Of mixture,of
R1528 T1528 T1524 arg2Of glycans,of
R1529 T1528 T1525 arg1Of glycans,oligomannose-
R1530 T1525 T1526 arg1Of oligomannose-,and
R15302 T68062 T89202 arg1Of quantifications,oligomannose
R1531 T1527 T1526 arg2Of complex-type,and
R1532 T1528 T1527 arg1Of glycans,complex-type
R1533 T1523 T1529 arg1Of mixture,can
R1534 T1531 T1529 arg2Of found,can
R1535 T1523 T1530 arg1Of mixture,be
R1536 T1531 T1530 arg2Of found,be
R15368 T80673 T36507 arg1Of 6VSB,Bank
R1537 T1523 T1531 arg2Of mixture,found
R1538 T1531 T1532 arg1Of found,at
R1539 T1544 T1532 arg2Of and,at
R1540 T1541 T1533 arg1Of ",",sites
R15402 T30840 T34970 arg1Of glycans,oligomannose-type
R1541 T1534 T1535 arg1Of N61,","
R1542 T1536 T1535 arg2Of N122,","
R1543 T1535 T1537 arg1Of ",",","
R1544 T1538 T1537 arg2Of N603,","
R1545 T1537 T1539 arg1Of ",",","
R15459 T47203 T51816 arg1Of key,defined
R1546 T1540 T1539 arg2Of N717,","
R1547 T1539 T1541 arg1Of ",",","
R1548 T1542 T1541 arg2Of N801,","
R1549 T1544 T1543 arg1Of and,","
R1550 T1541 T1544 arg1Of ",",and
R1551 T1545 T1544 arg2Of N1074,and
R1552 T1545 T1546 arg1Of N1074,(
R1553 T1547 T1546 arg2Of Fig.,(
R1554 T1549 T1546 arg3Of ),(
R1555 T1547 T1548 arg1Of Fig.,2
R1556 T1560 T1550 arg1Of contain,Of
R1557 T1553 T1550 arg2Of sites,Of
R1558 T1553 T1551 arg1Of sites,the
R1559 T1553 T1552 arg1Of sites,22
R1560 T1553 T1554 arg1Of sites,on
R1561 T1557 T1554 arg2Of protein,on
R1562 T1557 T1555 arg1Of protein,the
R1563 T1557 T1556 arg1Of protein,S
R1564 T1560 T1558 arg1Of contain,","
R1565 T1559 T1560 arg1Of 8,contain
R1566 T1562 T1560 arg2Of populations,contain
R15661 T3324 T13056 arg1Of domain,in
R1567 T1562 T1561 arg1Of populations,substantial
R1568 T1562 T1563 arg1Of populations,of
R1569 T1565 T1563 arg2Of glycans,of
R1570 T1565 T1564 arg1Of glycans,oligomannose-type
R1571 T1560 T1566 arg1Of contain,","
R1572 T1568 T1567 arg2Of how,highlighting
R1573 T1560 T1567 modOf contain,highlighting
R1574 T1576 T1568 arg1Of is,how
R1575 T1570 T1569 arg1Of processing,the
R1576 T1570 T1571 arg1Of processing,of
R1577 T1575 T1571 arg2Of glycans,of
R15770 T57577 T64683 arg1Of levels,of
R1578 T1575 T1572 arg1Of glycans,the
R1579 T1575 T1573 arg1Of glycans,SARS-CoV-2
R1580 T1575 T1574 arg1Of glycans,S
R15802 T23470 T34958 arg1Of system,the
R1581 T1570 T1576 arg1Of processing,is
R1582 T1577 T1576 arg2Of divergent,is
R15826 T34524 T14995 arg1Of highlighted,in
R1583 T1570 T1577 arg1Of processing,divergent
R1584 T1577 T1578 arg1Of divergent,from
R1585 T1580 T1578 arg2Of glycoproteins,from
R1586 T1580 T1579 arg1Of glycoproteins,host
R1587 T1580 T1581 arg1Of glycoproteins,(
R1588 T1582 T1581 arg2Of 25,(
R1589 T1583 T1581 arg3Of ),(
R1590 T1587 T1584 arg1Of sites,The
R1591 T1587 T1585 arg1Of sites,remaining
R1592 T1587 T1586 arg1Of sites,14
R15921 T75341 T80869 arg1Of N-terminal,and
R1593 T1587 T1588 arg1Of sites,are
R15932 T77053 T71519 arg2Of quantified,when
R1594 T1589 T1588 arg2Of dominated,are
R1595 T1594 T1589 arg1Of glycans,dominated
R1596 T1587 T1589 arg2Of sites,dominated
R1597 T1594 T1590 arg2Of glycans,by
R1598 T1594 T1591 arg1Of glycans,processed
R15980 T74120 T57933 arg1Of benchmark,detailed
R1599 T1591 T1592 arg1Of processed,","
R15990 T28293 T56709 arg1Of lower,than
R1600 T1593 T1592 arg2Of complex-type,","
R1601 T1594 T1593 arg1Of glycans,complex-type
R1621 T83830 T27742 arg2Of residues,of
R16316 T7141 T10679 arg1Of GPC,","
R16363 T71732 T31145 arg2Of quality,of
R16721 T90262 T45562 arg2Of vulnerabilities,exhibits
R16792 T80553 T16983 arg1Of representation,translucent
R16827 T56154 T16557 arg1Of particles,from
R1683 T92146 T98529 arg1Of cells,II
R16840 T5111 T58385 arg2Of sites,Across
R16891 T74101 T45562 arg1Of shield,exhibits
R16897 T65899 T96948 arg1Of number,are
R16950 T12006 T68446 arg1Of sandwiched,between
R16993 T33433 T1898 arg2Of holes,generated
R17307 T38613 T82325 arg1Of immunogens,recombinant
R17404 T63316 T49490 arg2Of proteins,of
R17467 T92543 T54557 arg1Of related,closely
R17492 T73516 T96270 arg3Of ),(
R17573 T63316 T28586 arg1Of proteins,glycosylated
R17628 T93073 T83016 arg1Of less,of
R1768 T51427 T86889 arg2Of feature,is
R17686 T63316 T97814 arg1Of proteins,viral
R17688 T97193 T91683 arg1Of hemagglutinin,and
R17739 T57734 T24105 arg1Of constraints,functional
R17882 T70291 T98752 arg1Of clusters,on
R17894 T95927 T60379 arg1Of subunit,S1
R17994 T53787 T5347 arg1Of subunits,S1
R18037 T80673 T86203 arg1Of 6VSB,(
R18039 T47203 T17383 arg1Of key,the
R18067 T81020 T65795 arg2Of advent,with
R18138 T92146 T21578 arg1Of cells,Madin-Darby
R18196 T69248 T58247 arg2Of 31,","
R1832 T14769 T22534 arg1Of glycans,The
R18378 T70291 T32762 arg1Of clusters,mannose
R18677 T91587 T42207 arg1Of we,mapped
R18832 T87038 T87754 arg1Of component,protected
R19015 T62387 T63621 arg1Of antibodies,neutralizing
R19069 T77788 T16706 arg2Of 34,","
R19144 T79925 T20094 arg3Of ),(
R1924 T92745 T59972 arg1Of form,to
R19439 T44325 T15404 arg2Of 10,(
R19513 T97863 T7043 arg1Of S,SARS-CoV-1
R19591 T59365 T8171 arg1Of content,the
R19609 T51716 T96313 arg1Of trimers,in
R19640 T7141 T80005 arg1Of GPC,was
R19719 T70291 T16287 arg2Of clusters,feature
R19751 T20226 T35288 arg1Of kits,serological
R19774 T30429 T58688 arg1Of S,","
R19781 T88864 T19325 arg1Of We,note
R19814 T79250 T39461 arg1Of expressed,as
R20003 T26508 T54396 arg1Of glycoproteins,respective
R20228 T26423 T9240 arg1Of dense,Highly
R20253 T56889 T75209 arg1Of syndrome,(
R20369 T18591 T69202 arg1Of S3,)
R20449 T43864 T36047 arg2Of rise,give
R20454 T33433 T36047 arg1Of holes,give
R20525 T99350 T58273 arg2Of but,demonstrated
R20662 T87754 T53039 arg2Of protected,are
R20672 T59586 T5292 arg1Of shielding,of
R20715 T74575 T93111 arg2Of processing,driven
R20765 T30860 T49489 arg1Of and,As
R20789 T58933 T32961 arg1Of This,in
R20956 T33433 T26582 arg1Of holes,have
R21004 T5233 T2047 arg2Of require,indicates
R21026 T17500 T25885 arg1Of protein,S
R2103 T62335 T33505 arg1Of there,is
R21038 T35190 T97187 arg1Of 10,","
R21041 T30860 T62659 arg1Of and,","
R21053 T88152 T26582 arg2Of shown,have
R21103 T12006 T50345 arg1Of sandwiched,partially
R21113 T43905 T58340 arg1Of signatures,site-specific
R21159 T87423 T5233 arg2Of optimization,require
R21273 T74643 T77178 arg2Of 4,(
R21278 T51716 T6442 arg1Of trimers,soluble
R21364 T93073 T21482 arg2Of less,form
R21390 T93230 T34762 arg1Of consistent,with
R21487 T21559 T99808 arg2Of %,(
R21636 T28392 T41548 arg1Of GPC,LASV
R21640 T57498 T45593 arg2Of ",",on
R21703 T57734 T9674 arg2Of constraints,Given
R21741 T43425 T11584 arg2Of glycans,of
R21744 T43581 T71912 arg1Of glycans,N-linked
R21894 T30911 T73157 arg1Of %,of
R2190 T28240 T81527 arg2Of 30,(
R22057 T90334 T29169 arg1Of monitor,as
R22259 T65502 T75209 arg2Of MERS,(
R22343 T37436 T93088 arg2Of are,and
R22393 T51040 T26765 arg2Of structures,on
R22423 T66781 T95854 arg1Of N74,and
R22543 T26972 T56128 arg1Of occupancy,high
R22871 T9150 T23777 arg2Of glycosylation,of
R22889 T33605 T83428 arg2Of glycans,fucosylated
R22894 T51427 T49590 arg1Of feature,of
R22972 T6682 T68390 arg3Of ),(
R2326 T22130 T24696 arg1Of occupancy,site
R23306 T84057 T3133 arg2Of presentation,and
R23420 T76708 T53360 arg3Of ),(
R23505 T98047 T54489 arg1Of represented,as
R23552 T4900 T62513 arg2Of N165,(
R2357 T37032 T67860 arg3Of ),(
R23628 T85605 T15079 arg1Of clusters,in
R23683 T79250 T49353 arg2Of expressed,were
R23707 T48495 T48208 arg2Of contain,considering
R2384 T61238 T16844 arg1Of integrity,immunogen
R24004 T61533 T20152 arg1Of glycoproteins,host
R24011 T58273 T9573 arg1Of demonstrated,previously
R24132 T53787 T50925 arg2Of subunits,rendered
R24135 T57413 T46336 arg1Of be,therefore
R24140 T28105 T75378 arg1Of use,to
R24143 T62450 T90541 arg2Of affect,how
R24221 T38335 T54929 arg1Of epitopes,can
R24284 T74906 T74217 arg3Of ),(
R24293 T17581 T67465 arg1Of derived,from
R24299 T58449 T19457 arg2Of Shielding,observed
R24467 T62172 T10699 arg1Of Env,HIV-1
R24529 T70120 T74292 arg2Of scaled,are
R24618 T70120 T29169 arg2Of scaled,as
R24632 T4647 T63554 arg2Of recognized,are
R24737 T53023 T64078 arg1Of We,characterized
R24822 T2972 T28105 arg2Of glycans,use
R24865 T97193 T85313 arg1Of hemagglutinin,influenza
R24907 T85605 T75459 arg1Of clusters,dense
R2494 T40374 T78348 arg1Of structure,determined
R2508 T43342 T18553 arg1Of understand,important
R25095 T52064 T43652 arg1Of mapping,Structure-based
R25150 T33765 T67493 arg2Of Env,is
R25182 T33313 T25890 arg1Of GPC,LASV
R25284 T91351 T34118 arg2Of region,of
R25367 T38613 T54133 arg1Of immunogens,will
R25408 T82646 T62704 arg2Of to,according
R25417 T82381 T44252 arg1Of is,Whereas
R25451 T40607 T15113 arg1Of one,at
R25464 T59318 T23777 arg1Of levels,of
R25492 T52029 T77436 arg1Of areas,conserved
R25702 T93436 T75195 arg1Of modifications,can
R25711 T87754 T10097 arg1Of protected,","
R26042 T24871 T58170 arg2Of vulnerable,and
R26078 T40050 T31145 arg1Of measure,of
R26231 T74575 T20432 arg1Of processing,the
R26387 T83026 T85530 arg1Of sites,binding
R26595 T98405 T12944 arg2Of and,including
R26626 T59383 T62142 arg1Of blue,light
R26730 T36047 T23465 arg1Of give,to
R26826 T92160 T24753 arg1Of glycan,which
R26895 T57413 T48513 arg2Of be,will
R26917 T59746 T9791 arg1Of proteins,the
R26921 T40050 T57413 arg2Of measure,be
R26923 T19380 T56834 arg1Of S,SARS-CoV-2
R26958 T35429 T94836 arg2Of influenced,be
R27170 T91351 T78710 arg1Of region,this
R27216 T75860 T3133 arg1Of processing,and
R27288 T5233 T47714 arg1Of require,that
R27311 T23189 T84265 arg1Of glycans,bearing
R27467 T38613 T5233 arg1Of immunogens,require
R27530 T50255 T21494 arg2Of spike,of
R27591 T66124 T51541 arg1Of analysis,glycan
R27705 T91220 T69994 arg1Of structure,of
R27739 T30840 T4647 arg2Of glycans,recognized
R27773 T24433 T69759 arg1Of observed,above
R27828 T5763 T57063 arg2Of 27,(
R27963 T23470 T99582 arg2Of system,used
R27972 T93693 T70311 arg2Of density,and
R2801 T16198 T6640 arg2Of engineering,in
R281 T286 T282 arg1Of coronavirus,Severe
R28123 T16242 T68390 arg1Of maps,(
R2818 T58449 T85870 arg1Of Shielding,on
R282 T286 T283 arg1Of coronavirus,acute
R28275 T80869 T35576 arg1Of and,the
R283 T286 T284 arg1Of coronavirus,respiratory
R28363 T29563 T75732 arg1Of glycoproteins,other
R284 T286 T285 arg1Of coronavirus,syndrome
R28431 T78348 T93076 arg1Of determined,experimentally
R2845 T50036 T30140 arg2Of with,compared
R28494 T45562 T79087 arg2Of exhibits,and
R285 T286 T287 arg1Of coronavirus,2
R286 T286 T288 arg1Of coronavirus,(
R28670 T91709 T16134 arg1Of status,the
R287 T289 T288 arg2Of SARS-CoV-2,(
R28714 T54872 T78149 arg1Of sites,glycosylation
R28753 T34862 T97151 arg1Of route,for
R288 T290 T288 arg3Of ),(
R2880 T78729 T6151 arg1Of colored,as
R28855 T6736 T95680 arg1Of structure,the
R289 T286 T291 arg1Of coronavirus,","
R28964 T78957 T4224 arg1Of glycans,Representative
R28990 T64679 T54192 arg1Of clusters,small
R290 T294 T291 arg2Of pathogen,","
R29042 T91709 T78920 arg1Of status,glycosylation
R29046 T59746 T26717 arg1Of proteins,SARS-CoV-1
R29071 T4213 T74217 arg1Of pool,(
R291 T294 T292 arg1Of pathogen,the
R2913 T52064 T18153 arg1Of mapping,3
R292 T294 T293 arg1Of pathogen,causative
R293 T294 T295 arg1Of pathogen,of
R294 T296 T295 arg2Of coronavirus,of
R29415 T54945 T17701 arg1Of is,Additionally
R295 T296 T297 arg1Of coronavirus,2019
R29512 T26054 T58385 arg1Of and,Across
R29515 T87200 T40154 arg1Of observed,on
R296 T296 T298 arg1Of coronavirus,(
R297 T299 T298 arg2Of COVID-19,(
R29787 T22249 T15404 arg3Of ),(
R298 T300 T298 arg3Of ),(
R299 T296 T301 arg1Of coronavirus,(
R29945 T50000 T71335 arg1Of residues,fucose
R300 T303 T301 arg2Of ",",(
R30095 T33097 T48675 arg1Of be,and
R301 T305 T301 arg3Of ),(
R30106 T51132 T72717 arg2Of observed,has
R30149 T2806 T74292 arg1Of processes,are
R302 T302 T303 arg1Of 1,","
R30249 T86957 T75378 modOf pressure,to
R303 T304 T303 arg2Of 2,","
R30337 T39591 T63829 arg2Of induce,;
R30352 T93436 T35429 arg2Of modifications,influenced
R30354 T81523 T66981 arg2Of those,as
R304 T307 T306 arg1Of induces,","
R30419 T98047 T13933 arg2Of represented,are
R30457 T78059 T80185 arg2Of and,of
R305 T286 T307 arg1Of coronavirus,induces
R3053 T81020 T37516 arg1Of advent,of
R306 T314 T307 arg2Of and,induces
R307 T308 T309 arg1Of fever,","
R308 T312 T309 arg2Of illness,","
R30804 T26054 T97279 arg1Of and,","
R30814 T50945 T99893 arg2Of important,be
R309 T312 T310 arg1Of illness,severe
R30911 T45140 T90831 arg1Of N1158,","
R30921 T59586 T86889 arg1Of shielding,is
R30946 T43425 T45691 arg1Of glycans,SARS-CoV-2
R310 T312 T311 arg1Of illness,respiratory
R31034 T74313 T84121 arg2Of colored,are
R31047 T61137 T99018 arg2Of that,and
R311 T314 T313 arg1Of and,","
R312 T309 T314 arg1Of ",",and
R31250 T75023 T31556 arg1Of glycans,the
R313 T315 T314 arg2Of pneumonia,and
R31307 T43925 T85697 arg1Of glycosylation,Env
R31340 T36047 T48675 arg2Of give,and
R31355 T52029 T24871 arg1Of areas,vulnerable
R314 T316 T317 arg1Of SARS-CoV-2,uses
R31431 T81020 T65559 arg1Of advent,the
R31496 T61183 T38802 arg1Of glycoproteins,viral
R315 T325 T317 arg2Of protein,uses
R316 T333 T317 arg3Of bind,uses
R31694 T18926 T96446 arg2Of 24,(
R317 T325 T318 arg1Of protein,an
R318 T320 T319 arg1Of glycosylated,extensively
R31813 T18108 T48759 arg2Of conformation,in
R31890 T48157 T19878 arg1Of domains,receptor
R319 T321 T320 arg1Of spike,glycosylated
R31908 T78957 T76680 arg2Of glycans,modeled
R31920 T95927 T19628 arg1Of subunit,the
R31957 T76134 T54945 arg1Of processing,is
R31995 T58459 T16503 arg1Of residues,these
R320 T325 T321 arg1Of protein,spike
R321 T321 T322 arg1Of spike,(
R32118 T93111 T11801 arg2Of driven,is
R32128 T96850 T67860 arg2Of 21,(
R32170 T9247 T26051 arg1Of colored,","
R322 T323 T322 arg2Of S,(
R323 T324 T322 arg3Of ),(
R32305 T7366 T74217 arg2Of S2,(
R324 T325 T326 arg1Of protein,that
R32427 T5233 T54133 arg2Of require,will
R32439 T18153 T91083 arg1Of 3,Fig.
R32490 T58459 T69365 arg2Of residues,of
R325 T325 T327 arg1Of protein,protrudes
R32564 T98675 T95854 arg2Of N149,and
R3257 T92216 T10101 arg1Of glycoprotein,S
R326 T327 T328 arg1Of protrudes,from
R327 T331 T328 arg2Of surface,from
R328 T331 T329 arg1Of surface,the
R32829 T94953 T10765 arg1Of structure,the
R3284 T40708 T82153 arg1Of analysis,glycosylation
R329 T331 T330 arg1Of surface,viral
R330 T333 T332 arg1Of bind,to
R331 T316 T333 arg1Of SARS-CoV-2,bind
R33143 T48495 T54929 arg2Of contain,can
R33161 T39591 T68824 arg1Of induce,","
R332 T333 T334 arg1Of bind,to
R333 T336 T334 arg2Of enzyme,to
R33343 T27606 T28293 arg1Of it,lower
R334 T336 T335 arg1Of enzyme,angiotensin-converting
R33481 T93537 T48759 arg1Of RBD,in
R33489 T33765 T93662 arg1Of Env,which
R335 T336 T337 arg1Of enzyme,2
R3350 T54945 T48208 modOf is,considering
R33571 T29563 T29111 arg1Of glycoproteins,","
R336 T336 T338 arg1Of enzyme,(
R337 T339 T338 arg2Of ACE2,(
R3371 T76385 T82169 arg3Of ],[
R33795 T82801 T96677 arg2Of shield,throughout
R338 T340 T338 arg3Of ),(
R33812 T15280 T96733 arg3Of ),(
R33831 T18452 T37781 arg2Of glycoproteins,to
R33866 T30911 T46382 arg1Of %,99
R339 T342 T341 arg1Of mediate,to
R33957 T77776 T71768 arg1Of S,SARS-CoV-1
R340 T333 T341 modOf bind,to
R34052 T34986 T22260 arg1Of camouflage,to
R341 T344 T342 arg2Of entry,mediate
R34199 T25051 T68781 arg2Of 24,(
R342 T344 T343 arg1Of entry,host-cell
R343 T344 T345 arg1Of entry,(
R34396 T92216 T87665 arg2Of glycoprotein,of
R344 T346 T345 arg2Of 3,(
R34405 T2087 T50724 arg3Of ),(
R34491 T38725 T49742 arg2Of glycosylated,is
R345 T347 T345 arg3Of ),(
R34546 T18452 T19871 arg1Of glycoproteins,viral
R34582 T97920 T3138 arg1Of left,to
R346 T350 T348 arg1Of protein,The
R34637 T47969 T35332 arg1Of glycoproteins,viral
R34656 T79252 T77178 arg3Of ),(
R34663 T33765 T5107 arg1Of Env,HIV-1
R34694 T74210 T15870 arg2Of to,according
R34699 T3324 T6856 arg1Of domain,receptor
R347 T350 T349 arg1Of protein,S
R348 T350 T351 arg1Of protein,is
R34846 T74014 T33886 arg1Of sites,glycan
R34866 T69070 T95534 arg1Of subunits,the
R349 T357 T351 arg2Of protein,is
R34980 T72397 T86083 arg1Of characterized,on
R350 T357 T352 arg1Of protein,a
R3501 T23470 T42310 arg2Of system,by
R35041 T70120 T94082 arg1Of scaled,for
R351 T357 T353 arg1Of protein,trimeric
R35119 T15784 T14271 arg2Of glycans,be
R352 T357 T354 arg1Of protein,class
R35289 T4862 T34118 arg1Of glycosylation,of
R353 T357 T355 arg1Of protein,I
R354 T357 T356 arg1Of protein,fusion
R355 T357 T358 arg1Of protein,","
R356 T357 T359 arg2Of protein,composed
R35651 T17500 T23500 arg1Of protein,SARS-CoV-2
R357 T359 T360 arg1Of composed,of
R358 T363 T360 arg2Of subunits,of
R359 T363 T361 arg1Of subunits,two
R360 T363 T362 arg1Of subunits,functional
R36046 T42144 T81150 arg2Of detected,were
R36094 T87038 T50880 arg2Of component,by
R361 T357 T364 arg1Of protein,","
R362 T357 T365 arg1Of protein,responsible
R3623 T59365 T39795 arg1Of content,oligomannose-type
R363 T365 T366 arg1Of responsible,for
R36388 T5111 T50825 arg1Of sites,glycosylation
R364 T373 T366 arg2Of and,for
R365 T368 T367 arg1Of binding,receptor
R36503 T34505 T43281 arg2Of loops,on
R36564 T53787 T6552 arg1Of subunits,S2
R36571 T74101 T93230 arg1Of shield,consistent
R366 T368 T369 arg1Of binding,(
R367 T371 T369 arg2Of subunit,(
R36722 T43282 T82409 arg2Of candidates,of
R36737 T47301 T38431 arg1Of we,detected
R36744 T91709 T42207 arg2Of status,mapped
R36781 T40374 T71501 arg1Of structure,(
R368 T372 T369 arg3Of ),(
R369 T371 T370 arg1Of subunit,S1
R3693 T14271 T9689 arg3Of be,determined
R36955 T42144 T65863 arg2Of detected,Although
R370 T368 T373 arg1Of binding,and
R37005 T40374 T78411 arg1Of structure,the
R37095 T25149 T36877 arg2Of sites,with
R371 T375 T373 arg2Of fusion,and
R37175 T18452 T38653 arg1Of glycoproteins,other
R372 T375 T374 arg1Of fusion,membrane
R37211 T59586 T61614 arg1Of shielding,by
R373 T375 T376 arg1Of fusion,(
R37324 T19113 T72545 arg3Of ),(
R37379 T7141 T35984 arg1Of GPC,which
R374 T378 T376 arg2Of subunit,(
R37482 T42207 T30763 modOf mapped,Using
R37484 T10589 T71736 arg1Of reside,sites
R375 T379 T376 arg3Of ),(
R37520 T66124 T40599 arg1Of analysis,offers
R37538 T23470 T16911 arg1Of system,cellular
R37561 T91383 T19325 arg2Of dispersion,note
R37583 T78729 T67317 arg2Of colored,are
R376 T378 T377 arg1Of subunit,S2
R37673 T23600 T82526 arg2Of regions,at
R377 T357 T380 arg1Of protein,(
R37750 T55820 T91160 arg1Of analysis,spectrometric
R378 T381 T380 arg2Of 4,(
R3786 T14769 T67317 arg1Of glycans,are
R379 T384 T380 arg3Of ),(
R37966 T59365 T22184 arg1Of content,is
R380 T381 T382 arg1Of 4,","
R381 T383 T382 arg2Of 5,","
R38136 T83078 T31115 arg2Of be,may
R382 T386 T385 arg1Of surface,The
R383 T386 T387 arg1Of surface,of
R38362 T26765 T93822 arg1Of on,and
R384 T390 T387 arg2Of spike,of
R385 T390 T388 arg1Of spike,the
R38503 T57734 T16190 arg1Of constraints,the
R38530 T22130 T32198 arg2Of occupancy,enhance
R386 T390 T389 arg1Of spike,envelope
R387 T386 T391 arg1Of surface,is
R38796 T12079 T61579 arg2Of SARS-CoV-2,of
R388 T392 T391 arg2Of dominated,is
R38853 T78729 T15870 arg1Of colored,according
R389 T386 T392 arg2Of surface,dominated
R3899 T87241 T82836 arg3Of ),(
R390 T392 T393 arg1Of dominated,by
R391 T395 T393 arg2Of glycans,by
R39101 T43342 T20438 arg1Of understand,to
R392 T395 T394 arg1Of glycans,host-derived
R39256 T88891 T28536 arg1Of mimetic,coronavirus
R393 T392 T396 arg1Of dominated,","
R394 T392 T397 arg1Of dominated,with
R395 T399 T397 arg2Of trimer,with
R39520 T91383 T93048 arg1Of dispersion,across
R39596 T6303 T82526 arg1Of mapped,at
R396 T400 T397 arg3Of displaying,with
R397 T399 T398 arg1Of trimer,each
R39703 T97193 T20094 arg1Of hemagglutinin,(
R398 T399 T400 arg1Of trimer,displaying
R39858 T45265 T18565 arg1Of glycans,oligomannose-type
R399 T404 T400 arg2Of sites,displaying
R400 T404 T401 arg1Of sites,66
R40002 T58978 T6297 arg2Of revealed,were
R40051 T99893 T90065 arg1Of be,also
R401 T404 T402 arg1Of sites,N-linked
R402 T404 T403 arg1Of sites,glycosylation
R403 T407 T405 arg1Of protein,The
R40310 T59318 T9101 arg1Of levels,at
R404 T407 T406 arg1Of protein,S
R4046 T31718 T42037 arg1Of terminus,the
R40460 T33433 T88152 arg2Of holes,shown
R405 T407 T408 arg1Of protein,is
R40503 T38335 T48495 arg1Of epitopes,contain
R40598 T19196 T33122 arg1Of component,a
R406 T411 T408 arg2Of target,is
R40617 T93293 T27600 arg1Of 8,","
R4067 T55200 T77052 arg2Of sequons,of
R40670 T31718 T81032 arg1Of terminus,that
R407 T411 T409 arg1Of target,a
R40732 T40599 T30860 arg1Of offers,and
R40780 T43581 T64078 arg2Of glycans,characterized
R408 T411 T410 arg1Of target,key
R40826 T82801 T15404 arg1Of shield,(
R409 T411 T412 arg1Of target,in
R40932 T68235 T16371 arg2Of independent,were
R410 T415 T412 arg2Of efforts,in
R41011 T70291 T48112 arg1Of clusters,so-called
R411 T415 T413 arg1Of efforts,vaccine
R412 T415 T414 arg1Of efforts,design
R413 T415 T416 arg1Of efforts,(
R41327 T91160 T84264 arg1Of spectrometric,and
R414 T417 T416 arg2Of 6,(
R4148 T47969 T85625 arg1Of glycoproteins,other
R415 T418 T416 arg3Of ),(
R416 T420 T419 arg1Of and,","
R41635 T68235 T82363 arg1Of independent,of
R41647 T41818 T82836 arg2Of 26,(
R41695 T55820 T10034 arg1Of analysis,cryo-EM
R417 T408 T420 arg1Of is,and
R418 T429 T420 arg2Of reveal,and
R419 T423 T421 arg2Of glycosylation,understanding
R41904 T51132 T60447 arg1Of observed,","
R41910 T75833 T54543 arg1Of glycans,~60
R41989 T19875 T9101 arg2Of Thr323/Ser325,at
R420 T423 T422 arg1Of glycosylation,the
R42036 T7141 T78049 arg1Of GPC,LASV
R42098 T13791 T45086 arg1Of mechanisms,those
R421 T423 T424 arg1Of glycosylation,of
R42109 T62246 T33097 arg2Of immunogenic,be
R42147 T5772 T65532 arg1Of GPC,LASV
R42170 T19457 T15145 arg1Of observed,","
R42194 T85605 T74600 arg1Of clusters,the
R422 T427 T424 arg2Of spikes,of
R423 T427 T425 arg1Of spikes,recombinant
R4234 T20422 T47865 arg1Of Fig.,3
R42369 T40589 T61056 arg1Of S2,table
R424 T427 T426 arg1Of spikes,viral
R425 T421 T428 arg1Of understanding,can
R42528 T72733 T91002 arg2Of spike,of
R42581 T68062 T15226 arg1Of quantifications,Site-specific
R426 T429 T428 arg2Of reveal,can
R427 T421 T429 arg1Of understanding,reveal
R42702 T59365 T52753 arg1Of content,(
R428 T435 T429 arg2Of and,reveal
R42841 T92216 T9342 arg1Of glycoprotein,with
R429 T431 T430 arg1Of features,fundamental
R42981 T76680 T38375 arg2Of modeled,are
R430 T431 T432 arg1Of features,of
R43003 T64679 T67961 arg1Of clusters,have
R43041 T52029 T36121 arg1Of areas,of
R431 T434 T432 arg2Of biology,of
R432 T434 T433 arg1Of biology,viral
R43228 T22100 T94527 arg2Of Env,","
R433 T431 T435 arg1Of features,and
R43307 T41077 T98405 arg1Of Env,and
R43321 T63316 T73507 arg1Of proteins,the
R43334 T12006 T5394 arg2Of sandwiched,is
R43336 T48381 T51156 arg2Of N343,","
R434 T439 T435 arg2Of strategies,and
R43403 T72733 T22272 arg1Of spike,the
R435 T439 T436 arg1Of strategies,guide
R43574 T57577 T16371 arg1Of levels,were
R436 T439 T437 arg1Of strategies,vaccine
R43665 T68457 T5059 arg1Of Fig.,3
R43677 T79926 T57413 arg1Of profiling,be
R437 T439 T438 arg1Of strategies,design
R43718 T55177 T53039 arg1Of structures,are
R438 T439 T440 arg1Of strategies,(
R43856 T4900 T14840 arg1Of N165,","
R439 T441 T440 arg2Of 7,(
R4391 T92216 T94320 arg1Of glycoprotein,","
R43924 T92216 T46332 arg1Of glycoprotein,the
R440 T444 T440 arg3Of ),(
R44057 T4878 T49699 arg2Of suggesting,","
R441 T441 T442 arg1Of 7,","
R44142 T38405 T62722 arg1Of conformation,the
R442 T443 T442 arg2Of 8,","
R443 T446 T445 arg1Of glycosylation,Viral
R444 T446 T447 arg1Of glycosylation,has
R44400 T93537 T9342 arg2Of RBD,with
R44415 T54583 T83730 arg2Of fucosylated,are
R44471 T88891 T68075 arg1Of mimetic,spike
R44475 T64078 T26765 arg1Of characterized,on
R445 T449 T447 arg2Of roles,has
R44554 T51462 T61661 arg1Of glycans,the
R44577 T54583 T26054 arg1Of fucosylated,and
R446 T449 T448 arg1Of roles,wide-ranging
R44668 T24822 T15827 arg1Of system,the
R44669 T5347 T24386 arg1Of S1,and
R447 T449 T450 arg1Of roles,in
R44722 T67334 T4878 arg2Of is,suggesting
R44745 T80553 T9247 arg2Of representation,colored
R448 T452 T450 arg2Of pathobiology,in
R44821 T60496 T93822 arg2Of at,and
R449 T452 T451 arg1Of pathobiology,viral
R44911 T45562 T88865 arg1Of exhibits,similarly
R44949 T7521 T46576 arg1Of glycoproteins,All
R44960 T56889 T77913 arg1Of syndrome,East
R450 T449 T453 arg1Of roles,","
R45010 T69394 T83730 arg1Of %,are
R45086 T40374 T62553 arg2Of structure,onto
R451 T449 T454 arg1Of roles,including
R452 T455 T454 arg2Of mediating,including
R45258 T48208 T17998 arg1Of considering,especially
R453 T460 T455 arg2Of and,mediating
R45311 T38285 T90544 arg2Of loops,on
R45319 T74120 T49219 arg2Of benchmark,offers
R45331 T43425 T99243 arg1Of glycans,N-linked
R454 T458 T456 arg1Of and,protein
R4541 T17607 T73157 arg2Of sites,of
R45411 T83900 T75814 arg2Of manufacture,in
R455 T457 T458 arg1Of folding,and
R456 T459 T458 arg2Of stability,and
R45610 T87423 T93225 arg1Of optimization,further
R45653 T17500 T48558 arg1Of protein,trimeric
R45664 T64589 T67847 arg1Of rates,resulting
R457 T458 T460 arg1Of and,and
R45734 T21233 T31888 arg1Of fig,(
R45773 T98405 T44859 arg1Of and,beneficial
R458 T463 T460 arg2Of tropism,and
R459 T463 T461 arg1Of tropism,shaping
R45933 T27482 T70290 arg2Of N149,and
R460 T463 T462 arg1Of tropism,viral
R46010 T77775 T96446 arg1Of GPC,(
R46036 T72606 T86203 arg2Of PDB,(
R461 T463 T464 arg1Of tropism,(
R462 T465 T464 arg2Of 9,(
R463 T466 T464 arg3Of ),(
R46329 T65172 T68502 arg2Of cell,by
R464 T468 T467 arg1Of sites,Glycosylation
R465 T468 T469 arg1Of sites,are
R46518 T76290 T70290 arg1Of N74,and
R46537 T58933 T8349 arg1Of This,is
R466 T470 T469 arg2Of under,are
R46651 T68457 T40385 arg2Of Fig.,(
R467 T468 T470 arg1Of sites,under
R46767 T10589 T34813 arg1Of reside,the
R468 T472 T470 arg2Of pressure,under
R46867 T6259 T81525 arg1Of N343,is
R469 T472 T471 arg1Of pressure,selective
R46964 T98047 T90544 arg1Of represented,on
R470 T469 T473 arg1Of are,as
R471 T475 T473 arg2Of facilitate,as
R47152 T85485 T2545 arg2Of gray,and
R47193 T23189 T88519 arg2Of glycans,detected
R472 T474 T475 arg1Of they,facilitate
R47211 T20226 T45219 arg1Of kits,testing
R47236 T80203 T42509 arg1Of strains,of
R47296 T74120 T48966 arg1Of benchmark,of
R473 T477 T475 arg2Of evasion,facilitate
R4730 T43342 T36320 arg1Of understand,will
R474 T477 T476 arg1Of evasion,immune
R47442 T97849 T85946 arg2Of fucosylated,reveals
R47478 T82471 T68390 arg2Of 4,(
R47493 T77776 T94527 arg1Of S,","
R475 T475 T478 arg1Of facilitate,by
R47550 T15784 T71510 arg1Of glycans,consistent
R476 T479 T478 arg2Of shielding,by
R47672 T18553 T53107 arg2Of important,be
R477 T474 T479 arg1Of they,shielding
R47738 T56154 T10445 arg1Of particles,virus-like
R478 T481 T479 arg2Of epitopes,shielding
R47845 T89974 T98072 arg1Of analysis,glycosylation
R479 T481 T480 arg1Of epitopes,specific
R480 T481 T482 arg1Of epitopes,from
R48030 T2972 T72006 arg1Of glycans,N-linked
R48064 T40374 T79174 arg1Of structure,(
R48071 T94803 T96472 arg1Of antibodies,against
R481 T484 T482 arg2Of neutralization,from
R4814 T64589 T37003 arg1Of rates,the
R48191 T55778 T79525 arg1Of S,(
R482 T484 T483 arg1Of neutralization,antibody
R48217 T78943 T68991 arg2Of how,reveals
R48232 T15458 T79174 arg3Of ),(
R483 T488 T485 arg1Of note,However
R484 T488 T486 arg1Of note,","
R48498 T85483 T24812 arg1Of antibodies,(
R485 T487 T488 arg1Of we,note
R48524 T61332 T31010 arg1Of shields,glycan
R486 T495 T488 arg2Of and,note
R48686 T93802 T58755 arg1Of structure,prefusion
R487 T492 T489 arg1Of rate,the
R48711 T32961 T8349 arg2Of in,is
R48732 T26508 T36121 arg2Of glycoproteins,of
R48789 T51503 T2576 arg1Of S,SARS-CoV-2
R48795 T58449 T58513 arg1Of Shielding,be
R488 T492 T490 arg1Of rate,low
R489 T492 T491 arg1Of rate,mutation
R4895 T55200 T78865 arg1Of sequons,of
R490 T492 T493 arg1Of rate,of
R49051 T85733 T33280 arg1Of shield,a
R491 T494 T493 arg2Of SARS-CoV-2,of
R492 T492 T495 arg1Of rate,and
R493 T496 T495 arg2Of that,and
R49323 T51132 T66450 arg1Of observed,Whereas
R49382 T79087 T6472 arg2Of and,suggests
R494 T502 T496 arg2Of been,that
R49422 T74101 T65358 arg1Of shield,the
R495 T498 T497 arg1Of yet,as
R4957 T2299 T25244 arg2Of elicitation,for
R496 T502 T498 arg1Of been,yet
R49627 T43905 T31488 arg1Of signatures,glycan
R497 T502 T499 arg1Of been,","
R49726 T40050 T41872 arg1Of measure,an
R498 T500 T501 arg1Of there,have
R49800 T43581 T72449 arg1Of glycans,the
R49893 T51462 T99410 arg1Of glycans,occlude
R499 T502 T501 arg2Of been,have
R49961 T18108 T62164 arg1Of conformation,the
R500 T500 T502 arg1Of there,been
R50016 T83830 T32319 arg1Of residues,these
R501 T505 T502 arg2Of mutations,been
R50116 T29563 T97967 arg1Of glycoproteins,viral
R502 T505 T503 arg1Of mutations,no
R50234 T25953 T65139 arg1Of densely,less
R50235 T24871 T50830 arg1Of vulnerable,potentially
R503 T505 T504 arg2Of mutations,observed
R50305 T85483 T39962 arg2Of antibodies,by
R50318 T65727 T27600 arg2Of 21,","
R504 T505 T506 arg1Of mutations,to
R50414 T31718 T60496 arg2Of terminus,at
R505 T509 T506 arg2Of sites,to
R50539 T74014 T71199 arg1Of sites,unoccupied
R506 T509 T507 arg1Of sites,N-linked
R5066 T16198 T89341 arg1Of engineering,immunogen
R507 T509 T508 arg1Of sites,glycosylation
R5071 T78957 T38375 arg1Of glycans,are
R508 T509 T510 arg1Of sites,(
R509 T511 T510 arg2Of 10,(
R50900 T65870 T96472 arg2Of S,against
R5099 T13027 T60989 arg1Of glycans,complex-type
R510 T512 T510 arg3Of ),(
R51019 T19457 T58350 arg2Of observed,can
R5102 T87754 T50034 arg1Of protected,as
R51067 T68062 T75794 arg1Of quantifications,N-linked
R511 T513 T514 arg1Of Surfaces,with
R512 T518 T514 arg2Of density,with
R51252 T15784 T16375 arg1Of glycans,complex-type
R513 T518 T515 arg1Of density,an
R51308 T62291 T85384 arg1Of Underprocessing,of
R51360 T17581 T80005 arg2Of derived,was
R514 T517 T516 arg1Of high,unusually
R515 T518 T517 arg1Of density,high
R51580 T9247 T50249 arg1Of colored,","
R516 T518 T519 arg1Of density,of
R517 T520 T519 arg2Of glycans,of
R518 T513 T521 arg1Of Surfaces,can
R51809 T15784 T46638 arg1Of glycans,","
R51875 T41077 T78853 arg1Of Env,HIV-1
R51882 T10034 T84264 arg2Of cryo-EM,and
R519 T523 T521 arg2Of enable,can
R51940 T30234 T40385 arg3Of ),(
R520 T523 T522 arg1Of enable,also
R52043 T7366 T34758 arg1Of S2,table
R521 T513 T523 arg1Of Surfaces,enable
R522 T525 T523 arg2Of recognition,enable
R52209 T33765 T65352 arg1Of Env,","
R5226 T57577 T3049 arg1Of levels,the
R523 T525 T524 arg1Of recognition,immune
R52323 T69070 T36311 arg1Of subunits,both
R52389 T10017 T25098 arg1Of use,clinical
R524 T525 T526 arg1Of recognition,(
R52453 T75023 T72708 arg2Of glycans,of
R52463 T48157 T80869 arg2Of domains,and
R525 T528 T526 arg2Of ",",(
R526 T532 T526 arg3Of ),(
R527 T527 T528 arg1Of 9,","
R528 T529 T528 arg2Of 11,","
R529 T528 T530 arg1Of ",",","
R52906 T49931 T50034 arg2Of exemplified,as
R52908 T21633 T43289 arg1Of phenomenon,been
R52951 T8349 T63829 arg1Of is,;
R52990 T67493 T16646 arg1Of is,","
R530 T531 T530 arg2Of 12,","
R5307 T64679 T50872 arg1Of clusters,been
R53097 T70317 T62423 arg2Of glycans,of
R531 T534 T533 arg1Of role,The
R53132 T38405 T68682 arg1Of conformation,“up”
R53136 T82813 T96601 arg1Of regions,distinct
R532 T534 T535 arg1Of role,of
R533 T536 T535 arg2Of glycosylation,of
R534 T534 T537 arg1Of role,in
R53423 T82381 T13550 arg1Of is,","
R53466 T63653 T15633 arg1Of research,immunogen
R535 T538 T537 arg2Of camouflaging,in
R536 T541 T538 arg2Of epitopes,camouflaging
R53689 T43905 T48966 arg2Of signatures,of
R537 T541 T539 arg1Of epitopes,immunogenic
R5379 T86957 T99016 arg1Of pressure,selective
R538 T541 T540 arg1Of epitopes,protein
R539 T534 T542 arg1Of role,has
R540 T544 T542 arg2Of studied,has
R541 T534 T543 arg1Of role,been
R542 T544 T543 arg2Of studied,been
R543 T534 T544 arg2Of role,studied
R544 T544 T545 arg1Of studied,for
R54438 T74014 T37277 arg2Of sites,by
R5445 T93293 T28102 arg2Of 8,(
R5446 T24433 T62977 arg1Of observed,on
R54495 T11027 T55772 arg2Of S,In
R545 T547 T545 arg2Of coronaviruses,for
R54507 T9646 T39612 arg1Of surface,protein
R54515 T55820 T3218 arg1Of analysis,mass
R546 T547 T546 arg1Of coronaviruses,other
R547 T547 T548 arg1Of coronaviruses,(
R54708 T42207 T62553 arg1Of mapped,onto
R548 T550 T548 arg2Of ",",(
R549 T554 T548 arg3Of ),(
R550 T549 T550 arg1Of 10,","
R55019 T97849 T29321 arg1Of fucosylated,that
R551 T551 T550 arg2Of 13,","
R5519 T43425 T79720 arg1Of glycans,S
R552 T550 T552 arg1Of ",",","
R55220 T55820 T31548 arg2Of analysis,combined
R5525 T28926 T60521 arg2Of and,in
R55264 T87038 T93426 arg1Of component,the
R553 T553 T552 arg2Of 14,","
R55327 T19196 T92745 arg2Of component,form
R55359 T67731 T41284 arg3Of ),(
R5539 T69394 T26983 arg1Of %,52
R554 T555 T556 arg1Of Coronaviruses,form
R5541 T75961 T58978 arg2Of they,revealed
R55420 T98405 T31115 arg1Of and,may
R555 T557 T556 arg2Of virions,form
R55509 T91683 T14459 arg1Of and,","
R55522 T45140 T30606 arg1Of N1158,","
R55549 T27437 T5292 arg2Of sites,of
R556 T556 T558 arg1Of form,by
R55601 T83026 T78059 arg1Of sites,and
R557 T559 T558 arg2Of budding,by
R558 T555 T559 arg1Of Coronaviruses,budding
R55823 T28392 T98405 arg2Of GPC,and
R55839 T4213 T83039 arg1Of pool,the
R559 T559 T560 arg1Of budding,into
R55910 T63166 T85870 arg2Of spike,on
R55975 T66981 T84675 arg1Of as,such
R55994 T10998 T3350 arg1Of and,","
R560 T562 T560 arg2Of lumen,into
R56023 T24076 T21165 arg1Of one,of
R56034 T96095 T52753 arg3Of ),(
R561 T562 T561 arg1Of lumen,the
R562 T562 T563 arg1Of lumen,of
R56222 T38725 T99018 arg1Of glycosylated,and
R56244 T38725 T7350 arg1Of glycosylated,that
R563 T567 T563 arg2Of compartments,of
R56384 T6638 T70492 arg2Of resolved,were
R564 T567 T564 arg1Of compartments,endoplasmic
R56483 T72397 T66450 arg2Of characterized,Whereas
R565 T567 T565 arg1Of compartments,reticulum–Golgi
R56504 T26717 T27044 arg1Of SARS-CoV-1,or
R566 T567 T566 arg1Of compartments,intermediate
R56628 T81826 T39766 arg1Of Fig.,4
R56659 T21633 T26837 arg1Of phenomenon,no
R567 T567 T568 arg1Of compartments,(
R56700 T68062 T84121 arg1Of quantifications,are
R568 T569 T568 arg2Of 15,(
R56838 T77469 T62347 arg1Of sites,binding
R569 T572 T568 arg3Of ),(
R570 T569 T570 arg1Of 15,","
R571 T571 T570 arg2Of 16,","
R57157 T57413 T92867 arg1Of be,also
R57176 T14515 T9468 arg2Of S2,and
R572 T583 T573 arg1Of suggests,However
R57200 T40050 T99603 arg1Of measure,important
R57246 T56889 T61088 arg2Of syndrome,of
R573 T583 T574 arg1Of suggests,","
R57347 T62677 T81150 arg1Of sites,were
R574 T575 T576 arg1Of observations,of
R575 T578 T576 arg2Of glycans,of
R57502 T97849 T21442 arg1Of fucosylated,with
R57508 T93285 T78865 arg2Of S,of
R576 T578 T577 arg1Of glycans,complex-type
R577 T578 T579 arg1Of glycans,on
R57798 T62677 T60194 arg1Of sites,unoccupied
R578 T582 T579 arg2Of material,on
R5780 T28240 T58247 arg1Of 30,","
R57808 T26972 T77052 arg1Of occupancy,of
R579 T581 T580 arg1Of derived,virally
R580 T582 T581 arg1Of material,derived
R58029 T67675 T49489 arg2Of developed,As
R58047 T52064 T11584 arg1Of mapping,of
R5807 T26972 T58684 arg1Of occupancy,The
R58083 T40607 T84490 arg1Of one,least
R581 T575 T583 arg1Of observations,suggests
R58126 T16242 T46002 arg1Of maps,the
R58172 T51040 T68798 arg2Of structures,extended
R582 T589 T583 arg2Of subjected,suggests
R58253 T94527 T57498 arg1Of ",",","
R58257 T81639 T81382 arg2Of example,for
R583 T589 T584 arg1Of subjected,that
R5833 T63166 T37663 arg1Of spike,SARS-CoV-2
R58330 T91220 T30763 arg2Of structure,Using
R584 T587 T585 arg1Of glycoproteins,the
R58434 T93693 T36895 arg1Of density,glycan
R585 T587 T586 arg1Of glycoproteins,viral
R58591 T76134 T62423 arg1Of processing,of
R586 T587 T588 arg1Of glycoproteins,are
R58603 T86047 T67493 arg1Of one,is
R58654 T33313 T91683 arg2Of GPC,and
R58686 T38725 T25953 arg1Of glycosylated,densely
R587 T589 T588 arg2Of subjected,are
R588 T587 T589 arg2Of glycoproteins,subjected
R58845 T2806 T25038 arg1Of processes,manufacturing
R589 T589 T590 arg1Of subjected,to
R58977 T1898 T37277 arg1Of generated,by
R590 T593 T590 arg2Of enzymes,to
R591 T593 T591 arg1Of enzymes,Golgi-resident
R59123 T2545 T9247 arg3Of and,colored
R59127 T33433 T17042 arg1Of holes,the
R592 T593 T592 arg1Of enzymes,processing
R59274 T19195 T38925 arg2Of 33,","
R59298 T99893 T24785 arg2Of be,will
R593 T593 T594 arg1Of enzymes,(
R594 T595 T594 arg2Of 13,(
R595 T598 T594 arg3Of ),(
R596 T595 T596 arg1Of 13,","
R5963 T92543 T48018 arg1Of related,more
R59661 T6736 T70311 arg1Of structure,and
R5969 T92160 T49931 arg1Of glycan,exemplified
R597 T597 T596 arg2Of 17,","
R59712 T98047 T36877 arg1Of represented,with
R59769 T75042 T31080 arg1Of RBDs,the
R59798 T14769 T78729 arg2Of glycans,colored
R598 T602 T599 arg1Of density,High
R599 T602 T600 arg1Of density,viral
R59944 T77775 T40283 arg1Of GPC,LASV
R600 T602 T601 arg1Of density,glycan
R601 T602 T603 arg1Of density,and
R60142 T64679 T75704 arg1Of clusters,mannose-type
R602 T606 T603 arg2Of architecture,and
R603 T606 T604 arg1Of architecture,local
R604 T606 T605 arg1Of architecture,protein
R605 T603 T607 arg1Of and,can
R60516 T52029 T21165 arg2Of areas,of
R606 T609 T607 arg2Of impair,can
R60693 T33433 T33097 arg1Of holes,be
R607 T609 T608 arg1Of impair,sterically
R608 T603 T609 arg1Of and,impair
R60849 T91220 T42306 arg1Of structure,cryo-EM
R609 T613 T609 arg2Of pathway,impair
R60900 T64589 T78059 arg2Of rates,and
R60934 T44859 T25244 arg1Of beneficial,for
R610 T613 T610 arg1Of pathway,the
R611 T613 T611 arg1Of pathway,glycan
R61177 T27437 T70689 arg1Of sites,receptor
R612 T613 T612 arg1Of pathway,maturation
R613 T616 T614 arg1Of maturation,Impaired
R61306 T54690 T89375 arg1Of sites,binding
R614 T616 T615 arg1Of maturation,glycan
R61414 T97863 T31844 arg2Of S,","
R61424 T16812 T28102 arg1Of Env,(
R61486 T76680 T71277 arg1Of modeled,onto
R615 T616 T617 arg1Of maturation,resulting
R616 T617 T618 arg1Of resulting,in
R61604 T54945 T99697 arg1Of is,","
R61619 T78772 T97187 arg2Of 13,","
R61644 T9150 T97663 arg1Of glycosylation,O-linked
R61667 T35997 T85354 arg1Of surface,the
R617 T620 T618 arg2Of presence,in
R61739 T61533 T34380 arg1Of glycoproteins,typical
R618 T620 T619 arg1Of presence,the
R61880 T92146 T16557 arg2Of cells,from
R619 T620 T621 arg1Of presence,of
R6191 T78311 T82646 arg2Of key,to
R620 T623 T621 arg2Of glycans,of
R62000 T17500 T69994 arg2Of protein,of
R621 T623 T622 arg1Of glycans,oligomannose-type
R622 T616 T624 arg1Of maturation,can
R623 T625 T624 arg2Of be,can
R62328 T21633 T36825 arg1Of phenomenon,such
R624 T616 T625 arg1Of maturation,be
R62424 T23470 T35429 arg1Of system,influenced
R625 T628 T625 arg2Of reporter,be
R626 T628 T626 arg1Of reporter,a
R62692 T71732 T69406 arg1Of quality,antigen
R62699 T57703 T38925 arg1Of 32,","
R627 T628 T627 arg1Of reporter,sensitive
R62788 T50925 T99323 arg1Of rendered,with
R628 T628 T629 arg1Of reporter,of
R629 T632 T629 arg2Of architecture,of
R62994 T85027 T41284 arg1Of S,(
R62995 T36301 T12029 arg2Of fig,and
R62999 T65282 T76324 arg1Of content,oligomannose
R630 T632 T630 arg1Of architecture,native-like
R63012 T12029 T40607 arg1Of and,one
R63094 T48018 T64666 arg1Of more,much
R631 T632 T631 arg1Of architecture,protein
R63130 T91220 T77178 arg1Of structure,(
R632 T632 T633 arg1Of architecture,(
R63222 T53787 T67051 arg1Of subunits,are
R633 T634 T633 arg2Of 8,(
R634 T635 T633 arg3Of ),(
R635 T637 T636 arg1Of and,","
R63517 T85483 T4647 arg1Of antibodies,recognized
R636 T625 T637 arg1Of be,and
R63677 T34505 T5639 arg1Of loops,the
R637 T643 T637 arg2Of used,and
R63715 T51462 T35615 arg1Of glycans,N-linked
R63787 T98432 T37332 arg2Of observed,as
R63790 T74120 T94729 arg1Of benchmark,a
R638 T640 T638 arg1Of analysis,site-specific
R63820 T5111 T66085 arg1Of sites,N-linked
R63823 T21690 T37516 arg2Of vaccines,of
R63825 T54872 T62513 arg1Of sites,(
R63887 T54945 T34295 arg1Of is,","
R63894 T44859 T83078 arg2Of beneficial,be
R639 T640 T639 arg1Of analysis,glycan
R63972 T69540 T82832 arg1Of These,were
R63997 T28069 T2545 arg1Of light,and
R640 T640 T641 arg1Of analysis,can
R64017 T3324 T48261 arg1Of domain,is
R64055 T48495 T59621 arg1Of contain,that
R64074 T81523 T87200 arg2Of those,observed
R641 T643 T641 arg2Of used,can
R6410 T70317 T20120 arg1Of glycans,complex-type
R64132 T80673 T82169 arg2Of 6VSB,[
R642 T640 T642 arg1Of analysis,be
R64251 T93436 T94836 arg1Of modifications,be
R643 T643 T642 arg2Of used,be
R64311 T62820 T54945 arg2Of consideration,is
R64365 T31844 T3138 arg2Of ",",to
R644 T640 T643 arg2Of analysis,used
R64442 T35429 T43397 arg1Of influenced,heavily
R645 T645 T643 arg3Of compare,used
R64521 T96850 T16706 arg1Of 21,","
R646 T645 T644 arg1Of compare,to
R647 T640 T645 arg1Of analysis,compare
R648 T648 T645 arg2Of and,compare
R64838 T67493 T28276 arg1Of is,For
R64896 T91709 T64071 arg1Of status,of
R649 T647 T646 arg1Of immunogens,different
R64908 T34505 T6303 arg2Of loops,mapped
R64997 T9689 T82832 arg2Of determined,were
R650 T647 T648 arg1Of immunogens,and
R651 T651 T648 arg2Of processes,and
R65174 T80203 T15079 arg2Of strains,in
R652 T651 T649 arg1Of processes,monitor
R653 T651 T650 arg1Of processes,manufacturing
R65315 T93802 T87665 arg1Of structure,of
R65330 T57703 T24812 arg2Of 32,(
R65364 T68767 T79525 arg2Of 10,(
R654 T651 T652 arg1Of processes,(
R65477 T72733 T59592 arg1Of spike,SARS-CoV-2
R655 T653 T652 arg2Of 18,(
R65536 T91299 T96446 arg3Of ),(
R65543 T65172 T45914 arg1Of cell,producer
R656 T654 T652 arg3Of ),(
R65618 T54690 T5747 arg1Of sites,the
R657 T659 T655 arg1Of influence,Additionally
R65732 T55200 T20466 arg1Of sequons,glycan
R65787 T63904 T43342 arg2Of Last,understand
R658 T659 T656 arg1Of influence,","
R6582 T5772 T67488 arg1Of GPC,and
R65894 T58633 T79087 arg1Of is,and
R659 T657 T658 arg1Of glycosylation,can
R660 T659 T658 arg2Of influence,can
R66041 T69070 T14515 arg1Of subunits,S2
R66046 T61332 T16287 arg1Of shields,feature
R66091 T16362 T28276 arg2Of example,For
R661 T657 T659 arg1Of glycosylation,influence
R66137 T59746 T2105 arg1Of proteins,SARS-CoV-2
R662 T661 T659 arg2Of trafficking,influence
R66208 T38967 T21137 arg3Of ),(
R66210 T79926 T48513 arg1Of profiling,will
R663 T661 T660 arg1Of trafficking,the
R66332 T85904 T42509 arg2Of Env,of
R664 T661 T662 arg1Of trafficking,of
R66425 T4900 T51156 arg1Of N165,","
R665 T664 T662 arg2Of immunogen,of
R66533 T24822 T31780 arg1Of system,expression
R66598 T7141 T87881 arg2Of GPC,from
R666 T664 T663 arg1Of immunogen,recombinant
R66613 T43282 T94196 arg1Of candidates,vaccine
R66682 T30911 T38431 arg3Of %,detected
R667 T664 T665 arg1Of immunogen,to
R66791 T63316 T45720 arg1Of proteins,spike
R668 T667 T665 arg2Of centers,to
R66806 T10589 T66781 arg1Of reside,N74
R66840 T88891 T64071 arg2Of mimetic,of
R669 T667 T666 arg1Of centers,germinal
R6692 T61183 T49590 arg2Of glycoproteins,of
R670 T667 T668 arg1Of centers,(
R67093 T66124 T50945 arg1Of analysis,important
R671 T669 T668 arg2Of 19,(
R67111 T27322 T29601 arg3Of ),(
R672 T670 T668 arg3Of ),(
R67259 T87423 T51599 modOf optimization,to
R673 T681 T671 arg1Of and,To
R67379 T38285 T16644 arg1Of loops,The
R674 T693 T671 modOf expressed,To
R67493 T7141 T17581 arg2Of GPC,derived
R675 T692 T672 arg1Of we,resolve
R676 T675 T672 arg2Of glycosylation,resolve
R677 T675 T673 arg1Of glycosylation,the
R67722 T89247 T62225 arg1Of shields,glycan
R678 T675 T674 arg1Of glycosylation,site-specific
R67850 T52029 T81527 arg1Of areas,(
R67896 T98047 T70266 arg1Of represented,","
R679 T675 T676 arg1Of glycosylation,of
R67953 T38285 T22152 arg1Of loops,flexible
R680 T680 T676 arg2Of protein,of
R6800 T31805 T7918 arg1Of S4,)
R68061 T18108 T16991 arg1Of conformation,“down”
R681 T680 T677 arg1Of protein,the
R68155 T34986 T28105 arg3Of camouflage,use
R68158 T26331 T40649 arg1Of coronaviruses,other
R68196 T55778 T98726 arg2Of S,","
R682 T680 T678 arg1Of protein,SARS-CoV-2
R68250 T54690 T28529 arg2Of sites,of
R683 T680 T679 arg1Of protein,S
R684 T672 T681 arg1Of resolve,and
R68495 T14271 T92598 arg1Of be,to
R685 T682 T681 arg2Of visualize,and
R686 T692 T682 arg1Of we,visualize
R68613 T6552 T24386 arg2Of S2,and
R6867 T16242 T39395 arg2Of maps,in
R687 T684 T682 arg2Of distribution,visualize
R68764 T88152 T57960 arg1Of shown,In
R688 T684 T683 arg1Of distribution,the
R689 T684 T685 arg1Of distribution,of
R68944 T6736 T83467 arg1Of structure,protein
R68974 T91220 T82169 arg1Of structure,[
R690 T686 T685 arg2Of glycoforms,of
R69032 T5233 T6430 arg1Of require,not
R69077 T16287 T90671 arg1Of feature,","
R691 T684 T687 arg1Of distribution,across
R69151 T16812 T7671 arg1Of Env,HIV-1
R69179 T87754 T53002 arg1Of protected,likely
R692 T690 T687 arg2Of surface,across
R69248 T57734 T80185 arg1Of constraints,of
R693 T690 T688 arg1Of surface,the
R69324 T77913 T88650 arg1Of East,Middle
R694 T690 T689 arg1Of surface,protein
R69441 T44595 T53360 arg2Of T323/S325,(
R69478 T75833 T66901 arg1Of glycans,oligomannose-type
R695 T693 T691 arg1Of expressed,","
R696 T692 T693 arg1Of we,expressed
R69651 T51132 T43289 arg2Of observed,been
R69688 T9247 T98176 arg1Of colored,respectively
R697 T698 T693 arg2Of replicates,expressed
R69704 T10341 T77141 arg3Of ),(
R698 T698 T694 arg1Of replicates,and
R69825 T59932 T12181 arg1Of especially,when
R69896 T69656 T92081 arg2Of 10,(
R699 T698 T695 arg2Of replicates,purified
R69932 T77436 T58170 arg1Of conserved,and
R700 T698 T696 arg1Of replicates,three
R70010 T59746 T85295 arg2Of proteins,for
R701 T698 T697 arg1Of replicates,biological
R702 T698 T699 arg1Of replicates,of
R70201 T83900 T39084 arg1Of manufacture,the
R70216 T65172 T25582 arg1Of cell,the
R703 T702 T699 arg2Of material,of
R70350 T55177 T90837 arg1Of structures,the
R704 T702 T700 arg1Of material,recombinant
R70404 T85605 T39591 arg1Of clusters,induce
R705 T702 T701 arg1Of material,soluble
R706 T693 T703 arg1Of expressed,in
R70625 T20514 T91101 arg1Of %,contain
R707 T706 T703 arg2Of manner,in
R70719 T59820 T43488 arg1Of epitopes,distracting
R70766 T67545 T92081 arg3Of ),(
R708 T706 T704 arg1Of manner,an
R709 T706 T705 arg1Of manner,identical
R70963 T67334 T67436 arg1Of is,that
R710 T693 T707 arg1Of expressed,to
R71033 T5111 T7279 arg1Of sites,22
R711 T708 T707 arg2Of that,to
R712 T708 T709 arg1Of that,which
R713 T708 T710 arg1Of that,was
R714 T711 T710 arg2Of used,was
R71419 T20514 T85194 arg1Of %,15
R715 T708 T711 arg2Of that,used
R71528 T89594 T71501 arg3Of ),(
R71564 T65282 T74210 arg2Of content,to
R71566 T30429 T62941 arg1Of S,SARS-CoV-2
R716 T713 T711 arg3Of obtain,used
R71623 T14487 T9711 arg2Of 29,","
R717 T713 T712 arg1Of obtain,to
R71740 T25149 T12694 arg1Of sites,glycan
R718 T708 T713 arg1Of that,obtain
R71839 T89247 T85384 arg2Of shields,of
R71873 T19380 T43467 arg2Of S,of
R719 T721 T713 arg2Of structure,obtain
R71973 T7521 T79250 arg2Of glycoproteins,expressed
R720 T721 T714 arg1Of structure,the
R72049 T59318 T93001 arg1Of levels,trace
R721 T717 T715 arg1Of microscopy,high-resolution
R722 T717 T716 arg1Of microscopy,cryo–electron
R72200 T63886 T86967 arg1Of glycans,the
R72236 T54543 T27723 arg1Of ~60,%
R72239 T20226 T63349 arg2Of kits,of
R72243 T67334 T27983 arg1Of is,when
R723 T721 T717 arg1Of structure,microscopy
R724 T717 T718 arg1Of microscopy,(
R72478 T5111 T33257 arg1Of sites,the
R725 T719 T718 arg2Of cryo-EM,(
R72516 T46370 T90817 arg1Of protein,S
R72543 T66124 T20755 arg1Of analysis,their
R72575 T11374 T32961 arg2Of contrast,in
R726 T720 T718 arg3Of ),(
R72604 T38431 T44884 arg1Of detected,","
R72689 T19196 T48286 arg1Of component,of
R727 T711 T722 arg1Of used,","
R72775 T6638 T19707 arg1Of resolved,not
R728 T724 T723 arg1Of without,albeit
R72833 T78019 T41689 arg1Of table,(
R72847 T40589 T52753 arg2Of S2,(
R729 T711 T724 arg1Of used,without
R72926 T53142 T8601 arg1Of glycans,oligomannose-type
R730 T727 T724 arg2Of blockade,without
R73043 T64589 T72670 arg1Of rates,low
R73052 T57577 T68235 arg1Of levels,independent
R731 T727 T725 arg1Of blockade,a
R732 T727 T726 arg1Of blockade,glycan-processing
R73293 T70291 T50448 arg1Of clusters,(
R733 T727 T728 arg1Of blockade,using
R734 T729 T728 arg2Of kifunensine,using
R73463 T33313 T68781 arg1Of GPC,(
R735 T729 T730 arg1Of kifunensine,(
R73524 T30840 T45153 arg1Of glycans,that
R736 T731 T730 arg2Of 4,(
R73624 T80553 T99323 arg2Of representation,with
R737 T732 T730 arg3Of ),(
R73752 T62172 T67488 arg2Of Env,and
R738 T734 T733 arg1Of variant,This
R73848 T23189 T40587 arg2Of glycans,of
R73862 T42207 T51300 arg1Of mapped,","
R739 T734 T735 arg1Of variant,of
R73912 T59365 T24433 arg2Of content,observed
R740 T738 T735 arg2Of protein,of
R741 T738 T736 arg1Of protein,the
R74106 T19457 T59932 arg1Of observed,especially
R7415 T75833 T82020 arg2Of glycans,exhibits
R742 T738 T737 arg1Of protein,S
R74257 T62820 T67133 arg1Of consideration,important
R743 T734 T739 arg1Of variant,contains
R74378 T92160 T43296 arg1Of glycan,the
R744 T742 T739 arg2Of glycans,contains
R74427 T50255 T57185 arg1Of spike,a
R74469 T16371 T93088 arg1Of were,and
R74487 T78019 T95450 arg1Of table,residue
R745 T741 T740 arg1Of 22,all
R74524 T66124 T24785 arg1Of analysis,will
R74584 T38290 T31132 arg1Of minor,very
R746 T742 T741 arg1Of glycans,22
R74655 T94953 T51038 arg1Of structure,native-like
R74659 T51427 T30307 arg1Of feature,a
R747 T739 T743 arg1Of contains,on
R74703 T22100 T57063 arg1Of Env,(
R74763 T12029 T91101 arg2Of and,contain
R748 T747 T743 arg2Of protein,on
R74821 T51040 T49458 arg1Of structures,flexible
R749 T747 T744 arg1Of protein,the
R74959 T55820 T90727 arg1Of analysis,This
R74989 T20092 T41284 arg2Of 10,(
R74995 T92160 T9232 arg1Of glycan,N234
R750 T747 T745 arg1Of protein,SARS-CoV-2
R75058 T99893 T69841 modOf be,to
R751 T747 T746 arg1Of protein,S
R75177 T46370 T49742 arg1Of protein,is
R75194 T58449 T63470 arg1Of Shielding,by
R752 T747 T748 arg1Of protein,(
R75227 T92543 T5056 arg1Of related,to
R753 T750 T748 arg2Of 1A,(
R754 T751 T748 arg3Of ),(
R75429 T85605 T89951 arg1Of clusters,glycan
R755 T750 T749 arg1Of 1A,Fig.
R75515 T42144 T48798 arg1Of detected,on
R7558 T89974 T54305 arg1Of analysis,site-specific
R75586 T35249 T68781 arg3Of ),(
R756 T752 T753 arg1Of Stabilization,of
R757 T757 T753 arg2Of structure,of
R75744 T36507 T88396 arg1Of Bank,Data
R75763 T93436 T89016 arg1Of modifications,Glycan
R758 T757 T754 arg1Of structure,the
R75808 T64679 T72397 arg2Of clusters,characterized
R759 T757 T755 arg1Of structure,trimeric
R760 T757 T756 arg1Of structure,prefusion
R761 T752 T758 arg1Of Stabilization,was
R76155 T13791 T83637 arg1Of mechanisms,delivery
R762 T759 T758 arg2Of achieved,was
R76217 T58449 T28529 arg1Of Shielding,of
R76241 T94966 T13056 arg2Of conformation,in
R763 T752 T759 arg2Of Stabilization,achieved
R76302 T38431 T47554 arg1Of detected,","
R7632 T47025 T75209 arg3Of ),(
R764 T759 T760 arg1Of achieved,by
R76411 T17500 T71591 arg1Of protein,the
R76475 T29563 T12944 arg1Of glycoproteins,including
R76485 T3335 T72545 arg2Of 36,(
R765 T761 T760 arg2Of using,by
R76501 T31718 T70492 arg1Of terminus,were
R76519 T58978 T71519 arg1Of revealed,when
R766 T765 T761 arg2Of mutations,using
R76634 T92160 T5394 arg1Of glycan,is
R7666 T89974 T24686 arg2Of analysis,reported
R76661 T92543 T37436 arg2Of related,are
R767 T765 T762 arg1Of mutations,the
R76705 T84329 T21494 arg1Of characteristic,of
R768 T765 T763 arg1Of mutations,2P
R76881 T66377 T59113 arg1Of This,suggests
R769 T765 T764 arg1Of mutations,stabilizing
R76938 T75961 T6297 arg1Of they,were
R76995 T91383 T80652 arg1Of dispersion,of
R770 T765 T766 arg1Of mutations,(
R77054 T80673 T60839 arg1Of 6VSB,ID
R771 T767 T766 arg2Of 20,(
R77160 T97187 T77141 arg2Of ",",(
R77180 T88152 T27827 arg1Of shown,","
R772 T768 T766 arg3Of ),(
R77292 T93438 T97151 arg2Of comparing,for
R773 T761 T769 arg1Of using,at
R77353 T74575 T86628 arg1Of processing,of
R774 T793 T769 arg2Of and,at
R77433 T19875 T53360 arg1Of Thr323/Ser325,(
R775 T772 T770 arg1Of and,residues
R77591 T38431 T13997 arg1Of detected,with
R776 T771 T772 arg1Of 986,and
R77602 T43342 T66422 arg1Of understand,it
R7764 T75042 T28926 arg2Of RBDs,and
R77697 T92146 T39899 arg1Of cells,kidney
R777 T773 T772 arg2Of 987,and
R778 T772 T774 arg1Of and,","
R77823 T92216 T44071 arg1Of glycoprotein,SARS-CoV-2
R77893 T38335 T17632 arg1Of epitopes,of
R779 T780 T774 arg2Of substitution,","
R77975 T34862 T90463 arg1Of route,a
R77992 T65172 T93111 arg1Of cell,driven
R780 T780 T775 arg1Of substitution,a
R78032 T98405 T20621 arg1Of and,","
R78090 T79087 T51130 arg1Of and,that
R781 T780 T776 arg1Of substitution,GSAS
R78175 T20422 T79174 arg2Of Fig.,(
R782 T780 T777 arg1Of substitution,(
R78260 T91683 T57498 arg2Of and,","
R783 T778 T777 arg2Of Gly-Ser-Ala-Ser,(
R7830 T54872 T63470 arg2Of sites,by
R78332 T54872 T24684 arg1Of sites,proximal
R7837 T75961 T92745 arg1Of they,form
R784 T779 T777 arg3Of ),(
R78400 T30429 T97920 arg2Of S,left
R78469 T72397 T50872 arg2Of characterized,been
R78477 T93111 T72928 arg1Of driven,that
R785 T780 T781 arg1Of substitution,at
R78524 T75042 T78420 arg1Of RBDs,two
R78593 T58273 T28968 arg1Of demonstrated,for
R786 T785 T781 arg2Of site,at
R78656 T9711 T20094 arg2Of ",",(
R78666 T3324 T47142 arg1Of domain,the
R7869 T62387 T33174 arg2Of antibodies,of
R787 T785 T782 arg1Of site,the
R788 T785 T783 arg1Of site,furin
R78803 T97181 T58273 arg1Of We,demonstrated
R789 T785 T784 arg1Of site,cleavage
R790 T785 T786 arg1Of site,(
R7903 T51716 T39461 arg2Of trimers,as
R79085 T67488 T40154 arg2Of and,on
R791 T790 T786 arg2Of 685,(
R79137 T46370 T84608 arg1Of protein,the
R792 T791 T786 arg3Of ),(
R79288 T31718 T40506 arg1Of terminus,C
R793 T790 T787 arg1Of 685,residues
R79336 T92146 T80613 arg1Of cells,canine
R794 T790 T788 arg1Of 685,682
R79410 T59820 T82836 arg1Of epitopes,(
R79430 T98405 T35209 arg1Of and,which
R79488 T83900 T63349 arg1Of manufacture,of
R795 T790 T789 arg1Of 685,to
R79548 T53107 T90541 arg1Of be,how
R79598 T88152 T97350 arg2Of shown,been
R796 T793 T792 arg1Of and,","
R79682 T22100 T22015 arg1Of Env,HIV-1
R79690 T61867 T96313 arg2Of cells,in
R797 T772 T793 arg1Of and,and
R798 T797 T793 arg2Of motif,and
R799 T797 T794 arg1Of motif,a
R79932 T24822 T82363 arg2Of system,of
R79975 T86047 T49490 arg1Of one,of
R800 T797 T795 arg1Of motif,C-terminal
R80016 T4213 T48286 arg2Of pool,of
R801 T797 T796 arg1Of motif,trimerization
R802 T798 T799 arg1Of This,helps
R80213 T94803 T17632 arg2Of antibodies,of
R80250 T3133 T62450 arg2Of and,affect
R803 T801 T799 arg2Of maintain,helps
R804 T801 T800 arg1Of maintain,to
R80432 T40708 T53028 arg1Of analysis,Our
R805 T798 T801 arg1Of This,maintain
R80570 T68062 T71346 arg1Of quantifications,glycan
R80574 T80869 T68446 arg2Of and,between
R80578 T58978 T76331 arg1Of revealed,","
R806 T803 T801 arg2Of architecture,maintain
R80690 T92160 T94522 arg2Of glycan,by
R807 T803 T802 arg1Of architecture,quaternary
R80782 T30840 T39591 arg2Of glycans,induce
R808 T801 T804 arg1Of maintain,during
R80841 T75833 T67860 arg1Of glycans,(
R809 T806 T804 arg2Of processing,during
R80986 T69070 T56006 arg1Of subunits,S1
R810 T806 T805 arg1Of processing,glycan
R81036 T77469 T17041 arg1Of sites,receptor
R81091 T90262 T4794 arg1Of vulnerabilities,numerous
R811 T817 T807 arg1Of purified,Before
R81137 T9646 T98752 arg2Of surface,on
R81174 T95768 T24812 arg3Of ),(
R812 T808 T807 arg2Of analysis,Before
R81204 T59365 T73596 arg1Of content,glycan
R813 T817 T809 arg1Of purified,","
R814 T810 T811 arg1Of supernatant,containing
R81470 T59746 T82926 arg1Of proteins,S
R815 T815 T811 arg2Of S,containing
R81536 T56889 T59650 arg1Of syndrome,respiratory
R81579 T94966 T64170 arg1Of conformation,“down”
R816 T815 T812 arg1Of S,the
R81689 T63904 T97760 arg1Of Last,","
R817 T815 T813 arg1Of S,recombinant
R818 T815 T814 arg1Of S,SARS-CoV-2
R819 T810 T816 arg1Of supernatant,was
R820 T817 T816 arg2Of purified,was
R82019 T17607 T21636 arg1Of sites,these
R82041 T9353 T96733 arg2Of 4,(
R821 T821 T817 arg1Of chromatography,purified
R82168 T67675 T96948 arg2Of developed,are
R822 T810 T817 arg2Of supernatant,purified
R82269 T51038 T41179 arg2Of native-like,is
R823 T821 T818 arg2Of chromatography,by
R82323 T16242 T1686 arg1Of maps,cryo-EM
R82337 T38405 T28926 arg1Of conformation,and
R824 T821 T819 arg1Of chromatography,size
R82433 T51427 T12215 arg1Of feature,common
R8247 T92216 T96919 arg1Of glycoprotein,(
R82487 T55177 T87754 arg2Of structures,protected
R825 T821 T820 arg1Of chromatography,exclusion
R82531 T30840 T63554 arg1Of glycans,are
R82558 T87881 T91642 arg1Of from,apart
R826 T823 T822 arg1Of ensure,to
R827 T817 T822 modOf purified,to
R828 T810 T823 arg1Of supernatant,ensure
R829 T830 T823 arg2Of analyzed,ensure
R82933 T13056 T48261 arg2Of in,is
R830 T830 T824 arg1Of analyzed,that
R83042 T45292 T30606 arg2Of N1194,","
R831 T828 T825 arg1Of protein,only
R83112 T32198 T51599 arg1Of enhance,to
R832 T828 T826 arg1Of protein,native-like
R83284 T48675 T88152 arg3Of and,shown
R83295 T85027 T95927 arg1Of S,subunit
R833 T828 T827 arg1Of protein,trimeric
R83302 T85817 T61395 arg2Of N343,at
R83307 T99016 T12318 arg1Of selective,likely
R83339 T68235 T17100 arg1Of independent,largely
R834 T828 T829 arg1Of protein,was
R83498 T23600 T82531 arg1Of regions,their
R835 T830 T829 arg2Of analyzed,was
R836 T828 T830 arg2Of protein,analyzed
R83613 T82323 T61614 arg2Of glycans,by
R837 T834 T830 arg3Of and,analyzed
R83732 T64078 T60496 arg1Of characterized,at
R83745 T99410 T78943 arg1Of occlude,how
R83780 T2806 T70120 arg2Of processes,scaled
R83796 T74101 T43467 arg1Of shield,of
R838 T834 T831 arg1Of and,(
R83893 T79926 T12304 arg1Of profiling,Glycan
R839 T834 T832 arg1Of and,Fig.
R840 T833 T834 arg1Of 1B,and
R84018 T98195 T31844 arg1Of right,","
R84085 T62677 T42144 arg2Of sites,detected
R841 T835 T834 arg2Of fig,and
R84174 T22568 T81074 arg2Of accessibility,with
R84178 T20514 T72708 arg1Of %,of
R842 T836 T837 arg1Of S1,)
R84237 T88282 T99350 arg2Of that,but
R843 T840 T838 arg1Of conformation,The
R84320 T89772 T50448 arg3Of ),(
R84383 T39942 T14840 arg2Of N234,","
R844 T840 T839 arg1Of conformation,trimeric
R84426 T26508 T20657 arg1Of glycoproteins,their
R8445 T6571 T82188 arg1Of %,98
R84451 T48157 T46080 arg1Of domains,binding
R845 T840 T841 arg1Of conformation,of
R846 T844 T841 arg2Of material,of
R84605 T2105 T27044 arg2Of SARS-CoV-2,or
R84645 T25149 T43281 arg1Of sites,on
R84661 T98166 T19270 arg1Of Fig.,4
R84670 T77776 T77141 arg1Of S,(
R847 T844 T842 arg1Of material,the
R84760 T89974 T75148 arg1Of analysis,The
R84791 T10589 T13933 arg1Of reside,are
R848 T844 T843 arg2Of material,purified
R84895 T92216 T49295 arg1Of glycoprotein,trimeric
R849 T840 T845 arg1Of conformation,was
R84918 T10589 T64342 arg1Of reside,glycan
R850 T846 T845 arg2Of validated,was
R851 T840 T846 arg2Of conformation,validated
R85112 T43905 T84329 arg1Of signatures,characteristic
R85113 T10589 T98675 arg1Of reside,N149
R85172 T75042 T32013 arg1Of RBDs,other
R852 T846 T847 arg1Of validated,by
R85241 T94803 T52650 arg1Of antibodies,neutralizing
R85283 T2299 T31092 arg1Of elicitation,the
R853 T848 T847 arg2Of using,by
R85308 T74101 T58633 arg1Of shield,is
R85383 T74313 T62704 arg1Of colored,according
R854 T850 T848 arg2Of EM,using
R8540 T2299 T33174 arg1Of elicitation,of
R855 T850 T849 arg1Of EM,negative-stain
R856 T850 T851 arg1Of EM,(
R85618 T77469 T46469 arg1Of sites,are
R857 T853 T851 arg2Of 1C,(
R85769 T69070 T93048 arg2Of subunits,across
R858 T854 T851 arg3Of ),(
R8587 T63653 T57960 arg2Of research,In
R859 T853 T852 arg1Of 1C,Fig.
R85946 T21633 T72717 arg1Of phenomenon,has
R860 T857 T855 arg1Of Expression,Fig.
R861 T855 T856 arg1Of Fig.,1
R86101 T43282 T8477 arg1Of candidates,glycoprotein-based
R86137 T19457 T58513 arg2Of observed,be
R86159 T81444 T96919 arg2Of 6VSB,(
R86175 T12029 T78019 arg1Of and,table
R862 T857 T858 arg1Of Expression,and
R86230 T78311 T60233 arg1Of key,the
R86233 T34524 T46469 arg2Of highlighted,are
R863 T859 T858 arg2Of validation,and
R86311 T64589 T69365 arg1Of rates,of
R86337 T46370 T79579 arg1Of protein,SARS-CoV-2
R86373 T81444 T52860 arg1Of 6VSB,PDB
R864 T859 T860 arg1Of validation,of
R86403 T69540 T9689 arg2Of These,determined
R865 T864 T860 arg2Of glycoprotein,of
R86560 T74101 T44449 arg1Of shield,glycan
R866 T864 T861 arg1Of glycoprotein,the
R86637 T45562 T96677 arg1Of exhibits,throughout
R86689 T7521 T49353 arg1Of glycoproteins,were
R867 T864 T862 arg1Of glycoprotein,SARS-CoV-2
R86701 T39591 T81382 arg1Of induce,for
R86704 T33765 T82020 arg1Of Env,exhibits
R86709 T99018 T59113 arg2Of and,suggests
R86760 T65899 T67675 arg2Of number,developed
R86766 T31805 T49699 arg1Of S4,","
R868 T864 T863 arg1Of glycoprotein,S
R869 T869 T865 arg1Of representation,(
R870 T866 T865 arg2Of A,(
R87026 T6259 T97849 arg2Of N343,fucosylated
R871 T867 T865 arg3Of ),(
R872 T869 T868 arg1Of representation,Schematic
R87241 T22568 T27742 arg1Of accessibility,of
R873 T869 T870 arg1Of representation,of
R87348 T32249 T71501 arg2Of 3D,(
R87354 T80203 T84691 arg1Of strains,several
R874 T874 T870 arg2Of glycoprotein,of
R875 T874 T871 arg1Of glycoprotein,the
R876 T874 T872 arg1Of glycoprotein,SARS-CoV-2
R87634 T82813 T99410 arg2Of regions,occlude
R877 T874 T873 arg1Of glycoprotein,S
R87734 T48495 T61395 arg1Of contain,at
R87770 T85904 T9223 arg1Of Env,HIV-1
R87771 T13791 T62450 arg1Of mechanisms,affect
R878 T876 T875 arg1Of positions,The
R87842 T79738 T6972 arg2Of 24,","
R879 T876 T877 arg1Of positions,of
R87971 T53787 T28104 arg1Of subunits,The
R87998 T6257 T67334 arg2Of minimal,is
R880 T882 T877 arg2Of N-X-S/T,of
R88003 T30429 T10998 arg1Of S,and
R881 T882 T878 arg1Of N-X-S/T,N-linked
R88107 T51503 T48798 arg2Of S,on
R88183 T93230 T58633 arg2Of consistent,is
R882 T882 T879 arg1Of N-X-S/T,glycosylation
R88210 T93537 T60521 arg1Of RBD,in
R88214 T41460 T79525 arg3Of ),(
R88226 T63653 T42540 arg1Of research,HIV-1
R88232 T48261 T59932 arg2Of is,especially
R883 T882 T880 arg1Of N-X-S/T,sequons
R88363 T83026 T49272 arg1Of sites,receptor
R884 T882 T881 arg1Of N-X-S/T,(
R88469 T33433 T97350 arg1Of holes,been
R8849 T21690 T28720 arg1Of vaccines,nucleotide-based
R885 T882 T883 arg1Of N-X-S/T,","
R88506 T31718 T50724 arg1Of terminus,(
R88573 T58449 T58350 arg1Of Shielding,can
R88583 T68894 T9711 arg1Of 28,","
R886 T882 T884 arg1Of N-X-S/T,where
R887 T890 T884 arg2Of shown,where
R888 T887 T885 arg1Of P,X
R88890 T25572 T59944 arg1Of densely,most
R889 T887 T886 arg1Of P,≠
R88927 T78019 T62355 arg1Of table,acid
R890 T887 T888 arg1Of P,)
R8903 T4862 T67334 arg1Of glycosylation,is
R891 T887 T889 arg1Of P,are
R89181 T89247 T57188 arg1Of shields,viral
R89185 T21559 T34115 arg1Of %,28
R89197 T62291 T98166 arg1Of Underprocessing,Fig.
R892 T890 T889 arg2Of shown,are
R893 T887 T890 arg2Of P,shown
R89328 T91101 T26054 arg2Of contain,and
R894 T890 T891 arg1Of shown,as
R89401 T54945 T6640 arg1Of is,in
R89424 T29563 T50036 arg2Of glycoproteins,with
R89433 T85817 T96270 arg1Of N343,(
R89442 T19196 T38290 arg1Of component,minor
R8945 T58151 T30603 arg1Of folded,natively
R895 T892 T891 arg2Of branches,as
R89571 T61332 T26423 arg1Of shields,dense
R896 T876 T893 arg1Of positions,(
R89620 T53107 T20374 arg1Of be,","
R897 T902 T893 arg2Of ;,(
R898 T914 T893 arg3Of ),(
R89840 T97920 T47349 arg1Of left,","
R89854 T98405 T83078 arg1Of and,be
R89867 T28293 T82381 arg2Of lower,is
R89868 T31718 T35879 arg1Of terminus,membrane-proximal
R89878 T59383 T14995 arg2Of blue,in
R89898 T36047 T32889 arg1Of give,potentially
R899 T894 T895 arg1Of N,","
R900 T896 T895 arg2Of Asn,","
R901 T894 T897 arg1Of N,;
R90153 T81444 T6088 arg1Of 6VSB,ID
R902 T894 T898 arg1Of N,X
R90241 T64589 T95866 arg1Of rates,mutation
R903 T894 T899 arg1Of N,","
R90361 T6638 T39395 arg1Of resolved,in
R90363 T35997 T46834 arg2Of surface,across
R90386 T24433 T44252 arg2Of observed,Whereas
R904 T901 T899 arg2Of residue,","
R90416 T93088 T88282 arg2Of and,that
R90460 T27437 T8257 arg1Of sites,binding
R90484 T97863 T92081 arg1Of S,(
R905 T901 T900 arg1Of residue,any
R90513 T78019 T99043 arg1Of table,sialic
R906 T894 T902 arg1Of N,;
R907 T903 T902 arg2Of S,;
R908 T903 T904 arg1Of S,","
R909 T905 T904 arg2Of Ser,","
R90991 T93802 T71277 arg2Of structure,onto
R910 T902 T906 arg1Of ;,;
R911 T907 T906 arg2Of T,;
R91199 T9646 T93512 arg1Of surface,the
R912 T907 T908 arg1Of T,","
R91239 T71510 T81074 arg1Of consistent,with
R913 T909 T908 arg2Of Thr,","
R91387 T51553 T62513 arg3Of ),(
R914 T907 T910 arg1Of T,;
R915 T911 T910 arg2Of P,;
R9156 T59365 T99808 arg1Of content,(
R916 T911 T912 arg1Of P,","
R917 T913 T912 arg2Of Pro,","
R91727 T51040 T29601 arg1Of structures,(
R91754 T80553 T63195 arg1Of representation,surface
R918 T916 T915 arg1Of domains,Protein
R91813 T48675 T81834 arg1Of and,to
R91843 T98195 T98726 arg1Of right,","
R91853 T46382 T37628 arg1Of 99,over
R91862 T59318 T38431 arg2Of levels,detected
R919 T916 T917 arg1Of domains,are
R920 T918 T917 arg2Of illustrated,are
R921 T916 T918 arg2Of domains,illustrated
R9217 T55820 T68991 arg1Of analysis,reveals
R922 T918 T919 arg1Of illustrated,:
R923 T967 T919 arg2Of SDS–polyacrylamide,:
R92350 T39891 T79027 arg1Of lines,dashed
R924 T921 T920 arg1Of domain,N-terminal
R92411 T6571 T21442 arg2Of %,with
R9247 T93693 T72545 arg1Of density,(
R925 T921 T922 arg1Of domain,(
R92566 T17607 T16530 arg2Of sites,unmodified
R92569 T66239 T85946 arg1Of analysis,reveals
R92587 T91220 T13476 arg1Of structure,the
R926 T923 T922 arg2Of NTD,(
R927 T924 T922 arg3Of ),(
R92721 T93111 T99350 arg1Of driven,but
R92771 T94966 T67892 arg1Of conformation,the
R92789 T24076 T34986 arg2Of one,camouflage
R928 T921 T925 arg1Of domain,","
R92826 T67675 T96900 arg2Of developed,being
R92830 T55778 T65645 arg1Of S,MERS-CoV
R929 T928 T925 arg2Of domain,","
R92980 T62820 T38495 arg1Of consideration,an
R930 T928 T926 arg1Of domain,receptor
R931 T928 T927 arg1Of domain,binding
R93105 T51816 T6151 arg2Of defined,as
R93150 T67362 T96919 arg3Of ),(
R93169 T95927 T61088 arg1Of subunit,of
R932 T928 T929 arg1Of domain,(
R93240 T6571 T40587 arg1Of %,of
R9325 T31718 T6638 arg2Of terminus,resolved
R93288 T65899 T30681 arg1Of number,an
R933 T930 T929 arg2Of RBD,(
R93334 T77469 T34524 arg2Of sites,highlighted
R934 T931 T929 arg3Of ),(
R93426 T52029 T9973 arg1Of areas,the
R935 T925 T932 arg1Of ",",","
R93533 T21633 T51132 arg2Of phenomenon,observed
R936 T934 T932 arg2Of peptide,","
R937 T934 T933 arg1Of peptide,fusion
R93728 T57577 T92543 arg1Of levels,related
R9373 T62677 T7395 arg1Of sites,glycosylation
R938 T934 T935 arg1Of peptide,(
R9381 T74575 T11801 arg1Of processing,is
R93896 T34862 T40599 arg2Of route,offers
R939 T936 T935 arg2Of FP,(
R93934 T66124 T99893 arg1Of analysis,be
R940 T937 T935 arg3Of ),(
R941 T932 T938 arg1Of ",",","
R94186 T86889 T37332 arg1Of is,as
R942 T940 T938 arg2Of repeat,","
R9428 T40708 T61579 arg1Of analysis,of
R943 T940 T939 arg1Of repeat,heptad
R94368 T45140 T50724 arg2Of N1158,(
R944 T940 T941 arg1Of repeat,1
R94435 T80604 T6972 arg1Of 22,","
R94453 T43342 T53107 arg1Of understand,be
R945 T940 T942 arg1Of repeat,(
R94528 T85027 T38619 arg1Of S,–CoV
R946 T943 T942 arg2Of HR1,(
R94686 T56154 T67465 arg2Of particles,from
R947 T944 T942 arg3Of ),(
R948 T938 T945 arg1Of ",",","
R94877 T87038 T45604 arg1Of component,protein
R949 T958 T945 arg2Of and,","
R94916 T21482 T61137 arg2Of form,that
R94955 T45265 T64683 arg2Of glycans,of
R94995 T79250 T87881 arg1Of expressed,from
R950 T947 T946 arg1Of helix,central
R95083 T88430 T13997 arg2Of Last,with
R951 T947 T948 arg1Of helix,(
R95112 T70290 T29601 arg2Of and,(
R95180 T41179 T27983 arg2Of is,when
R95196 T94953 T41179 arg1Of structure,is
R952 T949 T948 arg2Of CH,(
R95278 T91670 T90831 arg2Of N1173,","
R953 T950 T948 arg3Of ),(
R954 T947 T951 arg1Of helix,","
R95409 T54690 T98568 arg1Of sites,receptor
R955 T953 T951 arg2Of domain,","
R95535 T58978 T65863 arg1Of revealed,Although
R95570 T82813 T46834 arg1Of regions,across
R956 T953 T952 arg1Of domain,connector
R95637 T66124 T47361 arg1Of analysis,detailed
R957 T953 T954 arg1Of domain,(
R958 T955 T954 arg2Of CD,(
R95805 T35429 T75195 arg2Of influenced,can
R959 T956 T954 arg3Of ),(
R95930 T65899 T82409 arg1Of number,of
R95938 T68062 T74313 arg2Of quantifications,colored
R9598 T93285 T61277 arg1Of S,SARS-CoV-2
R960 T958 T957 arg1Of and,","
R961 T951 T958 arg1Of ",",and
R962 T960 T958 arg2Of domain,and
R96248 T11374 T37781 arg1Of contrast,to
R963 T960 T959 arg1Of domain,transmembrane
R96396 T65899 T53669 arg1Of number,increasing
R964 T960 T961 arg1Of domain,(
R96457 T61238 T93438 arg2Of integrity,comparing
R965 T962 T961 arg2Of TM,(
R966 T963 T961 arg3Of ),(
R96622 T85485 T22182 arg1Of gray,dark
R96681 T86889 T76907 arg1Of is,","
R96699 T97555 T57063 arg3Of ),(
R967 T958 T964 arg1Of and,(
R96733 T57577 T37436 arg1Of levels,are
R96740 T53107 T36320 arg2Of be,will
R968 T965 T964 arg2Of B,(
R969 T966 T964 arg3Of ),(
R970 T938 T967 arg1Of ",",SDS–polyacrylamide
R971 T970 T967 arg2Of analysis,SDS–polyacrylamide
R97120 T55200 T61237 arg1Of sequons,N-linked
R97132 T85733 T83016 arg2Of shield,of
R97197 T4862 T16574 arg1Of glycosylation,O-linked
R972 T970 T968 arg1Of analysis,gel
R97275 T97849 T81525 arg2Of fucosylated,is
R97285 T50255 T94639 arg1Of spike,trimeric
R973 T970 T969 arg1Of analysis,electrophoresis
R97368 T70311 T5056 arg2Of and,to
R974 T970 T971 arg1Of analysis,of
R97496 T22568 T80516 arg1Of accessibility,steric
R975 T975 T971 arg2Of protein,of
R976 T975 T972 arg1Of protein,the
R97654 T93802 T42592 arg1Of structure,the
R97683 T58273 T55441 arg2Of demonstrated,have
R977 T975 T973 arg1Of protein,SARS-CoV-2
R97761 T63904 T65795 arg1Of Last,with
R978 T975 T974 arg1Of protein,S
R9781 T40374 T54540 arg1Of structure,three-dimensional
R97835 T77469 T98341 arg1Of sites,ACE2
R979 T975 T976 arg1Of protein,(
R97902 T24686 T87402 arg1Of reported,here
R97960 T72397 T67961 arg2Of characterized,have
R980 T977 T976 arg2Of indicated,(
R98005 T97920 T41336 arg1Of left,From
R98014 T28148 T28102 arg3Of ),(
R981 T981 T976 arg3Of ),(
R98113 T10017 T94082 arg2Of use,for
R982 T980 T977 arg1Of arrowhead,indicated
R98228 T77436 T11278 arg1Of conserved,most
R98287 T98432 T45593 arg1Of observed,on
R983 T980 T978 arg2Of arrowhead,by
R984 T980 T979 arg1Of arrowhead,the
R98441 T55177 T15204 arg1Of structures,oligomannose-type
R98454 T86957 T33505 arg2Of pressure,is
R98476 T39891 T92476 arg1Of lines,gray
R98481 T59113 T30140 arg1Of suggests,compared
R985 T970 T982 arg2Of analysis,expressed
R98500 T59791 T12029 arg1Of S2,and
R986 T982 T983 arg1Of expressed,in
R98656 T92745 T58978 arg3Of form,revealed
R987 T991 T983 arg2Of cells,in
R988 T991 T984 arg1Of cells,human
R98841 T40708 T49219 arg1Of analysis,offers
R98845 T61867 T83301 arg1Of cells,293F
R98864 T3133 T67741 arg1Of and,immunogen
R989 T991 T985 arg1Of cells,embryonic
R98909 T87754 T74449 arg1Of protected,","
R98924 T48597 T81527 arg3Of ),(
R98958 T81826 T50448 arg2Of Fig.,(
R990 T991 T986 arg1Of cells,kidney
R99060 T77775 T58688 arg2Of GPC,","
R991 T991 T987 arg1Of cells,(
R9917 T50925 T67051 arg2Of rendered,are
R99198 T27606 T82381 arg1Of it,is
R992 T988 T987 arg2Of HEK,(
R993 T989 T987 arg3Of ),(
R994 T991 T990 arg1Of cells,293F
R99442 T16812 T10998 arg2Of Env,and
R99448 T47203 T74018 arg2Of key,by
R995 T992 T993 arg1Of Lane,1
R996 T992 T994 arg1Of Lane,:
R99688 T4862 T6257 arg1Of glycosylation,minimal
R99698 T38285 T78889 arg1Of loops,which
R997 T996 T994 arg2Of supernatant,:
R99766 T69540 T14271 arg1Of These,be
R998 T996 T995 arg2Of supernatant,filtered
R99891 T43925 T28968 arg2Of glycosylation,for
R999 T996 T997 arg1Of supernatant,from
R99903 T70291 T21137 arg1Of clusters,(
R99911 T13027 T86628 arg2Of glycans,of